Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,microtubule motor activity (GO:0003777),0.9238954846349151,2.141695471694037,0.0,0.0,0.0,15/51,1.19%,KIF11;CENPE;KIF23;KIF15;KIF20B;KIF18B;KIF4A;KIF14;KIFC1;KIF22;KIF2C;DNAH8;KIF24;KIF18A;KIF20A
prerank,motor activity (GO:0003774),0.9034166498144987,2.1119821967145587,0.0,0.0,0.0,15/60,1.19%,KIF11;CENPE;KIF23;KIF15;KIF20B;KIF18B;KIF4A;KIF14;KIFC1;KIF22;KIF2C;DNAH8;KIF24;KIF18A;KIF20A
prerank,DNA secondary structure binding (GO:0000217),0.8713533878246617,1.9362942014801439,0.0,0.0015483505255644043,0.005,17/31,8.41%,NEIL3;RAD51AP1;GEN1;CLSPN;HMGB2;MEN1;HMGA1;BLM;RAD51B;RAD51C;HMGB3;MSH6;RBBP8;XRCC3;LIN54;HMGB1;RAD18
prerank,damaged DNA binding (GO:0003684),0.7879854434555649,1.8336897373955987,0.0,0.05504386118381458,0.175,18/44,9.42%,NEIL3;POLQ;HMGB2;RAD1;ERCC4;RPA2;XRCC1;SMC6;POLD1;RBBP8;FEN1;PCNA;DCLRE1C;DCLRE1B;HMGB1;RAD18;RPA1;ERCC3
prerank,four-way junction DNA binding (GO:0000400),0.8746525310151221,1.8053790066936188,0.0,0.0938300418492029,0.344,10/17,7.33%,GEN1;HMGB2;MEN1;BLM;RAD51B;RAD51C;HMGB3;MSH6;XRCC3;HMGB1
prerank,microtubule binding (GO:0008017),0.7460380874030583,1.8052054448431833,0.0,0.07819170154100243,0.344,48/222,6.10%,CENPE;NUSAP1;KIF23;TPX2;KIF15;DLGAP5;PRC1;KIF20B;KIF18B;KIF14;KIFC1;KIF22;BIRC5;KNSTRN;GTSE1;SKA1;KIF2C;FAM83D;RACGAP1;SKA2;KIF18A;CKAP5;KIF20A;SPAG5;CCSAP;PLK1;CDK5RAP2;TUBGCP6;UXT;CCDC88A;NDE1;REEP4;CCDC69;CEP44;EZR;SUN2;GAS2L3;CEP57L1;HAUS6;FBXW11;S100A9;ABRAXAS1;MAP4;CEP295;TUBGCP4;S100A8;CLASP1;CCDC88C
prerank,"DNA binding, bending (GO:0008301)",0.8907034484150332,1.767966512228137,0.001321003963011889,0.1439965988774896,0.563,4/14,3.80%,TOP2A;HMGB2;LEF1;HMGB3
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.6890869688690294,-1.7671355427683209,0.0,1.0,0.53,9/12,17.38%,ACVR1;TGFBR1;BMPR2;LTBP1;BMPR1B;ENG;TGFBR3;ACVRL1;TGFBR2
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.7107047484928379,-1.7642352942017125,0.006535947712418301,0.5493033226152196,0.537,7/10,17.58%,NSF;SQSTM1;GNAS;SHISA6;SHANK2;SHANK3;DLG4
prerank,single-stranded DNA binding (GO:0003697),0.7381054505997412,1.7581312649134802,0.00101010101010101,0.15212543913670273,0.623,39/93,14.58%,NEIL3;RAD51AP1;RAD51;MCM10;HMGB2;ERCC4;CDC45;RPA2;RADX;POLA1;BLM;BRCA2;RAD51B;DDX11;SMC6;MCM6;NUCKS1;MCM9;PMS2;RBBP8;HMGB1;TDP2;NABP2;RPA1;LONP1;PCBP2;PARK7;RAD23A;RTF1;FAM111A;DHX9;CTC1;TOP3A;TDP1;HNRNPU;REXO4;APTX;RAD52;RPA3
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.5842333591087869,-1.7234393090676576,0.009708737864077669,0.5537692032868882,0.689,9/18,17.38%,ACVR1;TGFBR1;BMPR2;LTBP1;BMPR1B;ENG;TGFBR3;ACVRL1;TGFBR2
prerank,sterol transfer activity (GO:0120015),-0.6001339694479642,-1.7152971024850783,0.008968609865470852,0.4471463022508038,0.708,7/17,13.32%,OSBPL2;ABCA1;PLTP;MTTP;OSBP;GRAMD1B;NPC2
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.8043287814201295,1.7114100814437403,0.012269938650306749,0.2898512183856565,0.868,9/21,7.09%,POLK;POLQ;POLE2;POLA1;POLE;POLD1;POLH;POLN;PRIMPOL
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.8009513494103314,1.7061248976054217,0.004914004914004914,0.2817688286422103,0.892,2/21,1.37%,CHRNB4;P2RX1
prerank,DNA polymerase activity (GO:0034061),0.8012658842273406,1.7058093364778202,0.012300123001230012,0.257335857348804,0.892,9/22,7.09%,POLK;POLQ;POLE2;POLA1;POLE;POLD1;POLH;POLN;PRIMPOL
prerank,ankyrin binding (GO:0030506),0.8310149757879233,1.698200543648957,0.00878293601003764,0.261206733662715,0.917,2/19,0.51%,SLC4A1;RHAG
prerank,BMP binding (GO:0036122),-0.6782560189167711,-1.696972976871597,0.007326007326007326,0.4204180064308682,0.76,3/11,12.60%,BMPR2;ENG;GREM2
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.7460251676489225,1.6967135782645333,0.0032967032967032967,0.24597334656889291,0.921,10/42,5.36%,CCNF;CCNB2;CKS2;CCNB1;CCNA2;CCNE1;CDKN2C;CCNE2;CCNYL1;CDKN2A
prerank,tubulin binding (GO:0015631),0.6992149736493545,1.6948976316670357,0.0,0.23417695734500496,0.925,53/296,6.10%,CENPE;NUSAP1;KIF23;TPX2;KIF15;DLGAP5;PRC1;KIF20B;KIF18B;KIF14;KIFC1;KIF22;BIRC5;GTSE1;SKA1;KIF2C;FAM83D;RACGAP1;SKA2;KIF18A;CKAP5;KIF20A;SPAG5;CCSAP;PLK1;CDK5RAP2;BRCA1;STMN1;TUBGCP6;AGBL1;BRCA2;UXT;CCDC88A;NDE1;FYN;REEP4;CCDC69;CEP44;EZR;SUN2;GAS2L3;CEP57L1;HAUS6;S100A9;ABRAXAS1;MAP4;CEP295;TUBGCP4;S100A8;CLASP1;CENPJ;AGTPBP1;CCDC88C
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.7987845619859175,1.6937885820061636,0.015037593984962405,0.22259087155513876,0.928,2/18,1.35%,HSD17B3;SRD5A2
prerank,lipoprotein particle binding (GO:0071813),-0.5400978941387372,-1.6930053682428032,0.005076142131979695,0.36195962843872814,0.772,9/20,18.05%,TREM2;LPL;HSPD1;PLTP;CDH13;STAB1;SCARB1;CD36;THBS1
prerank,kinesin binding (GO:0019894),0.767498132599035,1.6831562618139353,0.011723329425556858,0.24142655569862978,0.957,3/27,0.62%,PRC1;KIF18B;FAM83D
prerank,single-stranded DNA helicase activity (GO:0017116),0.8069849050677237,1.6754940343899527,0.017811704834605598,0.2520350337848129,0.964,10/19,11.45%,RAD51;PIF1;POLQ;DSCC1;MCM6;RFC5;HELQ;DNA2;RFC2;DHX9
prerank,DNA polymerase binding (GO:0070182),0.796136594779624,1.6650392356755006,0.01903553299492386,0.27235485744677873,0.974,9/18,9.55%,RAD51;FANCD2;SMG6;PCNA;RTEL1;HMGB1;SMARCA4;NABP2;LONP1
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.8397996529897328,1.6588984668477376,0.018361581920903956,0.27650280701263286,0.979,6/13,8.71%,GEN1;EXO1;SLX4;FEN1;DNA2;DNASE1L1
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.5803507485669421,-1.6555878020073607,0.03070175438596491,0.4224085132445261,0.861,9/15,28.12%,HS6ST3;NDST3;HS3ST4;HS3ST1;HS6ST2;HS3ST5;HS6ST1;NDST2;HS3ST3A1
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.5452187217898835,-1.640740527401821,0.01990049751243781,0.41448954983922826,0.89,10/20,22.61%,SLC39A11;SLC30A4;SLC39A7;SLC39A14;SLC39A8;SLC39A6;SLC39A12;SLC39A3;SLC39A1;SLC30A1
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.8512091938157135,1.6376839632912885,0.012587412587412588,0.3385313589094014,0.992,1/11,0.81%,CHRNB4
prerank,WW domain binding (GO:0050699),0.7529558943670038,1.6210413457033663,0.013969732246798603,0.38792816453355033,0.995,2/26,0.21%,KIF20B;CDC25C
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.8276653582396867,1.6207431777923003,0.031205673758865248,0.3714774429106381,0.995,1/11,0.03%,NEIL3
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.7842435416964407,1.6079032103579072,0.03303684879288437,0.40836062122059463,0.998,4/16,7.57%,NEIL3;CD38;SMUG1;NEIL1
prerank,cholesterol transfer activity (GO:0120020),-0.5752074025539246,-1.6062408289375167,0.021739130434782608,0.47889127069191373,0.945,6/16,13.32%,OSBPL2;ABCA1;PLTP;MTTP;GRAMD1B;NPC2
prerank,protein kinase C binding (GO:0005080),0.6995234590029396,1.596139517582933,0.020765027322404372,0.4385315776029784,0.999,10/43,14.69%,TOP2A;CCDC88A;PICK1;NELL2;ITGAV;PRKCB;NELL1;RACK1;IRS1;PRKCSH
prerank,ATP hydrolysis activity (GO:0140603),0.7006754510408358,1.5887462366355014,0.021087680355160933,0.4526509860456002,0.999,11/41,11.45%,KIF20B;KIF14;SMCHD1;CHD1L;ABCB10;ABCD1;DNA2;RUVBL2;TOR1A;RUVBL1;DHX9
prerank,glutamate receptor binding (GO:0035254),-0.5275800995454976,-1.586740997128022,0.02912621359223301,0.4927652733118971,0.962,8/17,17.58%,NSF;SQSTM1;SYNDIG1;GNAS;SHISA6;SHANK2;SHANK3;DLG4
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.7849567996826197,1.5789350836989464,0.034106412005457026,0.47615351777702897,0.999,1/15,0.36%,SLC4A1
prerank,symporter activity (GO:0015293),0.8221359606458555,1.5725754948669233,0.027972027972027972,0.48652614292179286,1.0,1/10,1.13%,SLC5A5
prerank,single-stranded telomeric DNA binding (GO:0043047),0.8117840595601274,1.571806151726027,0.021798365122615803,0.47236856640986624,1.0,9/11,18.52%,RPA2;TERF2;HNRNPA2B1;NABP2;TERF1;RPA1;CTC1;RAD50;HNRNPA1
prerank,palmitoyltransferase activity (GO:0016409),-0.4724457582954815,-1.570767709679763,0.029850746268656716,0.50228977881711,0.973,19/28,35.76%,GLUL;ZDHHC17;ZDHHC13;ZDHHC5;GOLGA7;ZDHHC8;YKT6;ZDHHC24;ZDHHC16;ZDHHC20;ZDHHC15;ZDHHC3;ZDHHC12;HHAT;ZDHHC4;ZDHHC23;ZDHHC22;ZDHHC1;GOLGA7B
prerank,DNA replication origin binding (GO:0003688),0.7490980015092752,1.569526101439868,0.027744270205066344,0.4651458544385204,1.0,8/23,5.34%,MCM10;CDC45;POLA1;DDX11;MCM6;ORC5;MCM9;ORC3
prerank,nucleosomal DNA binding (GO:0031492),0.7381508200561407,1.5609248271955443,0.039119804400977995,0.4842311433650118,1.0,11/21,11.77%,SMARCC2;MBD3;RCC1;SMARCD2;HNRNPC;MBD2;RBBP4;H3-3A;SMARCA4;SMARCC1;MTA2
prerank,protein kinase regulator activity (GO:0019887),0.6473373016984043,1.5589482534010666,0.005060728744939271,0.47730152556124394,1.0,13/95,6.07%,TPX2;CCNF;CCNB2;CCNB1;CCNA2;CCNE1;CCNE2;CCNYL1;STK11;GPRC5B;GMFG;FAF1;KIDINS220
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.6988529817861893,1.5520431271520632,0.04827586206896552,0.4904303517817403,1.0,7/28,8.22%,TTK;AURKB;AURKA;MAP2K6;MAPKAPK3;MAPK14;PRKACA
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.8252118366161514,1.551609025444153,0.04,0.47765206122274995,1.0,1/10,0.70%,SLC6A12
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.8126292877609398,1.5463209051639553,0.03424657534246575,0.48532591826602856,1.0,6/11,14.22%,PPP1R11;PPP1R8;PPP1R14A;PPP1R14C;PPP1R2;PABIR1
prerank,diacylglycerol kinase activity (GO:0004143),-0.6120825569775279,-1.54342128785167,0.04498269896193772,0.5528760271525545,0.992,7/11,13.69%,DGKH;DGKA;DGKI;DGKZ;AGK;DGKQ;DGKB
prerank,syntaxin binding (GO:0019905),-0.3778378172815589,-1.5428808210750953,0.0,0.5124082776815896,0.992,19/61,13.54%,NSF;SCFD2;STX6;PTPN2;STX16;ABCA1;VAMP1;NAPA;SNAP47;SYT1;TMED9;STXBP5L;VAMP2;VAMP8;SYT9;GOLGA2;RAB11A;UNC13A;STXBP5
prerank,acylglycerol lipase activity (GO:0047372),-0.6162799677414198,-1.5420243949558208,0.0576271186440678,0.478200122492727,0.992,6/11,19.30%,MGLL;ABHD12;ABHD16A;ABHD6;ABHD3;ABHD15
prerank,solute:anion antiporter activity (GO:0140323),0.7653771391481028,1.5364538719440572,0.04563758389261745,0.5122562878777276,1.0,1/14,0.36%,SLC4A1
prerank,lysophospholipase activity (GO:0004622),-0.5130698665583314,-1.5286626533854628,0.04975124378109453,0.487406216505895,0.993,7/20,15.43%,MGLL;ABHD12;ENPP2;GDE1;ABHD16A;PLA2G6;PNPLA7
prerank,microtubule plus-end binding (GO:0051010),0.7065825604942156,1.5148854398355627,0.06030150753768844,0.5945407959746386,1.0,6/20,6.92%,KNSTRN;KIF2C;KIF18A;FBXW11;CLASP1;MAPRE3
prerank,histone deacetylase binding (GO:0042826),0.6399871191631246,1.5095357877609,0.011178861788617886,0.6033043204582946,1.0,15/88,8.03%,TOP2A;HEY2;LEF1;IKZF3;USF1;RAD9A;SMG5;HDAC10;MTA3;RBBP4;GMNN;HDAC6;PKN2;CAMTA2;CIR1
prerank,low-density lipoprotein particle binding (GO:0030169),-0.5254699217248774,-1.503556915995484,0.06222222222222222,0.531802652733119,0.996,7/16,18.05%,TREM2;PLTP;CDH13;STAB1;SCARB1;CD36;THBS1
prerank,phospholipase activity (GO:0004620),-0.36436071172733997,-1.5011677075806065,0.0,0.5063520585082908,0.996,19/67,17.87%,MGLL;PLA2G15;LPL;ABHD12;PLCB2;ENPP2;GDE1;ABHD16A;ABHD6;PLCB4;PLBD2;PDIA3;ABHD3;PLA2G6;SMPDL3A;PNPLA7;LIPH;SEC23IP;GPLD1
prerank,gamma-tubulin binding (GO:0043015),0.705232479045705,1.49671030116592,0.0484472049689441,0.6473001610321379,1.0,7/22,7.93%,RACGAP1;CDK5RAP2;TUBGCP6;BRCA2;TUBGCP4;CENPJ;OFD1
prerank,magnesium ion binding (GO:0000287),0.6181405506472019,1.4958468099663713,0.004020100502512563,0.6350142816999368,1.0,24/135,8.91%,TOP2A;GEN1;PIF1;PLK1;STK26;OXSR1;MSH6;STK11;FEN1;DUT;IMPA1;SIK2;UBA2;EPHX2;PDE2A;STK38L;MAP3K5;GNAI1;TDP2;RP2;PPA2;STK38;MARK2;MAST2
prerank,telomeric DNA binding (GO:0042162),0.6762435715554344,1.4891168697286647,0.05625717566016074,0.6508646269262531,1.0,12/32,12.36%,PIF1;BLM;SMG6;SMG5;TERF2;UPF2;XRCC6;HNRNPA2B1;TERF1;RPA1;CTC1;APEX1
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.5391492536344964,-1.4886277711768914,0.07630522088353414,0.5126086697630106,0.999,6/14,10.62%,SPOCK1;TIMP2;SPOCK2;BST2;TIMP3;RECK
prerank,endodeoxyribonuclease activity (GO:0004520),0.704524202800154,1.4871484666657186,0.06565656565656566,0.6441440303523642,1.0,10/20,14.98%,ERCC4;EXO1;RBBP8;FEN1;MBD4;DCLRE1C;ZRANB3;DNA2;APEX1;RAD50
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.5527481264597086,-1.4835265328159237,0.08264462809917356,0.500789755739832,0.999,7/13,14.06%,PTPRJ;ERN1;ITGA5;PDGFD;PDGFC;ITGB3;VEGFA
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.686805470296805,1.4807315026198105,0.058333333333333334,0.657805661139426,1.0,2/27,1.13%,SLC4A1;SLC5A5
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.7660144683535788,1.4785178506718,0.060191518467852256,0.651819563110857,1.0,7/12,16.37%,CDK1;MAPK1;CDK6;BRD4;CDK19;CCNK;CDK8
prerank,telomerase RNA binding (GO:0070034),0.685480889243828,1.4698208202121013,0.0625,0.6779875053599808,1.0,13/22,20.46%,SMG6;NOP10;SMG5;HNRNPC;EXOSC10;DCP2;TEP1;HNRNPU;DKC1;WRAP53;XRN1;SNRPB;SMG7
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.5275095979035453,-1.4673916736516275,0.064,0.4964145358036033,0.999,8/16,11.21%,PTPRZ1;PTPRG;PTPN6;PTPRE;PTPRD;PTPRK;PTPRO;PTPRT
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.5275095979035453,-1.4673916736516275,0.064,0.4964145358036033,0.999,8/16,11.21%,PTPRZ1;PTPRG;PTPN6;PTPRE;PTPRD;PTPRK;PTPRO;PTPRT
prerank,Wnt-activated receptor activity (GO:0042813),-0.5100375994025448,-1.46067557738104,0.08056872037914692,0.49211975056026497,0.999,13/15,47.21%,RYK;FZD3;PKD1;TSPAN12;FZD7;FZD4;FZD6;FZD2;LRP5;FZD5;FZD8;FZD1;FZD10
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.7126746658690474,1.4559938645047317,0.07642487046632124,0.7324110879393116,1.0,5/18,11.30%,BIRC5;DPEP1;BIRC2;TNFAIP8;XIAP
prerank,chloride transmembrane transporter activity (GO:0015108),0.7186682314449793,1.444175313761068,0.07651006711409396,0.7777230050733867,1.0,1/16,0.36%,SLC4A1
prerank,DNA binding (GO:0003677),0.5937815806791101,1.4415762392641995,0.0,0.7740830206232324,1.0,170/694,15.03%,TOP2A;NEIL3;RAD51AP1;BRIP1;RAD51;CLSPN;E2F2;POLQ;MCM10;FOXA2;HMGB2;TIPIN;MEN1;RAD1;ERCC4;CDC45;SMC1B;BRCA1;NR4A2;EXO1;RPA2;HMGA1;SOX6;MBD3;RADX;POLA1;HEY2;BLM;GTF3C5;BRCA2;MYRFL;RPL7;LEF1;POLE;E2F1;SMARCA5;RAD51B;IKZF3;DDX11;PBX4;LIN9;RAD51C;BATF;ELK4;SMC6;MCM6;LIG4;BCLAF3;USF1;HMGB3;POLR2A;TIMELESS;TFPT;NUCKS1;POLD1;ERG;MSH6;MCM9;CTCF;PMS2;RBBP8;FEN1;PCNA;SLPI;ETS2;CGAS;ATAD5;MBD4;TAF1;FOXO1;FOXJ3;DCLRE1C;MBD1;TCF7L1;TCF3;ARID4A;SETX;MND1;PHF19;XRCC6;DCLRE1B;HMGB1;AHR;CAMTA2;ILF2;MAX;TDP2;PHF1;SMARCA4;PALB2;ZBTB16;DNA2;ZNF638;RLF;RAD18;DNASE1L1;GTF2A1;NABP2;TERF1;SNAPC3;ZBTB7A;EGFR;FLI1;ZNF148;RPA1;ERCC3;RPS27;LONP1;MECP2;SRRT;EGR1;ZBTB32;SPTY2D1;NR2C2;RFX2;DNMT1;NR2F2;KAT6A;PCBP2;PMS1;TSHZ1;CUX1;NFYC;PARK7;ARID5B;NFE2;RAD23A;RTF1;RFC1;SMAD4;ATF6;TAF6;FAM111A;DHX9;JUN;ATF5;CCNT1;FOXP2;CBFB;CTC1;APEX1;TOP3A;PDS5B;TDP1;ZBTB33;KIN;NFE2L2;ING2;HNRNPU;HIVEP2;REXO4;PRKDC;DDIT3;CEBPZ;PSIP1;CREBBP;MYC;CEBPG;BCL6;APTX;POU6F1;CHTF18;RAD52;CAMTA1;RPA3;E2F3;TP53;RAD50;JUNB;LRRFIP1
prerank,phospholipase A2 activity (GO:0004623),-0.4493616176138851,-1.4410260032133728,0.05555555555555555,0.5233235472296007,1.0,15/26,44.41%,PLA2G15;PLA2G7;ABHD3;PLA2G6;PLA2G4E;PLA2G12A;PLA2G4A;PLA2G3;PLA2G4C;PNPLA3;PNPLA8;PLAAT1;PLA2G5;PLA2G4F;PLA2G2D
prerank,protein phosphatase inhibitor activity (GO:0004864),0.6620975379698016,1.4390666911838332,0.0881316098707403,0.7711172704942124,1.0,8/26,14.22%,PPP1R9B;PPP1R11;PPP1R8;PPP1R14A;PPP1R14C;LMTK2;PPP1R2;PABIR1
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.6394862759391922,1.4277034489378497,0.05399325084364454,0.8135855235063638,1.0,8/34,7.56%,UBE2C;UBE2T;UBE2I;UBE2O;TAF1;UBE2Z;BIRC6;UBE2K
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.6462990342122739,1.4259328572934644,0.06422018348623854,0.8064552745391689,1.0,7/31,7.56%,UBE2C;UBE2T;UBE2O;TAF1;UBE2Z;BIRC6;UBE2K
prerank,GABA receptor activity (GO:0016917),-0.4525084816847189,-1.4245282469575964,0.06857142857142857,0.5484659699892819,1.0,9/21,14.67%,GABRB3;GABRG2;GABRG3;GABRA2;GABRA3;GABBR1;GABBR2;GABRG1;GABRA1
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.6476665147152096,1.421790861730208,0.06844547563805105,0.8119003679403655,1.0,9/30,11.30%,BIRC5;UBE2O;DPEP1;BIRC2;UBE2Z;BIRC6;TNFAIP8;PTTG1;XIAP
prerank,anion:anion antiporter activity (GO:0015301),0.6838694675698704,1.4213573695386645,0.11573472041612484,0.7984486348675889,1.0,1/17,0.36%,SLC4A1
prerank,acetylcholine receptor activity (GO:0015464),0.6724115680815372,1.420660535309536,0.08567931456548347,0.7867490376162195,1.0,1/22,0.81%,CHRNB4
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.6419999008867023,1.4189142739129124,0.09228971962616822,0.7812116557261559,1.0,15/29,22.50%,CIT;CDKN2C;CDKN2A;CIB1;PKIG;CDKN2D;KAT2B;SPRED2;PRKAG2;HEXIM1;CDKN1A;PRKAR2A;YWHAG;PKIA;CDKN1B
prerank,kinase binding (GO:0019900),0.5837969936396223,1.4185870761991282,0.0,0.7686124616212654,1.0,107/435,14.97%,KIF11;TPX2;PRC1;KIF14;CDC25C;AURKB;FOXM1;CIT;FAM83D;RACGAP1;BORA;CKS2;BARD1;CCNB1;CCNA2;KIF20A;PLK1;CDKN2C;CDK5RAP2;CNTLN;CHEK2;POLA1;CDC25A;EXOC2;ATG13;ARHGAP33;RB1;AURKA;CEP152;FBXO5;OXSR1;SGO1;TIAM1;FLNA;USF1;RAD9A;TBL2;MAP2K6;AXIN1;POLR2A;PTPN22;CEP192;RPS19;GPRC5B;TFRC;SP100;RPS7;CAV1;CDKN2A;PPP1CB;PPP2R5A;FAF1;GSN;CENPJ;TRADD;MYOM1;SLC12A7;RND3;KIZ;MAPRE3;CDC25B;MAP3K1;CEP250;CIR1;PRKACA;CLTC;IBTK;GRB2;PLCG2;LRRC14;JAK2;UBQLN1;EGFR;CDKN2D;CAV2;PPP1R15A;MSN;LRBA;PARK7;RAD23A;VRK1;PPP1CC;ATF5;BECN1;KAT2B;CRK;HNRNPA0;FAS;ADIPOR1;TRIM68;PRAM1;CDK5RAP3;SPRED2;RAC2;DGKD;ADD2;PRKAG2;LATS1;SKI;CASP9;TRIM5;GSK3B;PPP1R12A;CCNK;LIMS1;PDCD10;TP53
prerank,leucine zipper domain binding (GO:0043522),0.7403129459156503,1.4133781988520737,0.10248901903367497,0.7803354859446263,1.0,4/10,13.56%,PMF1;ERC1;PAWR;DDIT3
prerank,hormone receptor binding (GO:0051427),0.7039477056275437,1.409886354146007,0.1051912568306011,0.784589957369946,1.0,7/14,21.26%,NPPC;PTHLH;JAK2;SOCS2;ADCYAP1;NCOA6;TYK2
prerank,neuropeptide binding (GO:0042923),-0.49218477395743915,-1.404503223438893,0.09340659340659341,0.5816720257234727,1.0,8/18,40.91%,GPR149;SORL1;OPRL1;OPRK1;GPR37;OPRD1;SSTR2;NMUR2
prerank,protein kinase activator activity (GO:0030295),0.5987805694818874,1.3997826771000483,0.06910994764397906,0.8204282303786312,1.0,20/60,19.33%,TPX2;INCENP;DBF4;ERBB3;STK11;GPRC5B;MARK2;CAB39L;MLST8;FGF13;PRKAG2;FAM20A;STK4;MAP2K1;PAK2;CD24;IQGAP1;TAOK1;CDKN1A;STK3
prerank,water transmembrane transporter activity (GO:0005372),0.7322594546690337,1.3981262947137603,0.09724238026124818,0.814521603426316,1.0,1/11,1.86%,AQP1
prerank,kinase activator activity (GO:0019209),0.6384663918624814,1.3975401823131535,0.09952038369304557,0.8037487578204823,1.0,6/30,13.57%,TPX2;STK11;GPRC5B;MARK2;FGF13;PRKAG2
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.48940169886672513,-1.396623006073842,0.08530805687203792,0.5616589258068357,1.0,7/16,14.05%,ATP6V1B2;ATP6V1C1;ATP6V0D2;ATP6V0A1;ATP6V0B;TCIRG1;ATP6V1A
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.48940169886672513,-1.396623006073842,0.08530805687203792,0.5616589258068357,1.0,7/16,14.05%,ATP6V1B2;ATP6V1C1;ATP6V0D2;ATP6V0A1;ATP6V0B;TCIRG1;ATP6V1A
prerank,potassium ion leak channel activity (GO:0022841),-0.5068002084879771,-1.3908664927777794,0.10236220472440945,0.5562892359516154,1.0,4/15,5.70%,KCNK13;TMEM175;KCNK6;KCNK10
prerank,histone acetyltransferase binding (GO:0035035),0.6615469615958202,1.390628760485192,0.10787878787878788,0.8243976619605912,1.0,8/21,14.97%,KANSL1;PCNA;TAF7;KANSL1L;ZBTB7A;EGR1;TRIM68;TP53
prerank,protein kinase binding (GO:0019901),0.5704759644437748,1.3879517437248963,0.0,0.8253657290290073,1.0,108/480,14.97%,TOP2A;KIF11;TPX2;PRC1;KIF14;CDC25C;FOXM1;CIT;FAM83D;RACGAP1;BORA;CKS2;CCNB1;CCNA2;KIF20A;PLK1;CDKN2C;CDK5RAP2;CNTLN;CHEK2;POLA1;CDC25A;EXOC2;ATG13;ARHGAP33;AURKA;CEP152;FBXO5;CCDC88A;OXSR1;EZR;PPM1D;USF1;RAD9A;TBL2;MAP2K6;AXIN1;NEDD9;CEP192;RPS19;GPRC5B;MAPKAPK3;TFRC;RPS7;CAV1;BANK1;CDKN2A;PPP1CB;FAF1;ATF7;CENPJ;TCF3;SLC12A7;RND3;KIZ;MAPRE3;CDC25B;PIN1;MAP3K1;MAP4K2;CEP250;CIR1;PRKACA;CLTC;IBTK;GRB2;PLCG2;STK38;PICK1;NELL2;JAK2;ITGAV;CDKN2D;CAV2;PRR7;PPP1R15A;MAP3K11;MSN;LRBA;VRK1;PPP1CC;BECN1;KAT2B;CRK;HNRNPA0;PRKCB;ADIPOR1;TRIM68;PRAM1;CDK5RAP3;NELL1;RACK1;SPRED2;RAC2;ADD2;PRKAG2;LATS1;SKI;CASP9;TRIM5;IRS1;GSK3B;PPP1R12A;PRKCSH;CCNK;LIMS1;PDCD10;TP53
prerank,metallocarboxypeptidase activity (GO:0004181),0.640069950873547,1.3874337632516285,0.10247349823321555,0.8148452699203604,1.0,7/26,16.54%,AGBL1;CPA6;CPM;AGTPBP1;VASH2;AGBL3;CPD
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.7280416571614173,1.3790030722247613,0.1415929203539823,0.8443542503534089,1.0,7/10,22.50%,CDKN2C;CDKN2A;CDKN2D;KAT2B;HEXIM1;CDKN1A;CDKN1B
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.4294630646102954,-1.3716150253272463,0.09210526315789473,0.5880178881620283,1.0,15/24,35.76%,GLUL;ZDHHC17;GOLGA7;ZDHHC8;YKT6;ZDHHC24;ZDHHC20;ZDHHC15;ZDHHC3;ZDHHC12;ZDHHC4;ZDHHC23;ZDHHC22;ZDHHC1;GOLGA7B
prerank,FMN binding (GO:0010181),-0.5282857466618379,-1.3712004886453732,0.10431654676258993,0.5695784208645945,1.0,5/11,26.63%,POR;DUS2;MTRR;PPCDC;NDOR1
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.7167761462694667,1.365989500377284,0.13525179856115108,0.8970523604909934,1.0,1/11,1.86%,AQP1
prerank,phospholipid transfer activity (GO:0120014),-0.43724041474392267,-1.365030676789201,0.1,0.568578639836808,1.0,9/21,18.06%,OSBPL2;PLTP;PRELID2;MTTP;PITPNB;PLEKHA3;C2CD2L;PITPNM2;PRELID3A
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.7157318482808777,1.3647477254979692,0.13876967095851217,0.8898229711279944,1.0,6/10,12.36%,EXO1;POLD1;FEN1;DCLRE1C;DCLRE1B;APEX1
prerank,steroid hydroxylase activity (GO:0008395),0.65891013191339,1.3608979193219255,0.13430851063829788,0.8954688832072369,1.0,4/16,12.04%,CYP1B1;CYP2A6;CYP27A1;CYP46A1
prerank,secondary active transmembrane transporter activity (GO:0015291),0.5942298255155222,1.3588573190167366,0.10610932475884244,0.8921094791367356,1.0,12/51,14.28%,SLC4A1;SLC5A5;SLC35E1;SLC25A16;SLCO4C1;SLC35D2;SLC35A1;SLCO4A1;SLC16A10;SLCO2A1;MCU;SLC35C2
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.671027309546027,1.3484440279372716,0.14511873350923482,0.932564789588634,1.0,7/14,17.64%,USP27X;MINDY4;DESI2;USP15;OTUD5;YOD1;USP7
prerank,ubiquitin-specific protease binding (GO:1990381),0.6555903556491447,1.3483658551777147,0.15108834827144688,0.9196405827296559,1.0,12/19,17.78%,CLTC;SART3;DERL2;AMFR;PARK7;SUMO1;RAD23A;PTEN;SPATA2;RHBDD2;CHMP3;SYVN1
prerank,methyl-CpG binding (GO:0008327),0.6507875557128714,1.3454754433564153,0.13349514563106796,0.9218137565578503,1.0,7/22,12.72%,UHRF1;MBD3;MBD2;MBD1;LRWD1;MECP2;ZBTB33
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.4300617853621238,-1.3429566072715544,0.08552631578947369,0.6123559753483386,1.0,6/22,8.62%,ATP6V1B2;ATP6V1C1;ATP6V0D2;ATP6V0A1;ATP6V0B;TCIRG1
prerank,LRR domain binding (GO:0030275),0.6699211400431512,1.3423867015362,0.1489071038251366,0.9247523513933407,1.0,6/14,17.19%,PMF1;LRRFIP2;ERC1;PAWR;DDIT3;POLR2J
prerank,protein phosphatase 1 binding (GO:0008157),0.6474302908925764,1.341163452937228,0.13196125907990314,0.9182694289530836,1.0,4/21,9.87%,PHACTR4;PPP1R9B;PPP1R11;PPP1R15A
prerank,ubiquitin binding (GO:0043130),0.5693742703235253,1.3375717005552876,0.08444902162718847,0.9230721818365456,1.0,7/73,8.17%,TOP2A;CKS2;IKBKG;FAF1;NPLOC4;BIRC2;FAF2
prerank,double-stranded DNA binding (GO:0003690),0.5511659273381604,1.335632164558021,0.001,0.9205996752837767,1.0,116/531,19.49%,NEIL3;E2F7;RAD51AP1;RAD51;E2F8;E2F2;UHRF1;GFI1;FOXA2;VAX2;HMGB2;SPIB;MEN1;DMRTA1;NR4A2;HEY2;LEF1;E2F1;RAD51B;DDX11;BATF;ELK4;USF1;HMGB3;NUCKS1;ERG;BACH2;MSH6;RBBP8;FEN1;FOXP1;ETS2;CGAS;NR1D1;FOXJ3;ATF7;TERF2;ZBTB26;MBD1;TCF7L1;ZFP41;IRF9;RUNX3;MND1;KLF10;XRCC6;HMGB1;AHR;CAMTA2;MAX;ZNF638;TERF1;ZBTB7A;EGFR;FLI1;MECP2;KLF13;EGR1;ZBTB32;NR2C2;RFX2;CUX1;PARK7;NFE2;ATF6;DHX9;JUN;APEX1;TDP1;ZBTB33;KIN;SP3;ZBTB7B;HNRNPU;REXO4;PRKDC;PSIP1;CEBPG;BCL6;GABPA;APTX;POU6F1;CAMTA1;E2F3;GMEB2;ELF1;RAD50;JUNB;IRF8;HOXB4;TCF4;HIVEP1;TFAP4;ZNF23;RFX7;RFX4;ZNF445;NFATC3;XBP1;RXRB;TDG;POU2F2;RARG;FOXE1;CREB1;ZNF740;RFX1;GMEB1;NKX2-8;PROX1;SAFB;ZBTB20;RPS3;PAX2;NPAS2;SREBF2
prerank,glutathione transferase activity (GO:0004364),-0.4163785600869106,-1.3349823330136588,0.09836065573770492,0.6161291370294587,1.0,11/23,33.69%,HPGDS;LANCL1;ALOX5AP;GSTT2;GSTO1;GSTA3;MGST1;PTGES;GSTA4;LTC4S;GSTZ1
prerank,neuropeptide receptor binding (GO:0071855),0.6703530341197967,1.3310583166784662,0.14420485175202155,0.9305382928309759,1.0,4/14,19.48%,AGRP;NMU;APLN;PPY
prerank,transcription corepressor binding (GO:0001222),0.6131462817007178,1.3307651410027321,0.15429917550058891,0.9198529279445904,1.0,8/27,10.75%,EZH2;SUZ12;NR1D1;HDAC6;PHF1;ZBTB16;ZBTB7A;EHMT1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.6325997804954507,1.330671253395157,0.14709517923362175,0.9085244468465596,1.0,1/21,0.81%,CHRNB4
prerank,methylated histone binding (GO:0035064),0.572337485140433,1.326154372974694,0.10509885535900104,0.9181561821606987,1.0,24/62,18.49%,UHRF1;SPIN4;NCAPD3;MORC4;CBX5;SUZ12;MSH6;NCAPG2;TAF1;LRWD1;PHF19;TAF7;PHF1;PHF2;ZMYND8;ING3;ING2;ING5;RBBP5;ATRX;GLYR1;MBTD1;MORC3;DPF2
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.6047316638166308,1.3258889517203525,0.1265678449258837,0.9078172675199799,1.0,14/34,19.33%,CKS2;CCNB1;INCENP;DBF4;CAB39L;MLST8;CCNT1;FAM20A;CCNK;STK4;MAP2K1;IQGAP1;TAOK1;STK3
prerank,histone methyltransferase activity (GO:0042054),0.591539505035815,1.3247912639968744,0.14768883878241262,0.9016790612466428,1.0,8/32,11.74%,EZH2;MEN1;SUV39H1;SUZ12;KMT2C;EHMT1;FBL;NSD3
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.6717462971517367,1.3226380910047428,0.17598908594815826,0.9005848655680981,1.0,3/13,10.11%,SLC38A5;SLC7A1;SLC3A1
prerank,deoxyribonuclease activity (GO:0004536),0.6603296433345329,1.3213104116464598,0.17024128686327078,0.8961032029639968,1.0,5/14,12.36%,ERCC4;MBD4;ZRANB3;DNASE1L1;APEX1
prerank,carbohydrate kinase activity (GO:0019200),-0.5459631152564588,-1.31878204572373,0.16279069767441862,0.6417470525187567,1.0,9/11,28.75%,HK2;HK3;GALK2;NAGK;GNE;POMK;XYLB;GALK1;KHK
prerank,transaminase activity (GO:0008483),-0.5217575729542254,-1.3134460575541045,0.17192982456140352,0.6372301332108405,1.0,3/11,25.20%,GOT2;AGXT;OAT
prerank,syntaxin-1 binding (GO:0017075),-0.4173820473612416,-1.3113357129541772,0.09090909090909091,0.6241068238656663,1.0,9/22,25.97%,NSF;SYT1;VAMP2;UNC13A;STXBP5;STXBP1;CPLX1;CPLX2;SNAP25
prerank,methylation-dependent protein binding (GO:0140034),0.5686330801299191,1.3075029053309213,0.11789473684210526,0.9492273493438692,1.0,21/57,17.99%,UHRF1;SPIN4;NCAPD3;MORC4;CBX5;SUZ12;MSH6;NCAPG2;LRWD1;PHF19;PHF1;PHF2;ZMYND8;ING3;ING2;ING5;RBBP5;ATRX;GLYR1;MBTD1;MORC3
prerank,C-C chemokine receptor activity (GO:0016493),0.6214562061449944,1.3058014446411592,0.17317073170731706,0.9464757092670091,1.0,4/21,10.57%,CXCR5;CCR2;GPR75;CCR6
prerank,protein heterodimerization activity (GO:0046982),0.5402391499109507,1.299395495845645,0.051,0.9653605445376489,1.0,37/178,15.43%,TOP2A;IL12A;BARD1;NR4A2;RCC1;AURKA;LSM6;ERBB3;SAE1;USF1;PSMF1;EXT1;TAF1;IKBKG;UBA2;YWHAH;TCF3;PEF1;TAF7;AHR;BOK;GTF2A1;PAFAH1B1;TCOF1;ATF6;LSM5;VAPA;FXR1;DGKD;ADD2;DDIT3;TPM4;MICU1;TLR6;TP53;GCA;CYBB
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),-0.5132176744130411,-1.2993910345149884,0.14642857142857144,0.6385243764664986,1.0,6/11,34.44%,AKR1B1;AKR1B10;RDH13;AKR1A1;DHRS13;RDH14
prerank,3'-5' exonuclease activity (GO:0008408),0.5696351925152352,1.2966427656556587,0.14946236559139786,0.9673987300931532,1.0,20/45,20.91%,ERI2;RAD1;RAD9A;POLD1;PDE12;EXOSC10;PNLDC1;ERI1;APEX1;REXO4;RAD50;ANGEL2;CNOT6;ERI3;DIS3L;TATDN1;CNOT8;PNPT1;CNOT7;WRN
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.43844262210575724,-1.294256432408824,0.17703349282296652,0.6352597732272804,1.0,5/18,13.08%,AKR1B1;ALDH6A1;ALDH1A1;AKR1B10;ALDH18A1
prerank,H4 histone acetyltransferase activity (GO:0010485),0.6852757085395795,1.292857777676048,0.18828451882845187,0.9748801996584882,1.0,2/10,2.18%,NAA40;BRCA2
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.48122566871781997,-1.2915856836444581,0.15126050420168066,0.6265974111633276,1.0,10/15,51.90%,PLA2G4E;PLA2G12A;PLA2G4A;PLA2G3;PLA2G4C;PLA2G5;PLA2G4F;PLA2G2D;PLA2G4B;PLA2G10
prerank,death receptor binding (GO:0005123),0.6440666789029101,1.2914639373041747,0.19720101781170485,0.9705861365295844,1.0,2/15,4.16%,NTF4;PIDD1
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.5896855593337205,1.2885216062511955,0.17458432304038005,0.9731486276540653,1.0,7/29,14.50%,SLC25A21;SLC25A12;SLC1A5;ABCC2;SLC19A1;SLC25A22;SLC25A13
prerank,retinoic acid receptor binding (GO:0042974),0.627121539827089,1.2878994229509169,0.20486555697823303,0.9655275669646461,1.0,10/17,22.94%,NR4A2;HMGA1;ASXL1;ACTN4;CNOT1;RARG;MED1;NCOA6;NRIP1;NSD1
prerank,GDP binding (GO:0019003),-0.3164160180911356,-1.2878600832776113,0.045454545454545456,0.6208802250803859,1.0,20/63,15.29%,RAP1B;RAB14;RALA;RAB28;DYNC1LI1;RAP2A;RRAGD;RAP2B;GNAI3;KRAS;NRAS;RIT1;RAP1A;MIEF1;RAP2C;RERG;RAB31;RAB12;RRAGC;MRAS
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.5615733117652706,1.2863918760572124,0.1299254526091587,0.9613944031787625,1.0,21/60,20.21%,CDKN3;PHLPP2;PPM1D;PPP3CA;LRRC40;PPP1CB;CTDSPL2;CTDSPL;TAB1;PPP2CB;PPP1CC;MTMR6;PTEN;LRRK1;PPP6C;PPP1CA;LRRK2;ILKAP;PPM1B;PPP2CA;RPAP2
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.3892256546041803,-1.2862353374214512,0.10828025477707007,0.6098868062635611,1.0,11/27,25.22%,RNF19B;ARIH1;RNF180;AUP1;UBE3D;PRKN;SIAH1;ANKIB1;DCUN1D2;SIAH3;RNF144B
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.6508395438043804,1.2860574344774018,0.1991701244813278,0.952445349744927,1.0,3/13,4.79%,GPSM2;CCDC88A;ARHGDIB
prerank,protein phosphatase 2A binding (GO:0051721),0.6039668799678473,1.280394929272237,0.1889168765743073,0.9680880471136319,1.0,6/23,8.93%,MASTL;PTPA;ANKLE2;SMG5;FOXO1;STRN
prerank,SH3 domain binding (GO:0017124),-0.31755264395535704,-1.2780702298105524,0.023255813953488372,0.6155897514418414,1.0,20/62,16.97%,DNM2;SYNJ1;EVL;SYNJ2;ADAM15;RUFY2;VASP;ABI1;LANCL1;AFAP1;WIPF1;SOCS7;PRKN;NCF1;ADAM9;ABI2;SHANK3;SKAP1;GPX1;DAB2IP
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.6700080064692284,1.2765672652552935,0.21237693389592124,0.9756466331686425,1.0,4/11,15.22%,NAA40;NAA16;NAA25;NAA20
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.5860115318278911,1.2755721430063618,0.1871345029239766,0.9699545095490364,1.0,9/27,14.18%,PRIM1;POLR1B;POLR2I;POLR2A;PRIMPOL;POLR1A;POLR1F;POLR1D;POLR1C
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),-0.4787017716176054,-1.270718445609938,0.15294117647058825,0.6188152745581894,1.0,9/12,28.40%,SLC25A25;SLC17A9;LRRC8A;SLC25A24;SLC35B2;SLC25A17;SLC25A5;SLC25A42;SLC25A23
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.5169295531891654,-1.2704656328790038,0.18394648829431437,0.605360274773458,1.0,3/10,13.40%,CACNB2;CACNA1C;CACNB4
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),-0.3637828598751135,-1.2645036719731795,0.13592233009708737,0.606734548052876,1.0,6/38,14.35%,APP;SPOCK1;SERPINE2;TFPI;SERPINI1;SERPINE1
prerank,ATP binding (GO:0005524),0.5243319775128453,1.2635746235493115,0.045,1.0,1.0,55/266,13.59%,KIF14;KIFC1;SMC4;RAD51;PIF1;EPB42;PLK1;STK26;TRIP13;BLM;SMARCA5;OXSR1;DAPK2;PTPA;MCM6;LIG4;HASPIN;RRM1;RPS6KA5;MSH6;MAP4K1;STK11;ABCD1;CDK6;TLK1;SIK2;UBA2;RUNX3;STK38L;CARS2;MAP3K5;EIF4A3;RTEL1;AKT3;MAP4K2;TAP1;STK38;MARK2;MYH10;MAST2;ABCA2;P2RY1;LONP1;PIM1;MAP4K5;ATP7A;BTK;ABCF2;DHX9;OLA1;BMPR1A;LMTK2;HNRNPU;PRKAG2;LATS1
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.5985815137742664,1.2612096131503716,0.2184049079754601,1.0,1.0,3/21,5.15%,CDK1;CDKL1;CDK6
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.5985815137742664,1.2612096131503716,0.2184049079754601,1.0,1.0,3/21,5.15%,CDK1;CDKL1;CDK6
prerank,tropomyosin binding (GO:0005523),0.609451904423314,1.2609119435955722,0.20838794233289645,0.9970696110403516,1.0,1/16,0.80%,TMOD4
prerank,flavin adenine dinucleotide binding (GO:0050660),-0.30994845054847286,-1.2605062628769352,0.06896551724137931,0.6042045295680134,1.0,30/53,35.43%,KDM1A;ACOX3;POR;SQOR;ACADL;MICAL3;DPYD;MTHFR;MTO1;MICAL2;MTRR;NOX4;ILVBL;CYB5R3;SDHA;CRY1;SQLE;NQO2;GCDH;GFER;NDOR1;AIFM2;KDM1B;DDO;AOX1;FOXRED2;NOS1;ACADVL;CRY2;GSR
prerank,lipase activity (GO:0016298),-0.3442312706460694,-1.2542494389964083,0.14772727272727273,0.6062860596109553,1.0,13/43,19.30%,LIPA;MGLL;PLA2G15;DAGLB;LPL;ABHD12;ABHD16A;ABHD6;PLBD2;ABHD3;LIPH;SEC23IP;ABHD15
prerank,amino acid:sodium symporter activity (GO:0005283),0.65714859351646,1.253492856069409,0.25884016973125884,1.0,1.0,1/11,0.70%,SLC6A12
prerank,disordered domain specific binding (GO:0097718),0.572359067454374,1.2471401036439325,0.2250879249706917,1.0,1.0,14/23,23.16%,RB1;FYN;CLTC;KCNA1;NUMA1;TP53;FKBP8;FN1;PPIL1;SMAD2;MDM2;GAPDH;CALM3;NCOA3
prerank,endonuclease activity (GO:0004519),0.5357519392395712,1.2467508862082615,0.1935135135135135,1.0,1.0,8/49,7.26%,ANKLE1;SLFN14;ERCC4;SMG6;FEN1;MBD4;YBEY;ZRANB3
prerank,transmitter-gated ion channel activity (GO:0022824),-0.3731242480772389,-1.2461357331717726,0.13740458015267176,0.613025857449089,1.0,10/29,14.67%,GABRB3;GABRG2;GRIA4;GABRG3;GABRA2;GABRA3;GLRA2;GRIK2;GABRG1;GABRA1
prerank,transcription coregulator binding (GO:0001221),0.5384487637837765,1.246085964941159,0.19957761351636746,1.0,1.0,13/50,11.17%,CIT;EZH2;SUZ12;UBE2I;CTCF;NR1D1;HDAC6;AHR;PHF1;ZBTB16;ZBTB7A;EHMT1;SMAD4
prerank,alanine transmembrane transporter activity (GO:0022858),0.6392116698317374,1.2445505757182551,0.2514124293785311,1.0,1.0,1/12,0.87%,SLC38A5
prerank,anion transmembrane transporter activity (GO:0008509),0.635913287569862,1.2430979338187438,0.22371967654986524,1.0,1.0,3/12,11.15%,SLC4A1;ABCC2;SLC19A1
prerank,retinoid X receptor binding (GO:0046965),0.6426275066451228,1.2416589587385916,0.22131147540983606,1.0,1.0,2/11,1.94%,NR4A2;HMGA1
prerank,histone acetyltransferase activity (GO:0004402),0.5614690526369058,1.2416218068037652,0.2098623853211009,1.0,1.0,12/30,16.57%,NAA40;BRCA2;EPC1;TAF1;KAT6A;KAT2B;HAT1;CREBBP;TADA2A;TADA3;TAF9;BAZ1A
prerank,transcription cis-regulatory region binding (GO:0000976),0.5115866092948835,1.2413377933011642,0.024,0.9986605198977929,1.0,98/406,19.37%,E2F7;E2F8;FOXM1;E2F2;UHRF1;GFI1;FOXA2;HMGB2;MEN1;SUV39H1;CDK5RAP2;BRCA1;HMGA1;SOX6;DEAF1;LEF1;E2F1;RB1;TWIST1;CTCF;RBL1;FOXP1;DACH1;NR1D1;NFXL1;HNRNPL;E2F6;TCF3;ARID4A;SETX;ZFP41;RUNX3;TFDP1;KLF10;TAF7;XRCC6;HMGB1;AHR;MAX;PSPC1;DMTF1;GABPB2;GABPB1;ETV6;SNAPC3;FLI1;NONO;LONP1;EGR1;TFDP2;SALL2;NR2C2;CUX1;MXI1;NFYC;PARK7;ARID5B;NFE2;SMAD4;ATF6;JUN;ATF5;ZNF25;SATB2;SP3;NFE2L2;ZBTB7B;ACTN4;DDIT3;TAF2;MYC;GABPA;NFX1;RBBP5;PBX2;E2F3;TP53;RUNX1;PLAGL1;TCF7L2;TFAP4;PURG;FOXK2;TAF9;XBP1;RXRB;MLXIP;ZBED4;SNCA;POU2F2;HDAC4;PROX1;HDAC1;BRD7;ZBTB20;RPS3;PAX2;TBL1XR1
prerank,C2H2 zinc finger domain binding (GO:0070742),0.6445600010009979,1.2409830173509737,0.23380281690140844,0.9910682044032639,1.0,4/11,16.35%,LEF1;MBD2;SRRM2;TAF9
prerank,protein phosphatase binding (GO:0019903),0.5218731368254239,1.2403953997376085,0.12537917087967643,0.9846588701736574,1.0,23/117,9.87%,NEK2;MASTL;RPA2;ITGA1;PHACTR4;PPP1R9B;PTPA;ANKLE2;SMG5;STX17;PPP1R11;CDC27;SNX3;KCNN4;FOXO1;ANK1;TRAF3;ANAPC7;MAP3K5;MAPK14;STRN;EGFR;PPP1R15A
prerank,U6 snRNA binding (GO:0017070),0.6133242018900851,1.239147009354836,0.24503311258278146,0.981283735046358,1.0,10/14,24.63%,SART3;LSM2;METTL16;PRPF4;LSM7;TUT1;DDX39B;PRPF8;LSM3;RBM22
prerank,mRNA 5'-UTR binding (GO:0048027),0.5736697018815112,1.2388560375852689,0.23169267707082833,0.973865893042073,1.0,7/24,11.87%,RPS7;UTP23;RPS14;RPL41;MYH10;IGF2BP3;CCT5
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.572873193693754,1.2363790239426111,0.22409638554216868,0.9753385929061882,1.0,2/22,7.28%,CDKN3;MTMR2
prerank,adenyl ribonucleotide binding (GO:0032559),0.513145241235037,1.235537568359292,0.049,0.9703068434430873,1.0,58/291,13.59%,KIF14;KIFC1;SMC4;RAD51;PIF1;EPB42;PLK1;STK26;TRIP13;BLM;SMARCA5;OXSR1;DAPK2;PTPA;MCM6;LIG4;HASPIN;RRM1;RPS6KA5;MSH6;MAP4K1;STK11;ABCD1;CDK6;PDE4A;TLK1;SIK2;UBA2;RUNX3;PDE2A;STK38L;CARS2;MAP3K5;EIF4A3;RTEL1;AKT3;MAP4K2;TAP1;STK38;MARK2;MYH10;MAST2;ABCA2;P2RY1;LONP1;PIM1;MAP4K5;ATP7A;BTK;SLC19A1;ABCF2;DHX9;OLA1;BMPR1A;LMTK2;HNRNPU;PRKAG2;LATS1
prerank,chloride channel inhibitor activity (GO:0019869),-0.5102285428636754,-1.231197886095154,0.23509933774834438,0.6369621803705404,1.0,5/10,29.09%,VTI1B;VAMP8;STX1A;WNK2;CFTR
prerank,active ion transmembrane transporter activity (GO:0022853),0.5435938865736808,1.2301268471919231,0.2159468438538206,0.9853595961897004,1.0,12/37,22.53%,SLC4A1;SLCO4C1;SLCO4A1;COX10;COX4I1;SLCO2A1;NDUFA4;SLC22A4;SLCO3A1;UQCRH;ATP13A3;SLCO5A1
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.5587048784350525,1.2296187407744508,0.21147356580427445,0.9791768723669293,1.0,16/35,19.89%,FOXP1;TAF1;KLF10;H3-3A;SMARCA4;GTF2A1;SNAPC3;RUVBL2;PARK7;MYC;TP53;POU2F1;TAF1C;HDAC1;AGO2;MMP12
prerank,mRNA 3'-UTR binding (GO:0003730),0.5188164015546368,1.2288185259372104,0.17045454545454544,0.9744452181337215,1.0,31/79,18.93%,RPS7;HNRNPC;BOLL;EXOSC8;ZFP36L1;PUM2;ELAVL4;UTP23;HNRNPA2B1;RPL41;AUH;RNPS1;CPEB3;RBMS2;PUM1;IGF2BP3;HNRNPA0;CCT5;FXR1;HNRNPU;DAZAP1;RNF20;TP53;RC3H1;ANGEL2;ZFP36L2;TUT1;LARP4B;CPSF1;ELAVL1;RPL5
prerank,cGMP binding (GO:0030553),0.6418741061214511,1.2286086973748778,0.2446351931330472,0.9670060565550558,1.0,2/11,12.21%,PDE2A;PDE5A
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.6260828804036945,1.2278096802841676,0.26788218793828894,0.9620211485436758,1.0,4/11,10.41%,PRPF19;UBE2K;UBE4B;AMFR
prerank,cation:chloride symporter activity (GO:0015377),0.638022568249196,1.2248116371836857,0.27717391304347827,0.9665546165122456,1.0,4/10,12.59%,SLC12A3;SLC12A7;SLC12A1;SLC12A6
prerank,GABA-A receptor activity (GO:0004890),-0.4145675591394068,-1.223537495355784,0.18947368421052632,0.6441318327974277,1.0,7/18,14.67%,GABRB3;GABRG2;GABRG3;GABRA2;GABRA3;GABRG1;GABRA1
prerank,5'-3' exonuclease activity (GO:0008409),0.6105652114166721,1.2220260687589368,0.2519582245430809,0.9700162214705983,1.0,6/14,13.24%,EXO1;FEN1;DCLRE1C;DCLRE1B;DCP2;DXO
prerank,single-stranded RNA binding (GO:0003727),0.5381258703213255,1.219654709621983,0.22209695603156707,0.972137542172656,1.0,16/43,22.08%,DDX11;EIF4B;DHX58;SNRPC;EXOSC10;LONP1;DHX9;RBM7;FXR1;HNRNPU;LACTB2;HNRNPA1;AGO2;ZFR;ENDOV;AGO1
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.6355249872975988,1.2155906766152504,0.27521613832853026,0.9817016826594223,1.0,6/10,22.73%,SUV39H1;EHMT1;SETDB2;ASH1L;SETDB1;SETD5
prerank,lysine-acetylated histone binding (GO:0070577),0.5853242148943806,1.2139249998495276,0.24469413233458176,0.9725410844002247,1.0,11/20,20.11%,BRD9;TAF1;BRD4;SMARCA4;YEATS4;ZMYND8;KMT2A;PSME4;DPF2;BRD7;BRD3
prerank,acetylation-dependent protein binding (GO:0140033),0.5853242148943806,1.2139249998495276,0.24469413233458176,0.9725410844002247,1.0,11/20,20.11%,BRD9;TAF1;BRD4;SMARCA4;YEATS4;ZMYND8;KMT2A;PSME4;DPF2;BRD7;BRD3
prerank,carboxylic ester hydrolase activity (GO:0052689),-0.28422251372839913,-1.213486596847472,0.15151515151515152,0.6580343820271947,1.0,13/85,7.85%,LIPA;MGLL;PLA2G15;DAGLB;NDST3;LPL;ABHD12;PLA2G7;ENPP2;GDE1;ABHD16A;ABHD6;CA2
prerank,peptidoglycan binding (GO:0042834),0.6391275757912315,1.210101482992894,0.27311522048364156,0.9801863481426516,1.0,1/10,1.49%,PGLYRP1
prerank,nuclease activity (GO:0004518),0.5163229987629187,1.1991486810520275,0.23845327604726102,1.0,1.0,12/52,15.00%,ANKLE1;RNASE6;EXO1;STK31;FEN1;PDE12;DNA2;DNASE1L1;APEX1;RNASE12;REXO4;RNASEH2A
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),-0.463088306695415,-1.197217626615085,0.23272727272727273,0.687118682496496,1.0,8/11,28.40%,SLC25A25;SLC17A9;LRRC8A;SLC25A24;SLC35B2;SLC25A17;SLC25A42;SLC25A23
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.49334784204110527,1.1969482493578336,0.12912912912912913,1.0,1.0,51/188,19.37%,GFI1;FOXA2;HMGB2;MEN1;SUV39H1;CDK5RAP2;BRCA1;SOX6;CTCF;NR1D1;HNRNPL;LIN54;ARID4A;TAF7;XRCC6;HMGB1;AHR;PSPC1;DMTF1;GABPB2;GABPB1;FLI1;NONO;EGR1;NFYC;ARID5B;SMAD4;ATF6;DHX9;JUN;ATF5;NFE2L2;DDIT3;TAF2;GABPA;RBBP5;TP53;RUNX1;TCF7L2;TFAP4;FOXK2;TAF9;ZBED4;SNCA;POU2F2;HDAC4;PROX1;BRD7;ZBTB20;PAX2;TBL1XR1
prerank,chemoattractant activity (GO:0042056),0.548687389749674,1.1956660690950567,0.25465116279069766,1.0,1.0,3/26,7.33%,HMGB2;PGF;HMGB1
prerank,calcium ion transmembrane transporter activity (GO:0015085),-0.2869400698327955,-1.1955995590777213,0.16279069767441862,0.6781734716576675,1.0,26/55,30.17%,ITPR2;SLC24A3;CACNB2;TRPC5;CUL5;ATP2B2;TRPC1;TMEM165;RYR2;PKD1;SEC61A1;ATP2B3;TRPV4;TRPC3;ORAI1;ANXA2;PKD2L1;PKD1L2;PKD2L2;ANXA6;ANXA9;CHRNA7;ATP2C1;SLC24A5;TRPM2;SLC8A2
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.3595018310472877,-1.193927250840054,0.18181818181818182,0.6693610813385733,1.0,13/30,22.61%,SLC39A11;TMEM165;SLC11A2;SLC30A4;SLC39A7;TTYH1;SLC39A14;SLC39A8;SLC39A6;SLC39A12;SLC39A3;SLC39A1;SLC30A1
prerank,serine-type endopeptidase activity (GO:0004252),0.5101530615224864,1.1937868631855346,0.2250770811921891,1.0,1.0,4/80,3.02%,PRTN3;TMPRSS4;TMPRSS3;FAP
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.4926762416005859,1.193390671987927,0.024,1.0,1.0,127/597,19.55%,E2F7;E2F8;KIF2C;E2F2;MCM10;GFI1;FOXA2;VAX2;HMGB2;SPIB;MEN1;SUV39H1;CDC45;CDK5RAP2;BRCA1;DMRTA1;NR4A2;SOX6;POLA1;HEY2;LEF1;E2F1;DDX11;BATF;ELK4;MCM6;USF1;ORC5;ERG;BACH2;MCM9;CTCF;FOXP1;ETS2;ORC3;NR1D1;MBD4;MBD2;HNRNPL;FOXJ3;ATF7;ZBTB26;TCF7L1;ARID4A;ZFP41;IRF9;RUNX3;KLF10;TAF7;XRCC6;HMGB1;AHR;MAX;PSPC1;DMTF1;GABPB2;GABPB1;ZW10;ZBTB7A;FLI1;NONO;KLF13;EGR1;ZBTB32;NR2C2;RFX2;CUX1;NFYC;ARID5B;NFE2;SMAD4;ATF6;DHX9;JUN;ATF5;ZBTB33;SP3;NFE2L2;ZBTB7B;HNRNPU;DDIT3;TAF2;CEBPG;BCL6;GABPA;POU6F1;RBBP5;E2F3;GMEB2;ELF1;TP53;JUNB;RUNX1;IRF8;HOXB4;TCF7L2;TCF4;HIVEP1;TFAP4;ZNF23;RFX7;FOXK2;RFX4;MCM3;TAF9;NFATC3;XBP1;RXRB;ZBED4;SNCA;POU2F2;HDAC4;RARG;FOXE1;CREB1;ZNF740;RFX1;GMEB1;NKX2-8;PROX1;BRD7;ZBTB20;PAX2;TBL1XR1;NPAS2;SREBF2;CENPC
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.6095711483716765,1.1918669631218026,0.2857142857142857,1.0,1.0,4/13,9.81%,AGPAT1;AGPAT4;GPAT3;AGPAT3
prerank,nuclear import signal receptor activity (GO:0061608),0.5817300019464832,1.1910207433692723,0.2880658436213992,1.0,1.0,8/15,22.60%,TNPO1;KPNA3;RANBP6;IPO5;KPNB1;TNPO2;TNPO3;KPNA4
prerank,aminopeptidase activity (GO:0004177),-0.37329446966088786,-1.1901809767008775,0.21264367816091953,0.6669833382052032,1.0,7/26,8.14%,XPNPEP3;XPNPEP1;LAP3;METAP1D;NPEPPS;MMP14;ANPEP
prerank,protein phosphatase activator activity (GO:0072542),0.6185682589095348,1.1898631262277772,0.3010610079575597,1.0,1.0,5/13,9.87%,PHACTR4;PTPA;PPP2R5E;PPP2R5A;PPP1R15A
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.6238323031603391,1.1894959130065483,0.282336578581363,0.9971832781848164,1.0,4/10,16.16%,USP27X;DESI2;OTUD5;YOD1
prerank,transforming growth factor beta binding (GO:0050431),-0.36888443997139014,-1.1875218401945173,0.20903954802259886,0.6614128770479253,1.0,9/23,18.05%,ACVR1;TGFBR1;LTBP1;ENG;TGFBR3;ACVRL1;CD36;TGFBR2;THBS1
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.5365680808518152,1.1865118807260249,0.2737430167597765,1.0,1.0,14/33,20.76%,ERI2;PDE12;EXOSC10;DCP2;PNLDC1;ERI1;ANGEL2;CNOT6;ERI3;DIS3L;XRN1;CNOT8;PNPT1;CNOT7
prerank,nuclear export signal receptor activity (GO:0005049),0.5979737281754467,1.1850057750385747,0.30575035063113604,1.0,1.0,5/11,18.91%,XPO1;NUP42;NUP214;XPO4;EIF4ENIF1
prerank,nuclear localization sequence binding (GO:0008139),0.5726533681473734,1.1824195297349218,0.28774193548387095,1.0,1.0,9/18,22.60%,POM121;TNPO1;KPNA3;NUP214;RANBP6;IPO5;KPNB1;TNPO2;KPNA4
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.5445605586795894,1.182017319123901,0.2853745541022592,0.9989050699919422,1.0,3/26,7.49%,SLC6A12;SLC16A12;SLC16A1
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.5202133883076632,1.1814410209770267,0.25934065934065936,0.9941135133943954,1.0,12/44,14.94%,EZH2;MEN1;SUV39H1;NSD2;KMT2C;EHMT1;KMT5C;NSD3;SETDB2;KMT2A;RBBP5;KMT2B
prerank,pre-mRNA binding (GO:0036002),0.5345727814175922,1.1796181884450767,0.2775881683731513,0.9939298178675534,1.0,12/28,18.52%,SLBP;SNRPC;HNRNPL;U2AF1;RNPC3;U2AF1L4;ERI1;RBM7;HNRNPU;TARBP2;PRPF8;HNRNPA1
prerank,rRNA binding (GO:0019843),0.5137364853557175,1.1793471757889509,0.2601536772777168,0.9879537460454085,1.0,17/42,21.09%,FASTKD5;MRPL18;MRPL16;UTP23;RPS14;EMG1;MRPS7;RPS5;RPLP0;ERI1;RPS9;RPL12;RPL5;RPS3;PTCD3;RPL23;MDM2
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.5026248947361516,1.177939668777123,0.26282051282051283,0.9862476731003402,1.0,7/55,11.15%,SLC6A12;SLC38A5;SLC7A1;SLC16A12;SLC16A1;SLC3A1;SLC19A1
prerank,hexose transmembrane transporter activity (GO:0015149),0.6002025026926568,1.175380067976221,0.30601092896174864,0.9897996248002496,1.0,4/12,18.59%,SLC2A4;SLC2A8;SLC2A3;SLC2A1
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.5085211661979558,1.173882397055454,0.2700106723585913,0.9887660404848427,1.0,6/48,7.84%,RHAG;P2RX1;AQP1;RHD;SLC12A7;TRPM7
prerank,exonuclease activity (GO:0004527),0.5183557699861462,1.172392197263006,0.2628755364806867,0.9876201225798029,1.0,15/46,15.84%,RAD1;EXO1;RAD9A;FEN1;EXOSC8;DCLRE1C;PDE12;DCLRE1B;EXOSC10;ERI1;APEX1;DXO;REXO4;RAD50;CNOT6
prerank,ligand-gated anion channel activity (GO:0099095),-0.4086186893479738,-1.172328192410736,0.215,0.6882392207743366,1.0,8/17,14.67%,GABRB3;GABRG2;GABRG3;GABRA2;GABRA3;GLRA2;GABRG1;GABRA1
prerank,RNA polymerase binding (GO:0070063),0.5571876114909313,1.1686287578620533,0.29701686121919585,0.9953968903050039,1.0,7/18,17.08%,BRCA1;ANP32B;PKN2;DHX9;CCNT1;TCERG1;SCAF8
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.40321730739115447,-1.1673408369485203,0.2798165137614679,0.6888466940163359,1.0,7/17,20.17%,ABCA1;ATP8B1;PLTP;MTTP;PITPNB;PITPNM2;ATP10B
prerank,O-acyltransferase activity (GO:0008374),0.5320410242076855,1.1648280556206347,0.294811320754717,1.0,1.0,4/30,7.36%,LRAT;GPAT3;MBOAT2;MOGAT2
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.5246411054038715,1.1644898948049498,0.27959413754227735,0.9978190126947246,1.0,3/34,1.50%,EZH2;MEN1;SUV39H1
prerank,calcium-release channel activity (GO:0015278),-0.41320629722416613,-1.1642242442880555,0.2676767676767677,0.6844151361563754,1.0,7/17,16.48%,ITPR2;TPCN2;MCOLN1;RYR2;MCOLN3;TPCN1;ITPR3
prerank,C-C chemokine binding (GO:0019957),0.5476446266049217,1.1636312868306495,0.313180169286578,0.9945824473974456,1.0,3/22,10.57%,CXCR5;CCR2;CCR6
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.5925376794020147,1.1631727155985772,0.31459170013386883,0.9896954694241518,1.0,6/12,18.96%,TAF1;H3-3A;GTF2A1;RUVBL2;POU2F1;HDAC1
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.6100200963417004,1.162245060930438,0.3290414878397711,0.9869793446232048,1.0,6/11,21.40%,TCF3;MAP4K2;STK38;MAP3K11;TRAF6;SASH1
prerank,cAMP binding (GO:0030552),0.6082387245858559,1.1610490936209918,0.33008356545961004,0.985161146605994,1.0,3/11,16.67%,PDE4A;PDE2A;CNBD2
prerank,MHC class II protein complex binding (GO:0023026),0.6001104253767964,1.159952306975843,0.3140161725067385,0.9826891307204032,1.0,2/11,3.68%,MS4A1;CD74
prerank,protein serine/threonine kinase activity (GO:0004674),0.4795989662869153,1.158145439646648,0.126,0.9833276428143076,1.0,86/335,16.37%,TTK;CDK1;AURKB;CIT;PBK;NEK2;MASTL;PLK1;CHEK2;MAPK1;CDKL1;AURKA;OXSR1;DAPK2;SLK;PRKCE;RPS6KA5;MAP4K1;STK11;MAPKAPK3;CHEK1;CDK6;GRK6;TLK1;TAF1;SIK2;ATM;PRKD3;CSNK1A1;STK38L;BRD4;MAP3K5;PIM2;AKT3;PKN2;CSNK1G2;PIM3;MAP3K1;MAP4K2;MAPK14;PRKCA;PRKACA;STK38;MARK2;CLK4;MAST2;STK24;EGFR;PIM1;PDPK1;MAP4K5;CDK19;RIOK3;HIPK2;TESK2;MAP3K11;MELK;DYRK1A;VRK1;PRKCB;RPS6KA6;BMPR1A;LMTK2;PDIK1L;GRK2;ROCK2;PRKDC;LATS1;CDK16;STK39;FAM20A;NRBP1;HTATIP2;CDC7;GSK3B;SGK3;CCNK;STK4;MAP3K20;BCR;PAK5;MAP2K1;MARK4;LIMK2;PAK2;CDK8
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.43334190772040226,-1.1552988647911293,0.2391304347826087,0.6963424437299035,1.0,7/13,14.67%,GABRG2;GABRG3;GABRA2;GABRA3;GLRA2;GABRG1;GABRA1
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.5770822044391272,1.1550745727023537,0.32679738562091504,0.9887450868886019,1.0,4/15,9.81%,AGPAT1;AGPAT4;GPAT3;AGPAT3
prerank,sodium channel regulator activity (GO:0017080),0.5124765604841868,1.1533123672013834,0.2969094922737307,0.9891843125992482,1.0,7/37,14.70%,TMPRSS3;GPD1L;YWHAH;FXYD5;NEDD4L;FGF13;SGK3
prerank,CoA-ligase activity (GO:0016405),0.5604466516191081,1.150982721747662,0.3315436241610738,0.9918733466765575,1.0,2/14,10.20%,ACSS3;SLC27A2
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.5884337007214953,1.1492281472292072,0.33764367816091956,0.9922004357250831,1.0,3/12,6.74%,PDE7B;PDE4A;PDE2A
prerank,3'-5' DNA helicase activity (GO:0043138),0.5694043542455989,1.1479013911769447,0.3291139240506329,0.9910462774517218,1.0,6/16,14.20%,BLM;MCM6;HELQ;ERCC3;DHX9;FANCM
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.4792286115220262,1.146792760948915,0.2801235839340886,0.9890060308884752,1.0,21/75,19.44%,H6PD;DHDH;DCXR;CBR4;GFUS;HPGD;IMPDH2;ME3;BDH1;ABCC4;DHRS4;RDH10;NSDHL;HADHA;RDH5;PHGDH;CRYL1;GLYR1;MDH2;HADHB;PGD
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.383486601552232,-1.146567768544898,0.2736842105263158,0.7067585613128811,1.0,8/19,18.50%,GABRG2;GABRG3;GABRA2;GABRA3;GRIK2;GABRG1;GABRA1;GRIK4
prerank,chemokine receptor activity (GO:0004950),0.5401063155910844,1.146280815450558,0.32109004739336494,0.9848991199534325,1.0,6/24,17.65%,CXCR5;CCR2;GPR75;CCR6;GPR35;CXCR4
prerank,calcium:sodium antiporter activity (GO:0005432),-0.46961419792437326,-1.145536217908984,0.3181818181818182,0.6980603671818275,1.0,5/10,16.39%,SLC24A3;SLC8A3;SLC8B1;SLC3A2;SLC8A1
prerank,fibroblast growth factor binding (GO:0017134),0.5373384466913452,1.14413576278222,0.3321212121212121,0.9866995900423544,1.0,7/21,16.13%,FGFBP3;RPS19;ITGAV;GLG1;CEP57;FGFR1;FIBP
prerank,glucose transmembrane transporter activity (GO:0005355),0.5585023363249472,1.1438851370739376,0.31572164948453607,0.9816204510145473,1.0,4/17,18.59%,SLC2A4;SLC2A8;SLC2A3;SLC2A1
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.47288533852448256,1.1437421531683762,0.116,0.9761324048275063,1.0,113/431,19.43%,KIF14;KIFC1;SMC4;RAD51;PIF1;EPB42;PLK1;RRAD;ARHGEF5;STK26;TRIP13;BLM;SMARCA5;GBP4;OXSR1;DAPK2;TUBA1C;PTPA;MCM6;LIG4;HASPIN;NOA1;ATL2;RRM1;RPS6KA5;ARL5C;MSH6;MAP4K1;STK11;ABCD1;CDK6;REM1;TLK1;TUBB4B;SIK2;ARL11;RAB1B;UBA2;RAB22A;TUBA1B;ARF4;RUNX3;RND3;GBP2;STK38L;CARS2;MAP3K5;EIF4A3;RTEL1;AKT3;GNAI1;MAP4K2;RAB8A;TAP1;STK38;MARK2;MYH10;MTG2;MAST2;ABCA2;P2RY1;LONP1;PIM1;SEPHS1;MAP4K5;RABL6;RIT2;RHOU;ATP7A;BTK;ABCF2;TUBB;DHX9;ARF3;OLA1;RAB11B;BMPR1A;LMTK2;RAC2;HNRNPU;PRKAG2;LATS1;RAB35;RAB2A;TUBD1;STK4;ATP5F1D;MAP3K20;ARL4C;MARK4;PDXK;RAB5A;MMAA;RAC1;SRPK1;AK6;TRNT1;PGK1;CLP1;TDG;DRG1;STK17B;TAOK1;LRRK2;RAB6A;YARS2;ABCD4;N4BP2;NIM1K;MTHFD1L;KSR1;STK3;TUBB3
prerank,protein tyrosine phosphatase activity (GO:0004725),0.48240141620401117,1.1430825340640276,0.2964876033057851,0.9724568456547792,1.0,16/71,16.22%,CDC25C;CDKN3;CDC25A;PTPRA;PTPN22;CDC25B;EYA3;PTPDC1;PTPN7;PTPN14;MTMR6;PTEN;EYA1;PTPN5;PTPRU;DUSP22
prerank,cytokine receptor activity (GO:0004896),0.48586862257143826,1.1406686495904421,0.2808641975308642,0.9750350347110445,1.0,17/83,14.33%,IL2RG;IL7R;IL2RA;IL18RAP;CD74;CD44;CCR2;GFRA2;IL21R;IL20RA;IL17RA;CCR6;IL1R1;IL10RA;FLT3;F3;GFRA1
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.4488763448165188,-1.1406185854519888,0.2830188679245283,0.699612106364518,1.0,7/12,14.67%,GABRB3;GABRG2;GABRG3;GABRA2;GABRA3;GABRG1;GABRA1
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.4242996687651666,-1.1401750452805983,0.2815884476534296,0.689936696141479,1.0,5/12,6.80%,KDM1A;KDM7A;KDM4A;PHF8;KDM4B
prerank,chemokine binding (GO:0019956),0.519061151212242,1.1396972607034386,0.31451612903225806,0.972701285671847,1.0,5/30,10.57%,CXCR5;CCR2;HMGB1;ITGAV;CCR6
prerank,CoA hydrolase activity (GO:0016289),0.5579327591986077,1.1386915662862553,0.34081902245706736,0.9704332458696244,1.0,4/16,8.69%,ABCD1;ACOT11;ACOT13;ACOT2
prerank,metalloaminopeptidase activity (GO:0070006),-0.41934832562769875,-1.1384633778814004,0.2788844621513944,0.6835270838486273,1.0,5/16,8.14%,XPNPEP3;XPNPEP1;NPEPPS;MMP14;ANPEP
prerank,triglyceride lipase activity (GO:0004806),-0.37939012498796754,-1.1366300671171259,0.24870466321243523,0.6776364935528923,1.0,3/20,2.76%,PLA2G15;DAGLB;LPL
prerank,aspartic-type endopeptidase activity (GO:0004190),0.5854157125012271,1.1363889351206384,0.34718498659517427,0.972950873411502,1.0,4/12,17.63%,NAPSA;CTSE;PSEN1;SPPL3
prerank,metal ion transmembrane transporter activity (GO:0046873),0.5285989204857471,1.1334526995895304,0.35,0.9777185422207582,1.0,4/27,3.00%,SLC12A3;AQP1;MAGT1;ITPR1
prerank,cyclic nucleotide binding (GO:0030551),0.5412181995229686,1.133050004025014,0.337888198757764,0.9733719003965186,1.0,5/21,16.67%,PDE4A;PDE2A;SLC19A1;PDE5A;CNBD2
prerank,carboxypeptidase activity (GO:0004180),0.50787976452635,1.1324695436362175,0.31561461794019935,0.9697265950212431,1.0,8/35,17.21%,AGBL1;CPA6;CPM;AGTPBP1;VASH2;AGBL3;CPD;NAALAD2
prerank,nucleotidyltransferase activity (GO:0016779),0.5487718332509766,1.1323934120577708,0.3421383647798742,0.9644985093845788,1.0,8/19,22.19%,DNTT;CGAS;TUT4;PAPSS2;TUT1;TENT2;PNPT1;TENT4A
prerank,protein homodimerization activity (GO:0042803),0.4671589701145206,1.1317685158644069,0.095,0.9611403482333375,1.0,116/590,17.66%,TOP2A;CENPF;KIF20B;GEN1;SLC4A1;KNSTRN;ECT2;CIP2A;MAD2L1;BARD1;STK26;SOX6;CHEK2;BLM;SMCHD1;PECAM1;GBP4;CCDC88A;IKZF3;FAP;FLNA;SLK;S100A11;PTPA;RBM44;USF1;PML;AXIN1;MSH6;PSMF1;ABCB10;ABCD1;TFRC;EXT1;SNRPC;IMPA1;IKBKG;TERF2;MYOM1;TCF3;CDADC1;EPHX2;PDE2A;DPY30;GBP2;MAP3K5;DCLRE1B;MGAT2;AHR;BOK;SNX9;TPST1;ST3GAL2;TAP1;ZBTB16;PEX11B;NRF1;TERF1;CAV2;TIMM9;NADK2;TXN;NR2F2;MAP3K11;UXS1;CARD9;PARK7;B2M;SMAD4;RNF8;DPP4;TRIM68;FOXP2;EFEMP2;BMPR1A;KMT2A;FXR1;GALM;SMIM1;RACK1;ZBTB7B;PON3;DGKD;ADD2;ACTN4;DDIT3;TPM4;NRBP1;NECTIN1;TYROBP;TRIM5;STK4;PDCD10;LRRFIP1;CEP57;GCA;APPL1;RPE;TARBP2;STARD3NL;PDXK;FGFR1;TFAP4;GSTM1;RDH5;TGFB2;MMAA;SYNE1;TARS2;PIP4K2A;ADCY8;CANT1;TRIM37;CRYL1;SPPL3;EPRS1
prerank,peptide hormone receptor binding (GO:0051428),0.5767866777859757,1.1290895972833062,0.34916201117318435,0.9653099500328916,1.0,2/11,13.65%,PTHLH;ADCYAP1
prerank,chloride channel activity (GO:0005254),-0.29141100254676533,-1.1269487189293537,0.25925925925925924,0.6912183455711793,1.0,13/59,14.67%,TTYH2;GABRB3;PACC1;CLCN7;GABRG2;GABRG3;GABRA2;GABRA3;CLCN4;GLRA2;GABRG1;TTYH1;GABRA1
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.5847486098983814,1.1259185844067408,0.35777126099706746,0.9708209986879566,1.0,6/10,25.16%,SLCO4C1;SLCO4A1;SLCO2A1;SLCO3A1;SLCO5A1;SLCO1C1
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.4212288693493804,-1.1258508347560934,0.3023255813953488,0.683811707962928,1.0,5/14,29.23%,SLC26A11;SLC25A11;SLC26A8;SLC26A6;SLC25A10
prerank,sequence-specific DNA binding (GO:0043565),0.4652684624758994,1.1257160754190645,0.103,0.9661032579292866,1.0,122/590,20.75%,E2F7;PIF1;E2F8;E2F2;UHRF1;GFI1;FOXA2;VAX2;SPIB;DMRTA1;NR4A2;MBD3;HEY2;MYRFL;LEF1;E2F1;SMG6;IKZF3;PBX4;BATF;ELK4;USF1;SMG5;ERG;BACH2;CTCF;FOXP1;ETS2;NR1D1;TAF1;MBD2;FOXO1;FOXJ3;ATF7;TERF2;ZBTB26;UPF2;MBD1;TCF7L1;ZFP41;IRF9;RUNX3;LRWD1;KLF10;XRCC6;AHR;MAX;TERF1;ZBTB7A;FLI1;ZNF148;LONP1;MECP2;KLF13;EGR1;ZBTB32;NR2C2;RFX2;NR2F2;CUX1;NFE2;SMAD4;ATF6;JUN;ATF5;FOXP2;CBFB;CTC1;ZBTB33;KMT2A;SP3;NFE2L2;ZBTB7B;HNRNPU;CEBPG;BCL6;GABPA;POU6F1;E2F3;GMEB2;ELF1;KMT2B;JUNB;IRF8;HOXB4;POU2F1;TCF7L2;TCF4;HIVEP1;TFAP4;ZNF23;RFX7;FOXK2;RFX4;NFATC3;XBP1;RXRB;POU2F2;HDAC4;RARG;KDM2B;FOXE1;CREB1;ZNF740;RFX1;GMEB1;NKX2-8;PROX1;SAFB;ZBTB20;PAX2;NPAS2;SREBF2;ZBTB18;MMP12;SLTM;ZCWPW1;KDM2A;SMG7;RBPJ;PRDM4;PPARD
prerank,microtubule minus-end binding (GO:0051011),0.567405365204527,1.1251779661095416,0.37466666666666665,0.962635327585483,1.0,6/13,13.42%,TUBGCP6;TUBGCP4;HAUS4;HAUS7;TUBGCP3;NUMA1
prerank,RNA stem-loop binding (GO:0035613),0.5793122499790129,1.121627395562206,0.3578363384188627,0.969666065105479,1.0,7/12,17.66%,CSDE1;MYH10;CPEB3;DHX9;METTL16;RC3H1;EPRS1
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.46656921192866213,-1.1214686216353875,0.3285198555956679,0.6850466781614551,1.0,6/10,14.67%,GABRG2;GABRG3;GABRA2;GABRA3;GABRG1;GABRA1
prerank,1-phosphatidylinositol binding (GO:0005545),-0.41326004452946236,-1.120926806099411,0.29218106995884774,0.6764469453376206,1.0,6/15,10.91%,WDFY3;SNAP91;EEA1;ZFYVE9;ZFYVE1;SCARB1
prerank,nucleoside-triphosphatase activity (GO:0017111),0.4586226546091972,1.1195935396368577,0.214,0.9713415381139359,1.0,35/248,12.50%,KIF15;KIF20B;KIF18B;KIF14;RAB33B;SMCHD1;CHD1L;GBP4;ATL2;ARHGDIB;ABCB10;ABCD1;RAB1B;RAB22A;RND3;GBP2;PIN1;GNAI1;RAB8A;DNA2;MTG2;GNAO1;KIF2A;RIT2;RHOU;RUVBL2;TOR1A;RUVBL1;DHX9;GPN2;RAB8B;DHX29;GFM2;RAB11B;RAB43
prerank,RNA binding (GO:0003723),0.4602981519325107,1.11942181473121,0.019,0.9666377713894078,1.0,405/1321,20.21%,TOP2A;MKI67;NUSAP1;RAD51AP1;MBNL3;ADAD1;HMGB2;BARD1;LBR;BRCA1;PTCD2;RADX;RBM15;ZC3H4;SUGP2;RPL7;RPL18A;FASTKD5;SMG6;NOL7;LSM6;CTNNA1;DDX11;RPS20;DHX38;KRI1;PRPF38B;FLNA;EIF4B;EZR;EIF2S1;EIF2A;DHX58;RBM3;RCAN3;NOP10;DEK;UTP3;NPM3;HMGB3;TBL2;NOA1;DDX18;SMG5;RPL36;RPL14;POLR2A;MKRN1;PA2G4;NUCKS1;UBE2I;SCAF11;SLBP;UBE2O;COA6;RPS19;MAP4;DDX49;DUT;ANKHD1;SLPI;TFRC;ZC3H7A;TNPO1;SNRPF;PPP1R8;RPS7;EIF3E;CDKN2A;HNRNPC;SNRPC;NKAP;RBM27;ZC3H18;RANGAP1;CRKL;TUBB4B;EDF1;HNRNPM;NUP42;R3HDM1;MRPL40;RPS4X;MRPL16;HEATR6;HNRNPL;RPS18;MRPL10;LRRC47;NAP1L4;HNRNPA3;CPSF2;SETX;CRNKL1;PEF1;TUBA1B;U2AF1;ZFP36L1;RPL23A;HMGN2;JAKMIP1;CSDE1;PSMC1;MTHFSD;SNRNP200;TNRC6B;PUM2;MRPL22;TAF15;TCP1;XRCC6;EIF4A3;DCP1B;CCDC137;HMGB1;METAP2;NOL10;SRSF3;RPL28;PKN2;EXOSC10;ZNF326;DYNC1H1;KMT2C;SPEN;UTP23;SAP18;ILF2;EWSR1;DCP2;HNRNPA2B1;PSPC1;DCN;NOVA2;MRPL37;TFB1M;CLTC;RPS14;GRB2;DNA2;ZNF638;RPL41;URB1;NOL11;TFB2M;MYEF2;MARK2;MYH10;SART3;NUDT4;SRSF4;NCBP1;NCOA5;PRPF38A;LSM2;SNRNP35;CSRP1;CCDC9;HNRNPUL2;RBM47;LLPH;RALY;DHX40;EDC3;NONO;CASC3;RNPS1;RPS27;EMG1;LONP1;RPS19BP1;MECP2;SRRT;MRPS7;CSTF3;BTF3;MRPL43;RBM19;RPS5;TXN;CPEB3;NIFK;SLC4A1AP;PUM3;RBMS2;UTP6;PCBP2;RBM38;RBFOX3;PNLDC1;MSN;SPATS2L;PARK7;TCOF1;SUMO1;LTA4H;RPLP0;RPS11;TUT4;RTF1;PUM1;PRPF31;PPP1CC;UBAP2;CCAR2;DHX9;JUN;RDX;IGF2BP3;MSI2;FBL;HNRNPA0;RPL27A;CNOT4;FASN;ERI1;LSM5;PELP1;TEP1;DHX29;DCP1A;NUP98;TEFM;APEX1;U2SURP;METTL16;CANX;UPF3B;RBM7;UCHL5;SRFBP1;KIN;FXR1;RTCA;VIRMA;HNRNPR;PPIG;ROCK2;RACK1;RPS9;RPS15A;THOC5;CWC15;DXO;HNRNPU;SF3B5;REXO4;DAZAP1;ACTN4;HELZ2;PRKDC;CEBPZ;LSM14A;PSIP1;DNAJC21;NAP1L1;NOL8;NFX1;SUMO2;CLNS1A;APTX;PPIA;HNRNPAB;PRRC2C;DIAPH1;NSA2;RPL12;RSRC2;PCBP3;TPT1;ANXA11;FDPS;KYAT3;CNOT1;CS;LARP1B;LUC7L2;DNAJC2;SRRM2;LRRFIP1;RPL22L1;LSM7;DDX43;METTL14;RC3H1;NOP58;MAP3K20;NTPCR;DIMT1;STAU1;THOC2;DHX57;SRSF10;IPO5;SART1;AHNAK;TARBP2;ASS1;NOSIP;PYM1;SAMD4A;ZFP36L2;ZC3H15;EEF2;PURG;UBAP2L;DARS1;TASOR;TRIM28;SNRNP40;VIM;TRUB2;SYNE1;SRSF7;ZGRF1;CDC40;POP4;TUT1;SRPK1;TCERG1;KPNB1;PSMD4;NAT10;LARP4B;SCAF8;TRNT1;RPL3;SCG3;ZCCHC24;DDX39B;TDRD7;POLDIP3;PNO1;SNRPG;PCF11;SEC63;HSP90B1;GSPT1;PRPF8;EPRS1;YWHAE;MEX3C;ERI3;HEXIM1;RPL18;ZBED4;MDH2;LACTB2;FLNB;DKC1;PTCD1;RBM25;FAM32A;REPIN1;PPIE;POLR1G;CAST;ALKBH5;HNRNPA1;RBBP6;CKAP4;PES1;YARS2;GNL3L;HADHB;ELAVL1;RTCB;EIF4ENIF1;RPL5;HNRNPLL;WRAP53;GPATCH8;RPS6;RPS17;NCBP2;SAFB;RPS3;TES;DDX54;CCT6A;THRAP3;ZCCHC8;NCBP3;RPL21;HELB;XRN1;AGO2;SRSF2;PTCD3;HELZ;SF3A2;SRBD1;CDK11B;AFF2;G3BP1;FAM120A;ZYX;SLTM;RPL23;RPL17;ZFR;SNRPB;CPSF7;PNPT1;TPR
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.4245510526275015,-1.1149720510455907,0.30514705882352944,0.6807323037905892,1.0,6/12,15.10%,FRS2;PIK3R1;SH2B2;BLNK;SH2B3;GAB2
prerank,cation transmembrane transporter activity (GO:0008324),0.48079343434516064,1.1138663911744697,0.33476394849785407,0.9813630759894381,1.0,3/48,2.84%,SLC38A5;SLC1A5;SLC7A1
prerank,acetyltransferase activity (GO:0016407),0.5131043882555113,1.1137538580816482,0.36877828054298645,0.9764701882589967,1.0,8/31,19.50%,ESCO2;PAFAH2;KAT6A;KAT2B;NAA16;CREBBP;NAT10;ELP3
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.49825006343318634,1.1136587820344797,0.35051546391752575,0.9715799654334343,1.0,2/32,2.20%,SLC38A5;SLC1A5
prerank,RNA methyltransferase activity (GO:0008173),0.5333234882866489,1.1118012972251092,0.3527180783817952,0.9730314939708122,1.0,6/19,11.69%,TRDMT1;METTL4;TRMT5;METTL8;TYW3;FBL
prerank,5'-3' RNA polymerase activity (GO:0034062),0.5131393022481149,1.1116416775613365,0.34418604651162793,0.968409247488616,1.0,11/27,22.39%,POLR1B;POLR2I;POLR2A;POLR1A;POLR1F;POLR1D;POLR1C;POLR2J;TENT2;POLR3B;POLR2B
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.522016491398318,1.1094974638625794,0.3609022556390977,0.9705601788072011,1.0,7/21,21.35%,PDE7B;PDE4A;PDE2A;PDE5A;PDE8A;PDE7A;PDE1C
prerank,copper ion binding (GO:0005507),0.4909757385488399,1.1090682227123112,0.3268398268398268,0.9668943780925573,1.0,10/42,17.91%,CUTA;CUTC;HEPH;COA6;ATP7A;PARK7;SUMF1;TP53;ATOX1;SNCA
prerank,TBP-class protein binding (GO:0017025),0.530093029647194,1.1090661558100567,0.36319612590799033,0.9618466956467641,1.0,9/21,21.59%,TAF1;PSMC1;AHR;GTF2A1;RUVBL2;RUVBL1;YEATS2;GTF2A2;TAF11
prerank,aspartic-type peptidase activity (GO:0070001),0.5859944011965121,1.107873311067853,0.38282387190684136,0.9609256905468389,1.0,3/10,14.04%,NAPSA;CTSE;PSEN1
prerank,NADPH binding (GO:0070402),0.5492055373732445,1.1067216686971555,0.3688639551192146,0.9597783668186665,1.0,2/13,7.13%,LBR;CBR4
prerank,vitamin D receptor binding (GO:0042809),0.5543319003457329,1.1050938820482328,0.3671562082777036,0.9601321609024872,1.0,12/14,29.47%,MED30;TAF7;MED14;MED1;THRAP3;MED13;TAF11;MED16;RXRA;MED12;MED4;SNW1
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.5616428028215539,1.1016569465865687,0.385049365303244,0.9669901626918717,1.0,7/12,21.91%,DCPS;CYFIP2;NCBP1;NCBP2;NCBP3;AGO2;EIF4E2
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.5364378348891706,1.1014293345889812,0.4007989347536618,0.9628623136659312,1.0,4/16,14.50%,SLC25A12;SLC1A5;SLC25A22;SLC25A13
prerank,MAP kinase kinase kinase activity (GO:0004709),0.5718450922965599,1.1002918197945282,0.36984352773826457,0.9619453815433385,1.0,5/11,17.72%,MAP3K5;MAP3K1;EGFR;MAP3K20;MAP3K7
prerank,organic anion transmembrane transporter activity (GO:0008514),0.4563389929800714,1.0988262055334568,0.3192771084337349,0.9619714136480061,1.0,20/134,12.40%,SLC4A1;SLC38A5;SLC25A21;SLC25A12;SLC1A5;SLC7A1;SLC16A12;SLC2A8;SLC16A1;SLCO4C1;SLC35D2;SLC35A1;SLCO4A1;ABCC2;SLC3A1;SLC52A1;SLC19A1;ABCC4;SLC25A22;SLCO2A1
prerank,serine-type peptidase activity (GO:0008236),0.46396824053102254,1.0973720838780647,0.336734693877551,0.9622819561296904,1.0,4/96,3.02%,PRTN3;TMPRSS4;TMPRSS3;FAP
prerank,PDZ domain binding (GO:0030165),0.47200589239590535,1.0967105513086528,0.36075949367088606,0.9597001711058547,1.0,6/61,8.39%,KIF14;CIT;PLEKHA2;KIDINS220;CCDC88C;ERC1
prerank,manganese ion binding (GO:0030145),-0.28111510428217834,-1.0956835674331675,0.27058823529411763,0.718597415743718,1.0,16/48,13.34%,XPNPEP3;XPNPEP1;FAM20C;GALNT3;ADCY2;EXD2;LARGE1;GYG1;GALNT1;ADPRM;MGAT1;MPPE1;HMGCL;XYLT2;ME1;B4GALT7
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.4002265193572133,-1.0933885456694876,0.34296028880866425,0.7138740841885801,1.0,6/14,16.71%,ACO2;SDHB;NFU1;ACO1;ISCU;RSAD1
prerank,acyl-CoA hydrolase activity (GO:0047617),0.5247844378566542,1.091360283261209,0.38976377952755903,0.9727708609387734,1.0,4/17,8.69%,ABCD1;ACOT11;ACOT13;ACOT2
prerank,growth factor activity (GO:0008083),0.4665558105421984,1.0909933500338713,0.35987590486039295,0.9691233250930171,1.0,4/74,6.89%,IL12A;NTF4;PGF;TGFA
prerank,MHC protein binding (GO:0042287),0.5197414970130001,1.0909552631474517,0.38366336633663367,0.9644774579193052,1.0,5/20,11.28%,CD74;TUBB4B;TAP1;PILRA;TUBB
prerank,calcium channel regulator activity (GO:0005246),0.4976458650241785,1.089133859795064,0.3776536312849162,0.9657608704601272,1.0,13/37,23.89%,RRAD;ITPR1;REM1;INAFM2;SGK3;NRXN2;STIMATE;YWHAE;CACNG8;NRXN1;CACNG4;FKBP1A;INAFM1
prerank,beta-tubulin binding (GO:0048487),0.49732301340607943,1.086132769688247,0.38875878220140514,0.9711148755328444,1.0,10/31,18.22%,RACGAP1;UXT;EMD;CCT5;FGF13;BBS4;APPL1;PEX14;TAOK1;TBCD
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.46388219115538043,1.083754361443878,0.3606027987082885,0.9743965280258664,1.0,9/53,15.61%,SLC38A5;SLC25A12;SLC1A5;SLC7A1;SLC43A2;SLC3A1;SLC25A22;SLC25A13;SFXN1
prerank,histone methyltransferase binding (GO:1990226),0.5607897461719249,1.0822846307981422,0.43828016643550627,0.9747158276642887,1.0,2/11,7.94%,LCORL;PHF1
prerank,antiporter activity (GO:0015297),0.5250689786200703,1.0816400145929692,0.4145141451414514,0.9721288998784468,1.0,5/20,14.28%,SLC35E1;SLC25A16;SLC35D2;SLC35A1;SLC35C2
prerank,signal sequence binding (GO:0005048),0.4764393740572418,1.0809761511911147,0.3742889647326507,0.9696067326113116,1.0,11/35,16.87%,POM121;TNPO1;KPNA3;NUP214;PEX5L;RANBP6;TOMM70;AP2B1;KDELR2;IPO5;KPNB1
prerank,N-methyltransferase activity (GO:0008170),0.5130869092268113,1.0806498140886243,0.3910891089108911,0.9661839995281217,1.0,6/20,15.24%,ZCCHC4;TRMO;TFB1M;TFB2M;METTL15;DIMT1
prerank,phosphatase binding (GO:0019902),0.4547696607394854,1.077091466762846,0.35721493440968716,0.9730920749460857,1.0,20/105,13.09%,NEK2;RPA2;ITGA1;MAPK1;RCAN3;STX17;CEP192;CDC27;SNX3;KCNN4;ANK1;TRAF3;ANAPC7;MAP3K5;MAPK14;MAST2;EGFR;CNST;PPP6R3;RACK1
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.3288710528834773,-1.0746595133830328,0.3231707317073171,0.7519879203962805,1.0,14/24,30.84%,EEF2K;CAMK1;PHKG2;CAMK4;CAMK2G;MAPKAPK2;CAMK2B;MKNK2;PHKA1;PTK2B;CAMK2D;CAMKK1;MAPKAPK5;MKNK1
prerank,phosphatase inhibitor activity (GO:0019212),0.510863687670828,1.0741352603994383,0.41035353535353536,0.9779849346038534,1.0,5/20,16.13%,PPP1R9B;LMTK2;ANP32E;PPP1R2;STYX
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.36442989932072134,-1.0705364879574697,0.3712871287128713,0.7528403001071812,1.0,7/18,24.20%,PIK3R5;WDR91;PIK3R1;SOCS7;AGAP2;PIK3R2;SOCS5
prerank,MHC class I protein binding (GO:0042288),0.5438211423120671,1.0681283402890862,0.42718446601941745,0.9922876940002999,1.0,5/13,17.92%,TUBB4B;TAP1;PILRA;TUBB;ATP5F1B
prerank,lipid phosphatase activity (GO:0042577),0.5336695471991231,1.0678478372860418,0.4157608695652174,0.9884713166900136,1.0,2/14,6.72%,PLPPR3;EPHX2
prerank,mRNA methyltransferase activity (GO:0008174),0.5331871841460378,1.0673163993673704,0.4122448979591837,0.9857706851167282,1.0,6/12,22.24%,CMTR2;METTL8;METTL16;METTL14;RNMT;TRMT10C
prerank,amino acid transmembrane transporter activity (GO:0015171),0.4615556352344345,1.0666520351246174,0.40303358613217766,0.983318710022814,1.0,5/47,10.11%,SLC38A5;SLC1A5;SLC7A1;SLC43A2;SLC3A1
prerank,acid-thiol ligase activity (GO:0016878),0.5308200436602861,1.0655435650975509,0.4064245810055866,0.9824862040432278,1.0,2/13,10.20%,ACSS3;SLC27A2
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.47525976230436595,1.0626818869685837,0.40386803185437997,0.9868944764085729,1.0,6/31,12.59%,SLC12A3;AQP1;SLC12A7;SLC12A1;KCNA1;SLC12A6
prerank,nuclear receptor binding (GO:0016922),0.44788134725639983,1.0621145174382307,0.3856998992950655,0.9843352127479879,1.0,43/111,23.16%,NR4A2;HMGA1;LEF1;BRD8;FOXP1;MED30;TAF1;YWHAH;TAF7;SMARCA4;NCOA7;TACC2;STRN;ZBTB7A;ASXL1;PARK7;PRKCB;TRIM68;STAT5B;ACTN4;LATS1;MED14;CNOT1;KDM4C;TADA3;TCF7L2;SIRT1;TMF1;MED1;PROX1;DDX54;THRAP3;NCOA6;NCOA2;MED13;MMS19;TAF11;NRIP1;RNF6;PHB2;BCAS3;NSD1;NCOA3
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.5231312488863115,1.0612190632205842,0.41578947368421054,0.9828253492417138,1.0,3/15,14.66%,SNX3;PHLDA3;RUBCNL
prerank,I-SMAD binding (GO:0070411),-0.39909066488357764,-1.0585177336317675,0.3968871595330739,0.7720038641620128,1.0,6/13,12.51%,TGFBR1;SMAD1;CTNNB1;SMAD3;SMAD6;SMAD7
prerank,double-stranded RNA binding (GO:0003725),0.4442331275133041,1.0571286095328525,0.4156378600823045,0.9914137457965708,1.0,17/70,16.42%,ADAD1;EIF4B;DHX58;TFRC;TUBB4B;TUBA1B;ILF2;CLTC;MSN;DHX9;FXR1;HNRNPU;APTX;LRRFIP1;RC3H1;TARBP2;VIM
prerank,solute:proton symporter activity (GO:0015295),-0.38239052919045124,-1.0544234735796798,0.3794642857142857,0.772991745660556,1.0,6/16,22.76%,CTNS;SLC25A3;SLC11A2;SLC2A9;SLC39A8;SLC36A1
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.5034786620213303,1.053446525601743,0.4318181818181818,0.9985145150118837,1.0,5/20,9.81%,AGPAT1;AGPAT4;GPAT3;MOGAT2;AGPAT3
prerank,ribosomal small subunit binding (GO:0043024),0.5143977722712006,1.0520051170706501,0.42091503267973857,0.9985611100228519,1.0,7/17,25.22%,EIF4B;PIM1;DHX29;PTCD3;ABCE1;NPM1;MTIF2
prerank,mRNA binding (GO:0003729),0.4332051039274001,1.0510418872794163,0.384,0.9970229946298854,1.0,89/249,20.70%,RBM15;RPL7;EIF2A;SLBP;SLPI;PPP1R8;RPS7;HNRNPC;HNRNPM;BOLL;HNRNPL;ZFP36L1;PUM2;EIF4A3;DCP1B;ELAVL4;UTP23;HNRNPA2B1;NOVA2;RPS14;RPL41;AUH;MYEF2;MYH10;SRSF4;NCBP1;SNRNP35;RBM47;EDC3;RNPS1;MRPS7;CSTF3;RPS5;CPEB3;SLC4A1AP;PUM3;RBMS2;PCBP2;RBFOX3;PARK7;PUM1;TYMS;DHX9;IGF2BP3;HNRNPA0;CCT5;DCP1A;NUP98;UPF3B;FXR1;HNRNPR;THOC5;DXO;HNRNPU;DAZAP1;LSM14A;HNRNPAB;RNF20;PCBP3;LUC7L2;SRRM2;TP53;METTL14;RC3H1;THOC2;ANGEL2;SAMD4A;TUT1;LARP4B;SCAF8;TDRD7;PCF11;RBM25;PPIE;ELAVL1;EIF4ENIF1;RPL5;HNRNPLL;NCBP2;RPS3;NCBP3;AGO2;SRBD1;G3BP1;TPR;FYTTD1;RBM4B;SYNCRIP;PTBP2
prerank,sulfuric ester hydrolase activity (GO:0008484),0.5376278728109503,1.0494263282975718,0.4353099730458221,0.9976001791537783,1.0,3/12,13.73%,SULF2;GALNS;ARSB
prerank,chloride channel regulator activity (GO:0017081),-0.4001225799496552,-1.0487130961271098,0.35655737704918034,0.7782312364305933,1.0,7/14,29.09%,VTI1B;VAMP8;STX1A;WNK2;CHRNA7;SGK1;CFTR
prerank,tau-protein kinase activity (GO:0050321),0.49225789008763093,1.0475502513763193,0.43625,0.9988176302726286,1.0,10/20,21.65%,FYN;MARK2;DYRK1A;ROCK2;GSK3B;MARK4;TAOK1;MARK1;ROCK1;BRSK1
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",-0.24861375789870666,-1.0471601852653982,0.32142857142857145,0.7719246475911378,1.0,21/74,13.69%,DGKH;HK2;HK3;FAM20C;PIK3CD;GALK2;DGKA;PI4KA;ETNK1;DGKI;PIK3C2B;DGKZ;AGK;PKM;PANK4;DGKQ;PANK3;NMRK1;PIK3CB;GNE;DGKB
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.4320990595728269,1.0466012549527788,0.302,0.9973437304717233,1.0,140/731,19.62%,E2F7;PAX5;E2F8;E2F2;UHRF1;GFI1;FOXA2;NKX6-1;VAX2;MYB;HMGB2;SPIB;MYBL1;DMRTA1;NR4A2;HMGA1;SOX6;HEY2;LEF1;E2F1;TEAD4;IKZF3;PBX4;BATF;ELK4;USF1;PBX3;ERG;BACH2;CTCF;FOXP1;ETS2;DACH1;NR1D1;FOXO1;FOXJ3;ATF7;E2F6;ZBTB26;BCL11A;EBF1;TCF7L1;TCF3;IRF9;RUNX3;HDAC6;EBF3;KLF10;H3-3A;AHR;DMTF1;ZBTB16;E2F5;PLAG1;NFE2L1;NRF1;SNAPC3;ZBTB7A;ZNF148;KLF13;EGR1;SALL2;ZBTB32;MYNN;NR2C2;RFX2;NR2F2;ZEB1;MXI1;NFYC;RUVBL2;NFE2;SMAD4;ATF6;MED8;DHX9;JUN;FOXP2;SATB2;ZBTB33;STAT5B;SP3;NFE2L2;ZBTB7B;HNRNPU;HIVEP2;CC2D1A;DDIT3;SKI;MYC;CEBPG;BCL6;GABPA;POU6F1;ZNF112;PBX2;E2F3;GMEB2;ELF1;TP53;JUNB;LRRFIP1;RUNX1;IRF8;HOXB4;POU2F1;PLAGL1;TCF7L2;TCF4;HIVEP1;TFAP4;ZNF23;RFX7;FOXK2;RFX4;ZNF445;NFATC3;XBP1;RXRB;MLXIP;ZNF467;POU2F2;HDAC4;RARG;FOXE1;ZBTB34;CREB1;ZNF740;RFX1;GMEB1;NKX2-8;PROX1;HDAC1;SAFB;ZBTB20;PAX2;THRAP3;NPAS2;SREBF2;PRRX1
prerank,protein kinase inhibitor activity (GO:0004860),0.4545543656061349,1.045480064492743,0.4244060475161987,0.9965102490399583,1.0,10/42,19.05%,CIT;GMFG;CIB1;IBTK;RACK1;SPRED2;PARVA;HEXIM1;SNCA;CDKN1A
prerank,leak channel activity (GO:0022840),0.49377861524093936,1.0453448426310008,0.43219264892268694,0.9925562436332473,1.0,1/18,0.51%,RHAG
prerank,snRNA binding (GO:0017069),0.455248883956483,1.0448515825911542,0.43688254665203075,0.989828177591051,1.0,16/42,19.12%,SNRPC;RNPC3;SART3;LSM2;SNRNP35;PRPF31;CCNT1;RBM7;HNRNPU;PRPF4;LSM7;TUT1;DDX39B;PRPF8;HEXIM1;NCBP2
prerank,neurexin family protein binding (GO:0042043),0.5446830910085818,1.0433110452204284,0.4405797101449275,0.9903008660129323,1.0,1/10,3.01%,CEL
prerank,calcium channel activity (GO:0005262),-0.2270032525055719,-1.0429747620171994,0.48,0.7733286441586281,1.0,37/84,29.80%,SLC24A3;CACNB2;CACNA1C;TRPC5;TPCN2;CUL5;MCOLN1;TRPC4;TRPC1;CACNA2D3;CACNG7;CACNG2;RYR2;PKD1;SEC61A1;CACNB4;CACNA2D2;TRPV4;TRPC3;NCS1;ORAI1;P2RX4;ANXA2;PKD2L1;CACNA1E;PKD1L2;PKD2L2;ANXA6;ANXA9;CACNB1;CHRNA7;STIM2;CACNA2D4;CATSPER3;SLC24A5;TRPC7;TRPM2
prerank,cytokine receptor binding (GO:0005126),0.44001427046518377,1.0412970133963548,0.44181256436663235,0.9921830167816703,1.0,22/83,23.11%,IL12A;INHBC;PGF;JAK2;SOCS2;IL22;SPRED2;TLR5;PIBF1;IL27;USP15;TGFB2;CCL25;KITLG;ERAP1;TRAF6;SMAD2;TYK2;SYK;PXDN;FKBP1A;ADAM17
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.549776899039971,1.0411714023302692,0.4362880886426593,0.9882955272646953,1.0,3/11,8.81%,DCPS;DCP2;NUDT4
prerank,store-operated calcium channel activity (GO:0015279),-0.4224480251639281,-1.0411361923473506,0.40202702702702703,0.7682141770208938,1.0,8/10,30.68%,TRPC5;TRPC4;TRPC1;TRPC3;ORAI1;STIM2;TRPC7;ORAI3
prerank,ubiquitin-protein transferase activity (GO:0004842),0.43343624653234586,1.0408285918229752,0.381,0.9849256199592813,1.0,90/346,19.65%,UBE2C;UBE2T;UHRF1;TRIM58;BARD1;NEURL1B;RFWD3;RNF26;BRCA1;MEFV;DTL;TRIM59;PML;PRPF19;PPP1R11;CDC23;FBXW11;MKRN1;FBXO3;UBE2O;TAF1;TRAIP;FBXO44;MSL2;TRAF3;BIRC2;UBE2Z;BIRC6;UBE2K;UBE3B;NEDD4L;TRIM11;RNF157;FBXO17;KLHL9;RNF141;KCMF1;TNFAIP1;ASB1;CUL3;TRIM47;CBLL1;IRF2BPL;AMFR;UBE3C;TRIM44;UBR2;RNF168;XIAP;MIB1;RNF8;TRIM3;CNOT4;TRIM68;RNF2;RNF152;FBXO11;NFX1;ARIH2;FANCL;RNF20;TRIM5;RNF111;RBCK1;RC3H1;MYLIP;TRIM28;RNF115;TRAF3IP2;UBE2R2;RNF103-CHMP3;SH3RF1;RNF4;RNF19A;TRIM37;UBE2M;DDB2;MEX3C;SYVN1;UBE2G1;MALT1;FBXW8;RNF214;RBBP6;RNF43;BSPRY;TRAF6;AKTIP;RNFT2;DTX3
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.5332846337244698,1.038696604110507,0.4380053908355795,0.9872691451988366,1.0,6/14,15.29%,MTMR12;MTMR2;MTMR14;MTMR6;PTEN;MTM1
prerank,pyrophosphatase activity (GO:0016462),0.4534725598793322,1.0386052735218605,0.4303931987247609,0.9833219904264701,1.0,11/50,13.24%,ALPL;DCPS;DCP2;ENTPD3;PPA2;ENTPD5;NUDT4;NUDT9;DHX9;DHX29;DXO
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.5244259688929339,1.038469798482845,0.43784530386740333,0.9795962989649936,1.0,3/12,12.97%,DCXR;CBR4;DHRS4
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.4634202014286389,1.038453453758222,0.44831460674157303,0.9755310923899281,1.0,5/35,11.00%,BLK;FYN;MELK;DYRK1A;BTK
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.24925358818981952,-1.0374087989899772,0.37254901960784315,0.7680116592162707,1.0,6/60,4.03%,MERTK;ACVR1;IGF1R;CSF1R;ERBB4;FLT1
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.5112482573109354,1.0373521202158735,0.4542974079126876,0.9746911907606499,1.0,4/15,14.50%,SLC25A12;SLC1A5;SLC25A22;SLC25A13
prerank,actin binding (GO:0003779),0.4302837217451899,1.03711016976648,0.42985971943887774,0.9713073808207482,1.0,43/170,18.13%,KIF18A;ANLN;MEFV;ALKBH4;PHACTR4;CCDC88A;SYNE2;SLC6A2;EZR;GAS2L3;PRKCE;PHACTR2;GSN;SORBS1;SYNPO2;FXYD5;SHROOM2;DBNL;MYH10;PDLIM7;FLII;LIMA1;PAWR;EMD;VPS16;MTSS1;VASH2;RDX;HNRNPU;ADD2;ACTN4;DAG1;PARVB;SYNE1;PARVA;ADCY8;CALD1;UTRN;CXCR4;PDLIM5;SNCA;FLNB;LRRK2
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.498665079670901,1.0354469254206553,0.43893591293833134,0.9719490950173029,1.0,5/18,18.86%,STXBP6;S100A11;PDLIM5;PPP1CA;CDC42EP1
prerank,protein tyrosine kinase activity (GO:0004713),0.43216619267931616,1.0329762536684295,0.44771573604060916,0.9753495034231582,1.0,15/108,12.67%,TTK;BLK;WEE1;ERBB3;FYN;BAZ1B;JAK2;EGFR;EPHA3;HIPK2;MELK;DYRK1A;BTK;FLT3;LMTK2
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.4279801567746269,-1.0329006098966436,0.4140127388535032,0.7696703211560065,1.0,5/10,32.37%,B4GALT5;B4GALT7;B3GALT5;B3GALT2;B3GALT6
prerank,clathrin adaptor activity (GO:0035615),0.5109963649507814,1.0310377335561034,0.4413702239789196,0.9771735744029891,1.0,5/15,17.61%,AP1G2;STON1;AP2B1;STON2;LDLRAP1
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.4273362491121996,1.0291563811398992,0.427,0.9786057594681555,1.0,48/254,17.40%,E2F2;MYB;SPIB;MYBL1;NR4A2;LEF1;SMARCD2;ELK4;ERG;FOXO1;FOXJ3;MDM4;TCF3;TFDP1;KLF10;ZBTB16;RLF;PLAG1;NRF1;EGR1;TFDP2;SALL2;NR2C2;NFYC;SMAD4;ATF6;JUN;ATF5;SATB2;DDIT3;MYC;CEBPG;GABPA;ZNF112;PBX2;E2F3;ELF1;TP53;RUNX1;PLAGL1;TCF4;TFAP4;FOXK2;RFX4;ZNF445;NFATC3;RXRB;MLXIP
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.46402281292376096,1.026710734214098,0.45128779395296753,0.9815467966407525,1.0,13/34,20.76%,ERI2;PDE12;EXOSC10;PNLDC1;ERI1;CNOT1;ANGEL2;CNOT6;ERI3;DIS3L;CNOT8;PNPT1;CNOT7
prerank,gated channel activity (GO:0022836),-0.379398493798743,-1.0262069695696716,0.43223443223443225,0.7776533711019241,1.0,4/14,10.16%,PACC1;TMEM63A;TMEM63B;TMEM266
prerank,carboxy-lyase activity (GO:0016831),0.47717422170390345,1.0259651741562255,0.4467065868263473,0.9797395656067076,1.0,4/23,11.99%,PISD;AZIN1;UXS1;CSAD
prerank,R-SMAD binding (GO:0070412),0.4966709871417379,1.0253329429288458,0.47029077117572693,0.9776874469220949,1.0,5/18,11.47%,MEN1;PMEPA1;TRIM33;SMAD4;JUN
prerank,SUMO transferase activity (GO:0019789),0.5072091394847654,1.024774900827945,0.43733681462140994,0.9754271170215504,1.0,8/16,21.09%,UBE2I;PIAS3;NSMCE2;RANBP2;PIAS1;TRIM28;HDAC4;MDM2
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.4218068361940698,1.0228285639370454,0.38,0.9772927349803991,1.0,155/830,19.49%,E2F7;PAX5;E2F8;FOXM1;E2F2;GFI1;FOXA2;NKX6-1;VAX2;MYB;SPIB;MYBL1;DMRTA1;NR4A2;SOX6;HEY2;DEAF1;LEF1;E2F1;RB1;TEAD4;IKZF3;PBX4;BATF;ELK4;TWIST1;USF1;PBX3;ERG;BACH2;CTCF;RBL1;FOXP1;ETS2;DACH1;NR1D1;TAF1;NFXL1;FOXO1;FOXJ3;ATF7;E2F6;ZBTB26;BCL11A;EBF1;TCF7L1;TCF3;ZFP41;IRF9;RUNX3;HDAC6;TFDP1;EBF3;KLF10;H3-3A;MAX;DMTF1;ZBTB16;E2F5;GTF2A1;ETV6;PLAG1;NFE2L1;NRF1;SNAPC3;ZBTB7A;ZNF148;KLF13;EGR1;TFDP2;SALL2;ZBTB32;MYNN;NR2C2;RFX2;NR2F2;ZEB1;CUX1;MXI1;NFYC;RUVBL2;NFE2;SMAD4;ATF6;MED8;DHX9;JUN;ATF5;FOXP2;ZNF25;SATB2;ZBTB33;STAT5B;SP3;NFE2L2;ZBTB7B;HNRNPU;HIVEP2;CC2D1A;ACTN4;DDIT3;SKI;MYC;CEBPG;BCL6;GABPA;NFX1;POU6F1;ZNF112;PBX2;E2F3;GMEB2;ELF1;TP53;JUNB;LRRFIP1;RUNX1;IRF8;HOXB4;POU2F1;PLAGL1;TCF7L2;TCF4;HIVEP1;TFAP4;ZNF23;PURG;RFX7;FOXK2;RFX4;ZNF445;NFATC3;XBP1;RXRB;MLXIP;ZNF467;POU2F2;HDAC4;RARG;FOXE1;ZBTB34;CREB1;ZNF740;RFX1;GMEB1;NKX2-8;PROX1;HDAC1;SAFB;ZBTB20;RPS3;PAX2;THRAP3;NPAS2;SREBF2
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.40950578596593423,-1.0225003398121693,0.42641509433962266,0.7782138578904231,1.0,6/11,17.07%,ITPR2;TRPC5;TRPC4;TRPC1;ITPR3;TRPC3
prerank,phospholipase inhibitor activity (GO:0004859),-0.4237346817529327,-1.0155362860134778,0.45741324921135645,0.7876567212542687,1.0,8/10,39.47%,ANXA4;APOC1;ANXA2;ANXA9;ANXA1;ANGPTL3;ANXA5;SNCB
prerank,RNA cap binding (GO:0000339),0.4984978966662533,1.0152291484598162,0.45225464190981435,0.9954085405965262,1.0,7/16,21.91%,DCPS;CYFIP2;NCBP1;NCBP2;NCBP3;AGO2;EIF4E2
prerank,purinergic nucleotide receptor activity (GO:0001614),0.49594021693913415,1.0138245229318048,0.4789473684210526,0.9953438725956114,1.0,2/15,9.48%,P2RX1;P2RY1
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.420626160642002,1.0126945377305654,0.467,0.9946124524872583,1.0,82/269,21.09%,UBE2C;UBE2T;CCNB1;BRCA1;RPA2;CHEK2;RB1;ERBB3;GLMN;SMC6;PML;AXIN1;SMG5;POLR2A;PA2G4;TANK;PTPN22;IKBKG;FOXO1;FAF1;NPLOC4;TUBA1B;HDAC6;TRAF3;CCT2;TCP1;DDRGK1;UBE2K;SNX9;FAF2;PRKACA;RAD18;BLZF1;EGFR;CASC3;CUL3;PRR7;PCBP2;SUMO1;TUBB;RNF8;JUN;BECN1;AMBRA1;ARRB2;CDK5RAP3;SPOP;SKI;SUMO2;BAG1;FANCL;RNF20;GSK3B;TP53;CCDC50;HGS;TRIOBP;YOD1;TRIM28;USP25;UBXN1;CAMLG;TRIM37;UBA52;USP7;CXCR4;YWHAE;UBE2G1;STAM;RPL5;WRAP53;CDKN1A;SLF1;TRAF6;CASP8;PRKAR2A;RPL23;PRR5L;UBE2N;SMAD2;RIPK1;MDM2
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.4207339477541085,1.0113786517097472,0.4744232698094283,0.9943274516597643,1.0,35/173,16.67%,E2F8;GFI1;HEY2;DEAF1;CTCF;FOXP1;ETS2;DACH1;NR1D1;E2F6;ZBTB26;BCL11A;TCF3;MAX;ZBTB16;ETV6;ZNF148;ZBTB32;ZEB1;MXI1;JUN;FOXP2;ZNF25;ZBTB33;CC2D1A;SKI;MYC;BCL6;NFX1;POU6F1;LRRFIP1;IRF8;PLAGL1;FOXK2;NFATC3
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.4170547543561631,1.009580756097004,0.454,0.9952151016297638,1.0,139/730,19.62%,E2F7;PAX5;E2F8;E2F2;GFI1;FOXA2;NKX6-1;VAX2;MYB;SPIB;MYBL1;DMRTA1;NR4A2;SOX6;HEY2;LEF1;E2F1;TEAD4;IKZF3;PBX4;BATF;ELK4;TWIST1;USF1;PBX3;ERG;BACH2;CTCF;FOXP1;ETS2;DACH1;NR1D1;FOXO1;FOXJ3;ATF7;E2F6;ZBTB26;BCL11A;EBF1;TCF7L1;TCF3;IRF9;RUNX3;HDAC6;EBF3;KLF10;H3-3A;AHR;MAX;DMTF1;ZBTB16;E2F5;PLAG1;NFE2L1;NRF1;SNAPC3;ZBTB7A;ZNF148;KLF13;EGR1;SALL2;ZBTB32;MYNN;NR2C2;RFX2;NR2F2;ZEB1;MXI1;NFYC;RUVBL2;NFE2;SMAD4;ATF6;MED8;DHX9;JUN;FOXP2;SATB2;ZBTB33;STAT5B;SP3;NFE2L2;ZBTB7B;HNRNPU;HIVEP2;CC2D1A;DDIT3;SKI;MYC;CEBPG;BCL6;GABPA;POU6F1;ZNF112;PBX2;E2F3;GMEB2;ELF1;TP53;JUNB;LRRFIP1;RUNX1;IRF8;HOXB4;POU2F1;PLAGL1;TCF7L2;TCF4;HIVEP1;TFAP4;ZNF23;RFX7;FOXK2;RFX4;ZNF445;NFATC3;XBP1;RXRB;MLXIP;ZNF467;POU2F2;HDAC4;RARG;FOXE1;ZBTB34;CREB1;ZNF740;RFX1;GMEB1;NKX2-8;PROX1;HDAC1;SAFB;ZBTB20;PAX2;THRAP3;NPAS2;SREBF2;PRRX1
prerank,nuclear receptor coactivator activity (GO:0030374),0.4336273264697579,1.008423111582005,0.47396386822529224,0.994569298179893,1.0,23/52,23.76%,PSMC3IP;HMGA1;BRD8;MED30;NCOA7;CCAR2;PRKCB;ACTN4;HELZ2;MED14;SS18;CNOT6;TMF1;RNF4;MED1;THRAP3;NCOA6;NCOA2;MED13;CALCOCO1;ACTN1;NCOA3;WDR77
prerank,filamin binding (GO:0031005),0.5205316960935336,1.0070594719239951,0.48337950138504154,0.9944220767994983,1.0,2/11,6.71%,RFLNB;SYNPO2
prerank,tRNA binding (GO:0000049),-0.26880276826850596,-1.0062914792303266,0.4,0.8009633982579986,1.0,15/43,21.44%,NEMF;CARS1;SARS1;TRNAU1AP;AIMP1;NSUN2;ELP5;TYW5;ALKBH1;TRMT10B;IGHMBP2;RPUSD4;YRDC;DARS2;TRMT10A
prerank,MAP kinase phosphatase activity (GO:0033549),-0.39058700305063965,-1.0055401144854639,0.4216417910447761,0.7939625353210562,1.0,3/12,12.82%,DUSP3;DUSP10;DUSP7
prerank,phosphatidylinositol binding (GO:0035091),-0.23112075240135885,-1.0027706497800195,0.4583333333333333,0.7917855895564627,1.0,26/91,17.90%,SNX24;ITPR2;WDFY3;APPL2;SNAP91;SNX5;EEA1;ZFYVE9;TULP3;PHF12;SNX16;SNX11;ZFYVE1;SNX27;SCARB1;FES;PITPNB;MPPE1;NCF1;GAP43;MCF2L;ITPR3;SH3YL1;C2CD2L;PITPNM2;THY1
prerank,sequence-specific mRNA binding (GO:1990825),0.5402012354250416,1.0021808514654114,0.4918032786885246,1.0,1.0,2/10,11.45%,TYMS;DHX9
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.5267078386881835,1.0011064594340158,0.4802919708029197,1.0,1.0,7/10,31.50%,PML;ANKRD13A;DNAJB2;LAPTM5;ANKRD13B;FAAP20;ANKRD13D
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.47228822422734734,1.0005489091455229,0.4975369458128079,1.0,1.0,8/22,18.78%,EXOSC8;ZFP36L1;ELAVL4;CPEB3;HNRNPA0;ZFP36L2;CPSF1;ELAVL1
prerank,heme binding (GO:0020037),0.42129693267065255,0.9953213484446208,0.49686192468619245,1.0,1.0,9/65,12.99%,CYP1B1;SDHD;NR1D1;CYP2A6;JAK2;PGRMC2;CYP27A1;CYP46A1;HEBP1
prerank,receptor antagonist activity (GO:0048019),-0.3499947627993441,-0.9952695961573185,0.4366812227074236,0.8015213766821483,1.0,9/17,49.38%,DKK2;IL18BP;CCL5;DKK3;ESR2;FST;IGSF1;WFIKKN1;AGTR2
prerank,Toll-like receptor binding (GO:0035325),0.5127380397056428,0.9944617407515215,0.4695035460992908,1.0,1.0,4/11,14.19%,S100A9;S100A8;MYD88;TLR6
prerank,metal ion binding (GO:0046872),0.40865469721035713,0.9941283232157481,0.551,1.0,1.0,82/477,17.93%,TOP2A;EFCAB11;GEN1;PIF1;PLK1;STK26;SLC25A12;C2CD5;OXSR1;ITPR1;S100A11;PPP3CA;RCN3;S100A9;MSH6;STK11;FEN1;DUT;SYT8;RASGRP1;IMPA1;SIK2;S100A8;UBA2;GSN;EPHX2;PDE2A;STK38L;MAP3K5;GNAI1;CIB1;TDP2;RP2;PPA2;STK38;MARK2;CDH18;CDH24;MAST2;SMOC2;CAPN1;CEMIP2;MELK;DNER;MICU3;SYT3;SLIT3;SLIT1;CRACR2A;APEX1;CANX;NT5C3A;DXO;BAIAP3;LATS1;TPM4;MICU1;ADGRL3;SLC25A13;TPT1;ANXA11;ADGRV1;STK4;IDH2;MAP3K20;GCA;RPE;NDUFAB1;CDH4;PDXK;FOXK2;PIR;ACER3;SRPK1;TRPM4;ADPRH;CANT1;HSP90B1;MCTP1;TDG;SNCA;IQGAP1
prerank,cadherin binding (GO:0045296),0.40980069375155925,0.9926270854929976,0.526,1.0,1.0,86/315,19.54%,DIAPH3;CIP2A;CCNB2;TMPO;CKAP5;ANLN;CTNNA1;STXBP6;FLNA;SLK;EZR;S100A11;EIF2A;VASN;RPL14;SWAP70;EIF3E;CNN2;RANGAP1;CRKL;STX5;RPL23A;FXYD5;PKN2;SNX9;DBNL;ERC1;STK38;MARK2;CDH18;CDH24;UNC45A;STK24;EGFR;CLIC1;LIMA1;CEMIP2;PARK7;EMD;RUVBL1;AHSA1;UBAP2;BSG;RDX;FASN;VAPA;DHX29;OLA1;PACSIN2;RAB11B;HCFC1;PLCB3;RACK1;CC2D1A;TXNDC9;PSEN1;BAG3;PPL;LRRFIP1;SPTAN1;AHNAK;PPFIBP1;CTNND2;CDH4;ZC3H15;EEF2;PAK2;PARVA;LASP1;SEPTIN9;DNAJB1;CHMP2B;CALD1;YWHAE;PDLIM5;NDRG1;PPP1CA;IQGAP1;FLNB;CAST;NUDC;CDC42EP1;CLINT1;TES;TAGLN2;ARHGAP1
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.47593507091434906,0.9916882595204348,0.5077519379844961,1.0,1.0,10/20,21.36%,SENP1;DESI2;OTUD5;USP50;YOD1;USP21;USP25;USP7;USP47;COPS2
prerank,tumor necrosis factor receptor binding (GO:0005164),0.50148533029831,0.9897413201117047,0.49868073878627966,1.0,1.0,5/12,26.47%,TRAF3;TRIM37;TRAF6;BABAM2;TRAP1
prerank,ribosome binding (GO:0043022),0.4290882449929608,0.9865726221844622,0.4983783783783784,1.0,1.0,14/46,22.90%,SLFN14;EIF2S1;EIF2A;CPEB3;ERI1;NAA16;RACK1;PYM1;EEF2;NCLN;CCDC47;EIF6;EFL1;SRP68
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.2750534691739403,-0.9843920639356484,0.45871559633027525,0.8201859769383885,1.0,10/35,14.95%,GPCPD1;PLCB2;ENPP2;GDE1;APEX2;PLCB4;PDIA3;MPPE1;PLCXD2;SMPDL3A
prerank,E-box binding (GO:0070888),0.44030833004510245,0.9827978152294031,0.4915254237288136,1.0,1.0,8/34,16.05%,TWIST1;TCF3;AHR;MAX;ZEB1;MYC;TCF4;TFAP4
prerank,protein kinase C activity (GO:0004697),0.4834561754376461,0.9811038276730465,0.5066137566137566,1.0,1.0,4/14,11.86%,PRKCE;PRKD3;PRKCA;PRKCB
prerank,phosphatidate phosphatase activity (GO:0008195),0.49532804349782295,0.980650294807739,0.5095628415300546,1.0,1.0,1/13,1.23%,PLPPR3
prerank,ubiquitin protein ligase activity (GO:0061630),0.4086382746478548,0.9785029985882837,0.559,1.0,1.0,56/228,19.65%,UHRF1;TRIM58;NEURL1B;RFWD3;RNF26;MEFV;TRIM59;PRPF19;PPP1R11;MKRN1;UBE2O;FBXO44;MSL2;BIRC2;UBE2K;UBE4B;UBE3B;NEDD4L;TRIM11;RNF157;FBXO17;KCMF1;ASB1;CUL3;CBLL1;IRF2BPL;AMFR;UBE3C;TRIM44;UBR2;XIAP;RNF8;TRIM3;TRIM68;RNF2;RNF152;NFX1;ARIH2;FANCL;TRIM5;RNF111;RC3H1;MYLIP;RNF115;TRAF3IP2;SH3RF1;RNF19A;TRIM37;MEX3C;SYVN1;RBBP6;RNF43;BSPRY;TRAF6;RNFT2;DTX3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.5149778520855678,0.9763671195601047,0.523876404494382,1.0,1.0,1/11,2.63%,DDAH2
prerank,transcription coactivator binding (GO:0001223),0.4617984603803672,0.9760265849603414,0.5276752767527675,1.0,1.0,3/20,11.17%,CIT;AHR;SMAD4
prerank,cAMP response element binding (GO:0035497),0.5060652824401074,0.9755464196844131,0.48405797101449277,1.0,1.0,4/10,23.92%,ATF7;JUN;CREB1;HMGA2
prerank,protein phosphatase regulator activity (GO:0019888),0.4256546857900573,0.9750323450365893,0.5505376344086022,1.0,1.0,11/53,13.71%,PHACTR4;PPP1R9B;PTPA;RCAN3;ANKLE2;PPP2R5E;PPP2R5A;PPP1R15A;LMTK2;PPP6R3;PPP1R2
prerank,ubiquitin-dependent protein binding (GO:0140036),0.5023944967645095,0.9729496614030239,0.5057471264367817,1.0,1.0,8/10,31.50%,USP15;DNAJC2;ANKRD13A;DNAJB2;LAPTM5;ANKRD13B;FAAP20;ANKRD13D
prerank,glutamate receptor activity (GO:0008066),-0.3280019295871829,-0.9706924403550367,0.4577114427860697,0.8458863413952189,1.0,6/19,18.50%,GRIA1;GRIA4;GRM5;GRIK2;GRM8;GRIK4
prerank,voltage-gated ion channel activity (GO:0005244),0.48096189475689943,0.9695449066275154,0.5205843293492696,1.0,1.0,4/14,19.97%,VDAC2;HVCN1;ANO6;PKD2
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.4517084452786441,0.9689735315112626,0.5197044334975369,1.0,1.0,7/23,21.35%,PDE7B;PDE4A;PDE2A;PDE5A;PDE8A;PDE7A;PDE1C
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.48271068535706,0.9683921398126085,0.5203145478374837,1.0,1.0,7/16,19.71%,MTMR12;MTMR2;MTMR14;MTMR6;PTEN;MTM1;INPP5F
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.43885005941190347,0.9680787673988929,0.527122641509434,1.0,1.0,10/28,22.78%,EXO1;FEN1;EDC3;APEX1;PRORP;RNASEH2A;POP4;AGO2;ENDOV;RPP30
prerank,semaphorin receptor binding (GO:0030215),-0.3011258602014406,-0.9680631499976131,0.4909090909090909,0.8437489195449988,1.0,14/23,36.86%,SEMA3D;SEMA3E;SEMA4C;SH3BP1;SEMA4G;SEMA3A;SEMA7A;SEMA4D;SEMA4F;PLXNB1;SEMA6C;SEMA6B;SEMA3B;SEMA3F
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.4846310218272825,0.9680093867357157,0.5068681318681318,1.0,1.0,2/12,4.65%,CCDC88A;PGF
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.42580695773478655,0.9663012980534315,0.5327604726100966,1.0,1.0,20/49,23.05%,ABRAXAS1;IKBKG;HDAC6;ZRANB3;RAD18;UBQLN1;TAB3;RNF169;RAD23A;RNF168;ZFAND2B;PSMD4;UBXN1;PRPF8;ATRIP;OTUD7A;UBQLN2;MINDY2;ZBTB1;UIMC1
prerank,glycine binding (GO:0016594),-0.38814458589121503,-0.9648497367832939,0.5017301038062284,0.8424836377733689,1.0,9/11,44.23%,GRIN3A;GLRA2;GRIN2B;GLRA3;GRIN1;SRR;GNMT;GRIN3B;GLDC
prerank,phosphatase activator activity (GO:0019211),0.4942094848970726,0.9647151827171293,0.5330739299610895,1.0,1.0,4/14,9.87%,PHACTR4;PPP2R5E;PPP2R5A;PPP1R15A
prerank,neuropeptide hormone activity (GO:0005184),0.4526831542817067,0.9638666778860732,0.5139732685297691,1.0,1.0,4/22,19.87%,AGRP;ADCYAP1;PPY;HCRT
prerank,growth factor receptor binding (GO:0070851),0.40403053266850497,0.9626126046138519,0.5647773279352226,1.0,1.0,15/95,15.38%,IL12A;CCDC88A;GLMN;FYN;PGF;ARF4;TGFA;GRB2;JAK2;IL1R1;FGF9;TLR5;PIBF1;PSEN1;EGF
prerank,androgen receptor binding (GO:0050681),0.4525569941676838,0.9613576603851556,0.5386416861826698,1.0,1.0,8/25,17.13%,FOXP1;SMARCA4;ZBTB7A;PARK7;PRKCB;TRIM68;KDM4C;TMF1
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.44011511157128874,0.9610320011358479,0.5437003405221339,1.0,1.0,10/28,26.47%,PIDD1;TRAF3;MYD88;TRIM37;TRAF6;RIPK1;MADD;BABAM2;CASP8AP2;TRAP1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.5023022017805253,0.9603743681178164,0.5233380480905233,1.0,1.0,6/10,26.05%,NSD2;NSD3;ASH1L;SETD5;NSD1;SETD2
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.49255017286393343,0.9603492777915648,0.5206043956043956,1.0,1.0,3/11,13.84%,SGMS2;PIGF;SGMS1
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.3999753583169197,0.9576144595384293,0.624,1.0,1.0,57/232,19.65%,UHRF1;TRIM58;NEURL1B;RFWD3;RNF26;MEFV;TRIM59;PRPF19;PPP1R11;MKRN1;UBE2O;FBXO44;MSL2;BIRC2;UBE3B;NEDD4L;TRIM11;RNF157;FBXO17;KCMF1;ASB1;CUL3;PIAS3;CBLL1;IRF2BPL;AMFR;UBE3C;TRIM44;NSMCE2;UBR2;XIAP;RNF8;TRIM3;TRIM68;RNF2;RNF152;NFX1;ARIH2;FANCL;TRIM5;RNF111;RC3H1;PIAS1;MYLIP;RNF115;TRAF3IP2;SH3RF1;RNF19A;TRIM37;MEX3C;SYVN1;RBBP6;RNF43;BSPRY;TRAF6;RNFT2;DTX3
prerank,galactosyltransferase activity (GO:0008378),-0.3823214014165982,-0.9568459779958146,0.4918032786885246,0.853020815704857,1.0,7/11,40.81%,B4GALT5;B4GALT7;B3GALT6;B4GALT4;B4GALT2;A4GALT;B3GNT6
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.3688120863151986,-0.9553608234944941,0.4962121212121212,0.8480428277956413,1.0,8/13,25.92%,TRMT1;WDR4;METTL1;FTSJ1;TRMT10B;TRMT10A;TRMT11;THUMPD2
prerank,proton transmembrane transporter activity (GO:0015078),-0.2763180996473244,-0.9549881745350287,0.5164835164835165,0.8401840863636867,1.0,11/39,19.28%,ATP6V1B2;CTNS;SLC9A1;COX6B1;CLCN4;SLC11A2;COX5A;ATP6V1F;UQCRQ;UQCRFS1;NNT
prerank,death domain binding (GO:0070513),0.4897343215910262,0.9540290938270947,0.5236728837876614,1.0,1.0,3/11,13.09%,DAP;TRADD;RACK1
prerank,epidermal growth factor receptor binding (GO:0005154),0.4368378030745036,0.952386210232633,0.552168815943728,1.0,1.0,4/25,8.31%,CCDC88A;ARF4;TGFA;GRB2
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.48329709534129084,0.95172230900599,0.5239398084815321,1.0,1.0,5/11,20.49%,NDUFAF7;FBXO11;PRMT9;PRMT3;PRMT7
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.43618197807734727,0.9515836761512056,0.5542725173210161,1.0,1.0,3/28,10.28%,CHRNB4;GABRA4;GABRA5
prerank,ATPase regulator activity (GO:0060590),-0.2701909388414867,-0.9485701383324834,0.5233644859813084,0.8477426340311044,1.0,12/38,15.44%,PFN1;DNAJC19;DNAJB6;HSPH1;DNAJA2;ATP1B2;FNIP1;TSC1;ATP1B1;HSPBP1;SIL1;DNAJC1
prerank,ribonuclease activity (GO:0004540),0.40905701306402764,0.946729012040897,0.5549626467449307,1.0,1.0,7/56,7.55%,SLFN14;RNASE6;SMG6;PPP1R8;EXOSC8;YBEY;EXOSC10
prerank,hyaluronic acid binding (GO:0005540),0.49725097852204125,0.9462372648737625,0.5584795321637427,1.0,1.0,1/10,3.89%,CD44
prerank,hexosaminidase activity (GO:0015929),-0.3670738676396966,-0.9450260867573886,0.5359712230215827,0.8478406790303896,1.0,2/12,10.93%,HEXB;HEXD
prerank,peptide N-acetyltransferase activity (GO:0034212),0.4984662943279211,0.9445433817116574,0.5497159090909091,1.0,1.0,3/10,15.22%,NAA16;NAA25;NAA20
prerank,chemokine receptor binding (GO:0042379),-0.26736736676767675,-0.943792178365524,0.5631067961165048,0.842416934619507,1.0,16/35,47.33%,CX3CR1;CCL15;CCL4;CCL3;CCL14;PF4;CCL13;CCL2;CCL5;CCRL2;CCL28;CXCL12;CCL7;CXCL10;CKLF;CCL24
prerank,SUMO binding (GO:0032183),0.48010801218638594,0.9432059082835516,0.5412087912087912,1.0,1.0,6/13,17.81%,PML;UBA2;RNF111;USP25;RNF4;TDG
prerank,methyltransferase activity (GO:0008168),0.40894791998776375,0.9427176084245324,0.5598705501618123,1.0,1.0,14/46,20.49%,SUV39H1;ARMT1;LCMT1;METTL4;DNMT1;EHMT1;NDUFAF7;NSUN3;COQ5;LRTOMT;PRMT3;GCSH;DNMT3B;PRMT7
prerank,protein tyrosine kinase binding (GO:1990782),-0.22844203085562434,-0.9424904131885142,0.7096774193548387,0.8372863009773646,1.0,13/71,9.98%,ACVR1;SIRPA;TREM2;PTPN2;SQSTM1;HSP90AA1;BMPR2;GRM5;ANGPT1;TJP2;DUSP3;BLNK;SH2B3
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.4153985967088063,0.9401346099775498,0.5535714285714286,1.0,1.0,14/40,21.22%,SUV39H1;ARMT1;LCMT1;METTL4;DNMT1;METTL8;METTL9;FBL;LRTOMT;ICMT;DNMT3B;THUMPD3;PRMT7;PCMTD1
prerank,phosphotyrosine residue binding (GO:0001784),-0.2630569646720968,-0.9373042019674752,0.5625,0.841647752348528,1.0,6/37,4.52%,BCAR3;YES1;PTPN6;PFN1;PIK3R1;VAV2
prerank,endopeptidase activity (GO:0004175),0.3891901130393822,0.933749202197478,0.661,1.0,1.0,35/257,14.89%,PRTN3;TMPRSS4;TMPRSS3;ADAMTS7;KEL;ESPL1;NAPSA;USP1;SENP1;NRDC;FAP;PSMB7;PIDD1;MBTPS2;CASP2;USP38;CTSE;PITRM1;PREP;USP48;ATG4B;PSMA4;DPP4;CTSK;CTSO;F3;USP14;MMP19;PSEN1;USP24;CASP9;USP15;PSMB1;PCSK1;ADAMTS1
prerank,pyridoxal phosphate binding (GO:0030170),-0.3015116650635764,-0.9296362482427465,0.5169082125603864,0.8514916908604667,1.0,15/20,47.47%,PYGB;PYGL;PLPBP;AGXT;OAT;SHMT2;SHMT1;SRR;CBS;PYGM;THNSL2;CTH;GLDC;ACCS;SDS
prerank,thioesterase binding (GO:0031996),0.4738922334647021,0.9293581912928907,0.5609756097560976,1.0,1.0,4/11,19.36%,TRAF3;HAUS7;RAC1;TRAF6
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),-0.23017541893508414,-0.9284899263647537,0.6551724137931034,0.8459966815071317,1.0,6/60,4.03%,MERTK;IGF1R;CSF1R;ERBB4;NRP2;FLT1
prerank,metalloendopeptidase activity (GO:0004222),0.38746384022048763,0.9273254475978803,0.6080246913580247,1.0,1.0,18/76,24.40%,ADAMTS7;KEL;NRDC;MBTPS2;PITRM1;MMP19;ADAMTS1;ADAMTSL3;ADAMTS5;ADAM10;MMP12;MME;ADAMTS3;ADAMTS2;ADAM17;ADAMTS10;ADAMTS9;ZMPSTE24
prerank,ubiquitin protein ligase binding (GO:0031625),0.3844625109665155,0.9273164077736566,0.692,1.0,1.0,75/254,21.09%,UBE2T;BRCA1;RPA2;CHEK2;RB1;ERBB3;GLMN;SMC6;PML;AXIN1;SMG5;POLR2A;PA2G4;TANK;PTPN22;IKBKG;FOXO1;FAF1;NPLOC4;TUBA1B;HDAC6;TRAF3;CCT2;TCP1;UBE2K;SNX9;FAF2;PRKACA;RAD18;BLZF1;EGFR;CASC3;CUL3;PCBP2;SUMO1;TUBB;RNF8;JUN;BECN1;AMBRA1;ARRB2;SPOP;SKI;SUMO2;BAG1;FANCL;RNF20;GSK3B;TP53;CCDC50;TRIOBP;YOD1;TRIM28;USP25;UBXN1;CAMLG;TRIM37;UBA52;USP7;CXCR4;YWHAE;UBE2G1;RPL5;WRAP53;CDKN1A;SLF1;TRAF6;CASP8;PRKAR2A;RPL23;PRR5L;UBE2N;SMAD2;RIPK1;MDM2
prerank,protease binding (GO:0002020),0.390396049200763,0.9268800457103505,0.6134282807731435,1.0,1.0,27/99,17.78%,CD177;BRCA2;FAP;COL1A2;CLTC;INSL3;SART3;ITGAV;RIOK3;DERL2;AMFR;PARK7;SUMO1;RAD23A;DPP4;PTEN;F3;SPATA2;FLOT1;CFLAR;RHBDD2;GSK3B;CCBE1;TP53;CHMP3;FN1;SYVN1
prerank,aminoacyl-tRNA ligase activity (GO:0004812),-0.2568173612525111,-0.9248002308724517,0.6057692307692307,0.8469478895523912,1.0,13/37,16.54%,IARS2;CARS1;WARS2;SARS1;NARS1;FARSA;IARS1;HARS2;HARS1;NARS2;TARS1;QARS1;TARS3
prerank,sulfotransferase activity (GO:0008146),0.41048727989793826,0.9199976560360664,0.5785310734463277,1.0,1.0,4/33,13.19%,CHST3;TPST1;CHST12;SULT6B1
prerank,alpha-tubulin binding (GO:0043014),0.4174311327824481,0.9197745585038203,0.5990836197021764,1.0,1.0,8/31,18.06%,RACGAP1;FYN;HDAC6;OFD1;BBS4;ARL4C;SNCA;TAOK1
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.4378153505196507,0.91934966610833,0.5783847980997625,1.0,1.0,11/22,23.05%,IKBKG;ZRANB3;TAB3;RNF169;RNF168;PRPF8;ATRIP;OTUD7A;MINDY2;ZBTB1;UIMC1
prerank,metalloexopeptidase activity (GO:0008235),0.3942863503498745,0.9186070620187646,0.6015037593984962,1.0,1.0,12/51,18.46%,AGBL1;CPA6;CPM;AGTPBP1;DPEP1;METAP2;LTA4H;VASH2;AGBL3;CPD;ERAP1;RNPEP
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.4722352772469228,0.9175048652557504,0.5892116182572614,1.0,1.0,3/12,13.09%,APAF1;BCL2L13;RACK1
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.4390756044498639,0.9170646328387839,0.55819774718398,1.0,1.0,1/17,1.17%,LBR
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.47672317804055264,0.9153600307564886,0.5642458100558659,1.0,1.0,5/10,24.79%,GFUS;GALM;RPE;GALE;GLCE
prerank,hormone activity (GO:0005179),0.3940145203014697,0.9152429438285353,0.6231578947368421,1.0,1.0,9/54,19.87%,AGRP;NPPC;PTHLH;ADCYAP1;CCL25;INSL6;APLN;PPY;HCRT
prerank,chemokine activity (GO:0008009),-0.2733867438439887,-0.914837245852034,0.624,0.8629218993306235,1.0,17/31,52.17%,CCL15;CCL4;CCL3;CCL14;PF4;CCL13;CCL2;CCL5;CCL28;CXCL12;CCL7;CXCL10;CKLF;CCL24;CCL19;CCL8;CXCL9
prerank,mitogen-activated protein kinase binding (GO:0051019),0.4137250163692589,0.9140806927665936,0.5798816568047337,1.0,1.0,9/29,21.34%,PPM1D;MAPKAPK3;ATF7;MAPK14;CDK5RAP3;SIRT1;TPR;DUSP16;NBR1
prerank,lipase activator activity (GO:0060229),0.4711517715662886,0.9134806164449677,0.5671428571428572,1.0,1.0,3/10,11.00%,FYN;PDPK1;BTK
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.4859690425496794,0.9132805953502152,0.5941422594142259,1.0,1.0,1/11,3.00%,ITPR1
prerank,dipeptidyl-peptidase activity (GO:0008239),0.4756999973481755,0.9110140703201518,0.5591549295774648,1.0,1.0,5/10,20.61%,FAP;DPP4;NAALAD2;DPP9;PRCP
prerank,general transcription initiation factor binding (GO:0140296),0.42573179981478493,0.9097592990252776,0.5840188014101058,1.0,1.0,7/25,14.84%,TAF1;PSMC1;AHR;GTF2A1;RUVBL2;RUVBL1;YEATS2
prerank,calcium channel inhibitor activity (GO:0019855),0.478791326102117,0.9080568384463887,0.5839112343966713,1.0,1.0,1/11,3.00%,ITPR1
prerank,AMP binding (GO:0016208),-0.36567043794907067,-0.9072397894907855,0.563573883161512,0.8721614528553255,1.0,5/11,20.87%,PFKL;PYGL;APRT;PFKP;PFKM
prerank,miRNA binding (GO:0035198),0.41341643745617324,0.9064437286757357,0.6175478065241845,1.0,1.0,13/30,24.92%,ZC3H7A;PUM2;HNRNPA2B1;TUT4;PUM1;RC3H1;HNRNPA1;ELAVL1;AGO2;PNPT1;AGO1;YBX1;ZNF346
prerank,hydro-lyase activity (GO:0016836),-0.24965958736514715,-0.9063392497173002,0.6697247706422018,0.8660707197014806,1.0,10/41,12.65%,TBXAS1;HACD3;ACO2;ECHS1;ENO1;ECHDC1;NAXD;CA2;ACO1;TGDS
prerank,zinc ion binding (GO:0008270),0.3751536293305841,0.9061219342073146,0.746,1.0,1.0,67/293,18.46%,UHRF1;RNF26;TK1;MEFV;BLM;ZCCHC4;DHX58;HDAC10;S100A9;TNFSF10;CTCF;RASGRP1;SNRPC;S100A8;MDM4;DPEP1;MBD1;CDADC1;PDE2A;BIRC2;GDA;PRIMPOL;BAZ1B;PHF2;SEC24B;SEC24A;PITRM1;TAB3;CSRP1;RPS27;TIMM9;EGR1;ZBTB32;TMEM163;KAT6A;ZEB1;NAPEPLD;ZMYND8;RPS29;LTA4H;RNF8;RNF2;KMT2A;HHIP;GLO1;SKI;ARIH2;KDM4C;LIMS1;KMT2B;TP53;RC3H1;PDXK;TRIM28;CRIP1;ACER3;KPNB1;DUSP12;SLC30A5;EPRS1;LACTB2;SNCA;HDAC4;RASSF1;KDM2B;ERAP1;RNPEP
prerank,transforming growth factor beta receptor binding (GO:0005160),0.43489198207103913,0.902805605230633,0.5871212121212122,1.0,1.0,1/18,0.90%,INHBC
prerank,alkali metal ion binding (GO:0031420),0.4587432597926162,0.9026560355529365,0.5953678474114441,1.0,1.0,6/13,17.98%,IMPA1;PDXK;ADPRH;TDG;DRG1;HDAC4
prerank,ADP binding (GO:0043531),0.422425463037717,0.9021741773612421,0.6067961165048543,1.0,1.0,11/25,23.64%,MSH6;ABCD1;TAP1;MYH10;LONP1;PRKAG2;ATP5F1D;PGK1;PRKAG1;GCLC;MYH9
prerank,ligand-gated ion channel activity (GO:0015276),0.40813283798532957,0.9019276210377722,0.5878220140515222,1.0,1.0,1/30,0.81%,CHRNB4
prerank,endopeptidase activator activity (GO:0061133),-0.3744036117856936,-0.9008093823504139,0.562874251497006,0.8707729824871923,1.0,2/10,2.22%,PSMD14;VSIR
prerank,phospholipase binding (GO:0043274),0.44293444453867,0.899359981036657,0.579155672823219,1.0,1.0,4/13,11.00%,FYN;PDPK1;PAFAH1B1;BTK
prerank,tau protein binding (GO:0048156),0.39177015248940755,0.8954521262883601,0.6370699223085461,1.0,1.0,17/40,22.05%,FYN;HDAC6;PIN1;MARK2;PPP2CB;DYRK1A;ROCK2;GSK3B;MARK4;SNCA;TAOK1;PPP2CA;MARK1;SMAD2;ROCK1;BRSK1;DCTN1
prerank,regulatory RNA binding (GO:0061980),0.3952271347185339,0.8953679264760503,0.6408296943231441,1.0,1.0,14/38,23.21%,ZC3H7A;PUM2;HNRNPA2B1;TUT4;PUM1;DHX9;RC3H1;TARBP2;HNRNPA1;ELAVL1;AGO2;PNPT1;AGO1;YBX1
prerank,ligand-gated channel activity (GO:0022834),0.40813334356281294,0.8937115769356591,0.5983412322274881,1.0,1.0,1/29,0.81%,CHRNB4
prerank,ephrin receptor binding (GO:0046875),0.42292089841426794,0.893579208435954,0.5968331303288672,1.0,1.0,5/21,15.71%,FYN;GRB2;ANKS1A;CRK;ANKS1B
prerank,cytokine activity (GO:0005125),0.36873977216523746,0.8898439812812752,0.7142857142857143,1.0,1.0,4/131,7.33%,IL12A;INHBC;IL16;HMGB1
prerank,vinculin binding (GO:0017166),0.45493272175060495,0.8877517433749381,0.6168741355463347,1.0,1.0,6/11,22.52%,CTNNA1;DAG1;UTRN;RTCB;ACTN1;PXN
prerank,MAP kinase activity (GO:0004707),0.44209827965256177,0.8864339817428806,0.5984147952443857,1.0,1.0,2/14,8.10%,MAPK1;MAPK14
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.42920498213383185,0.885045763614751,0.6126582278481013,1.0,1.0,6/17,19.00%,AK9;NME4;AK3;AK5;CLP1;CMPK2
prerank,signaling receptor complex adaptor activity (GO:0030159),0.39275968408775047,0.8838875309040488,0.6353591160220995,1.0,1.0,9/38,18.13%,CARD10;AXIN1;TRADD;SORBS1;SPATA2;IRS1;SPAG9;LDLRAP1;LRRK2
prerank,DNA-binding transcription factor binding (GO:0140297),0.36735536180727196,0.8787575025885471,0.7705410821643287,1.0,1.0,63/189,23.97%,HEY2;RB1;CBX5;TWIST1;ZFPM1;USF1;MTA3;RBL1;RBBP8;TAF1;PTMA;TCF3;DDRGK1;HMGB1;SPEN;TLE4;ZBTB7A;PIAS3;HIRA;HIPK2;ZMYND8;PARK7;DHX9;JUN;MTA2;HCFC1;NFE2L2;BBS4;BEX1;DDIT3;CREBBP;SKI;MYC;GABPA;RERE;GSK3B;TP53;PIAS1;SIN3A;TCF7L2;TAF9;TCERG1;SIRT1;HCLS1;HDAC4;CREB1;TLE3;HDAC1;PRRX1;FIZ1;RBPJ;PPARD;SMAD2;MEF2D;CIITA;PURB;HDAC9;ATN1;BBS7;BHLHE40;NPM1;MIER1;DAPK3
prerank,receptor ligand activity (GO:0048018),0.36268302297192284,0.8741280455418038,0.7977977977977978,1.0,1.0,11/245,7.33%,IL12A;INHBC;NTF4;HMGB2;TNFSF13B;NPPC;IL16;PGF;PTHLH;TGFA;HMGB1
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.32416821292628945,-0.8694218637880133,0.6360153256704981,0.9372746760206567,1.0,4/13,12.77%,PIK3CD;PIP4K2B;PIK3C2B;PIK3CB
prerank,deubiquitinase activity (GO:0101005),0.36460287662541674,0.8692416262660734,0.6979591836734694,1.0,1.0,21/88,17.64%,USP27X;MINDY4;USP1;TANK;USP38;DESI2;USP48;USP31;BAP1;UCHL5;USP14;USP24;USP15;VCPIP1;OTUD5;USP50;YOD1;USP21;USP25;USP40;USP7
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.34397932204240705,-0.8691781564211646,0.640926640926641,0.9292894180353988,1.0,4/12,5.61%,PIK3R1;IGF1;ARRB1;GNAS
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.2953220113715891,-0.8668449775398823,0.6224066390041494,0.9262914369928036,1.0,4/17,10.81%,GRIA1;GRIA4;GRIN3A;GRIK2
prerank,ribosomal large subunit binding (GO:0043023),-0.33625205948506487,-0.8664613865105826,0.6091549295774648,0.9188529721423897,1.0,4/11,9.59%,NEMF;DHX33;MRRF;NMD3
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.4310521663341338,0.866221892748218,0.6502659574468085,1.0,1.0,2/14,13.00%,KCNJ3;KCNJ2
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.24474687569863993,-0.8645638476168946,0.7163120567375887,0.9149766834019668,1.0,10/33,19.72%,RNF19B;ARIH1;RNF180;RNF185;AUP1;UBE3D;PRKN;SIAH1;ANKIB1;DCUN1D2
prerank,exopeptidase activity (GO:0008238),0.37759967011418893,0.8627639108184783,0.6663090128755365,1.0,1.0,14/50,20.61%,DPEP3;FAP;DPEP2;CPM;DPEP1;METAP2;LTA4H;DPP4;NAALAD2;ERAP1;RNPEP;MME;DPP9;PRCP
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.39828958669022335,0.8611576323737606,0.6548463356973995,1.0,1.0,4/25,12.04%,KMO;FMO5;CYP27A1;CYP46A1
prerank,ligand-gated cation channel activity (GO:0099094),0.35984797274636926,0.8603651082695227,0.7016460905349794,1.0,1.0,13/75,22.19%,CHRNB4;P2RX1;SHROOM2;KCNJ3;GRIA3;KCNJ2;GRIA2;TRPM4;KCNJ10;GRIK5;GRIK3;GRIN2D;KCNN3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.4482362504318128,0.8592756937419007,0.6323529411764706,1.0,1.0,2/10,6.99%,CDADC1;GDA
prerank,endoribonuclease activity (GO:0004521),0.3892206165214443,0.8588468403817617,0.6635838150289017,1.0,1.0,3/32,6.66%,SLFN14;SMG6;YBEY
prerank,actinin binding (GO:0042805),0.3985051613439533,0.858245029947367,0.6517533252720678,1.0,1.0,7/21,19.97%,CSRP3;SYNPO2;CSRP1;MAGI1;DAG1;PDLIM5;PKD2
prerank,glycerophospholipid flippase activity (GO:0140333),0.434360291588743,0.8563632959559238,0.6242937853107344,1.0,1.0,4/11,20.69%,ATP11C;ATP8A1;ATP11A;ATP8B2
prerank,MAP kinase kinase activity (GO:0004708),0.420664972736249,0.852052058220933,0.6209573091849935,1.0,1.0,5/15,18.13%,MAP2K6;MAPKAPK3;MAPK14;MAP2K1;LRRK2
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.4227694237827091,0.8516635656850557,0.6283068783068783,1.0,1.0,5/14,23.80%,KMO;CYBB;CYBA;NCF4;AIFM1
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.35288958842557094,-0.8508099207800031,0.6442953020134228,0.9376368889510229,1.0,4/10,6.80%,KDM7A;KDM4A;PHF8;KDM4B
prerank,NADP binding (GO:0050661),0.3705766371488632,0.8461369889707996,0.6488991888760139,1.0,1.0,7/32,19.44%,LBR;CBR4;ME3;DHCR7;GMDS;DECR1;PGD
prerank,GTP binding (GO:0005525),0.3492268598433735,0.84489592313859,0.8108108108108109,1.0,1.0,37/172,18.44%,RRAD;ARHGEF5;GBP4;TUBA1C;NOA1;ATL2;ARL5C;REM1;TUBB4B;ARL11;RAB1B;RAB22A;TUBA1B;ARF4;RND3;GBP2;GNAI1;RAB8A;MTG2;SEPHS1;RABL6;RIT2;RHOU;TUBB;ARF3;RAB11B;RAC2;RAB35;RAB2A;TUBD1;ARL4C;RAB5A;MMAA;RAC1;DRG1;LRRK2;RAB6A
prerank,guanyl ribonucleotide binding (GO:0032561),0.3480716828607618,0.8436253211485402,0.831,1.0,1.0,38/196,16.74%,RRAD;ARHGEF5;GBP4;TUBA1C;NOA1;ATL2;ARL5C;REM1;TUBB4B;ARL11;RAB1B;RAB22A;TUBA1B;ARF4;RND3;PDE2A;GBP2;GNAI1;RAB8A;MTG2;SEPHS1;RABL6;RIT2;RHOU;SLC19A1;TUBB;RAB8B;ARF3;PDE5A;RAB11B;RAC2;RAB35;RAB2A;TUBD1;ARL4C;RAB5A;MMAA;RAC1
prerank,cytochrome-c oxidase activity (GO:0004129),0.41779111323308277,0.8421252771449138,0.6588541666666666,1.0,1.0,3/15,13.44%,COX10;COX4I1;NDUFA4
prerank,phospholipase activator activity (GO:0016004),0.4387340995847203,0.8415839385146557,0.6547277936962751,1.0,1.0,3/10,11.00%,FYN;PDPK1;BTK
prerank,translation elongation factor activity (GO:0003746),0.41657486758280343,0.8398388927555096,0.6432291666666666,1.0,1.0,4/14,16.02%,EEF1B2;GFM2;EIF5A2;EEF2
prerank,thiol-dependent deubiquitinase (GO:0004843),0.3533437059888881,0.8394881973719535,0.7340862422997947,1.0,1.0,20/83,17.64%,USP27X;USP1;TANK;USP38;DESI2;USP48;USP31;BAP1;UCHL5;USP14;USP24;USP15;VCPIP1;OTUD5;USP50;YOD1;USP21;USP25;USP40;USP7
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.38782387631349646,0.8366005447513722,0.6753086419753086,1.0,1.0,6/23,16.54%,PLCG2;PLCB1;PLCB3;CHRM3;PLCD1;PLCG1
prerank,potassium:proton antiporter activity (GO:0015386),0.4307346195413577,0.8341245636508826,0.6719653179190751,1.0,1.0,4/10,19.26%,SLC9A8;SLC9A9;SLC9A7;SLC9A6
prerank,Hsp70 protein binding (GO:0030544),0.37518075742610335,0.8326224567894326,0.686411149825784,1.0,1.0,12/31,25.77%,SPN;DNAJC18;DNAJC2;DNAJC8;DNAJB1;SNCA;RPS3;HDAC8;DNAJB12;DNAJB14;DNAJC10;DNAJB2
prerank,carboxylic acid binding (GO:0031406),-0.2324509139574695,-0.830878047806368,0.7747747747747747,0.9727843072033115,1.0,22/38,42.32%,PSAP;GRIN3A;MAG;GLRA2;GLUD1;SESN3;SESN2;GRIN2B;SHMT2;SHMT1;GLRA3;NOS1;CAD;GRIN1;CASTOR1;CASTOR2;SRR;GNMT;UBR1;RTN4R;THNSL2;GRIN3B
prerank,frizzled binding (GO:0005109),-0.23676315324214964,-0.8300611613334367,0.6695652173913044,0.966405126372972,1.0,23/34,47.26%,RYK;DVL3;DVL2;WNT5B;DVL1;FZD7;WNT4;WNT5A;WNT2B;LRP6;BAMBI;MYOC;WNT7B;WNT7A;NDP;WNT3;WNT9A;SFRP1;ZNRF3;SDCBP;FZD1;WNT6;WNT8B
prerank,pentosyltransferase activity (GO:0016763),-0.238742172517601,-0.8279418419323433,0.7631578947368421,0.9627114102494232,1.0,11/36,18.92%,LACC1;UPP2;PARP6;LARGE1;QTRT1;SIRT3;PPAT;PARP16;UMPS;PARP2;SIRT5
prerank,cell-cell adhesion mediator activity (GO:0098632),0.3659681280548625,0.8264825221875907,0.7276688453159041,1.0,1.0,12/42,23.27%,CD47;STXBP6;S100A11;BSG;PALLD;EMB;PDLIM5;PPP1CA;CDC42EP1;CNTN4;RAB10;DSCAM
prerank,transition metal ion binding (GO:0046914),0.34249898223010367,0.8263482531593119,0.933,1.0,1.0,82/397,18.46%,UHRF1;RNF26;TK1;MEFV;BLM;CUTA;CUTC;ZCCHC4;RIOX1;HEPH;DHX58;HDAC10;S100A9;TNFSF10;COA6;CTCF;FEN1;RASGRP1;SNRPC;IMPA1;S100A8;MDM4;DPEP1;MBD1;CDADC1;PDE2A;BIRC2;GDA;PRIMPOL;MGAT2;BAZ1B;TDP2;PHF2;SEC24B;SEC24A;PITRM1;TAB3;CSRP1;RPS27;PIM1;TIMM9;EGR1;ZBTB32;TMEM163;KAT6A;ZEB1;NAPEPLD;ZMYND8;ATP7A;RPS29;PARK7;LTA4H;RNF8;ISCA2;RNF2;KMT2A;HHIP;GLO1;SKI;ARIH2;KDM4C;LIMS1;KMT2B;TP53;RC3H1;PDXK;TRIM28;CRIP1;ACER3;KPNB1;DUSP12;ATOX1;SLC30A5;EPRS1;LACTB2;SNCA;CYP2R1;HDAC4;RASSF1;KDM2B;ERAP1;RNPEP
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.4140004623935982,0.8258238287097535,0.6763540290620872,1.0,1.0,1/14,2.57%,PYCR3
prerank,calcium-activated potassium channel activity (GO:0015269),-0.3375420626615375,-0.8239502222294273,0.68,0.9633354949696921,1.0,2/11,2.11%,KCNMA1;KCNN2
prerank,RNA polymerase II complex binding (GO:0000993),0.3724302250021991,0.822430973472803,0.6927437641723356,1.0,1.0,14/32,23.16%,BRD4;ZNF326;CCAR2;DHX9;RPRD1B;HNRNPU;ELOF1;SCAF8;PCF11;AGO2;RPRD2;AGO1;ELP4;NCOA3
prerank,small GTPase binding (GO:0031267),0.3414902743952992,0.8192724879759695,0.8266533066132264,1.0,1.0,41/170,19.88%,BIRC5;RCC1;EXOC2;FLNA;ARHGDIB;EXOC4;CAV1;RANGAP1;RIN3;EVI5;CIB1;RAB8A;ERC1;CYRIB;FGD6;LSM2;TNFAIP1;PEX5L;PDE6D;WHAMM;GGA1;FGD3;RANBP2;RNF152;EXOC5;BRK1;CHML;TRIOBP;PAK2;FMNL1;ATP6AP1;NDRG1;GGA2;IQGAP1;LRRK2;AP3M1;SGSM3;MAPKAP1;ARHGAP1;OCRL;HPS4
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.339671701852912,0.8182310227354039,0.8228228228228228,1.0,1.0,23/147,15.38%,ECT2;ARHGEF5;PSD;RCC1;CCDC88A;TIAM1;ARHGEF18;RASGRP1;RIN3;CCDC88C;DENND4C;EEF1B2;SOS1;FGD6;ARHGEF28;FGD3;DENND1B;DENND1A;LAMTOR4;DENND6A;LAMTOR3;BCR;EGF
prerank,endopeptidase regulator activity (GO:0061135),0.3611232611715872,0.8176534634396397,0.7138157894736842,1.0,1.0,7/40,13.47%,PSMF1;SLPI;ABCA2;PCSK1N;UCHL5;USP14;PSME1
prerank,sialyltransferase activity (GO:0008373),-0.2682891180470203,-0.8160862847459115,0.7675675675675676,0.9716639871382636,1.0,9/20,20.64%,ST8SIA1;ST3GAL6;ST6GALNAC4;ST6GAL2;ST6GALNAC6;ST3GAL4;ST8SIA5;ST6GALNAC3;ST8SIA3
prerank,voltage-gated sodium channel activity (GO:0005248),0.37859123941200457,0.8134678280685352,0.6961722488038278,1.0,1.0,2/22,3.75%,CACNA1I;HCN3
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.33919809096224646,0.8133074357895272,0.847,1.0,1.0,50/181,20.75%,HEY2;RB1;ZFPM1;MTA3;RBL1;RBBP8;CDKN2A;TAF1;FAF1;TCF3;DDRGK1;SPEN;SMARCA4;MAPK14;NCOA7;TACC2;PIAS3;HIRA;HIPK2;TAF6;DHX9;JUN;MTA2;CDK5RAP3;NFE2L2;BBS4;BEX1;ACTN4;CREBBP;RERE;GSK3B;TADA3;TP53;PIAS1;SIN3A;TCF7L2;COMMD6;TCERG1;SIRT1;HCLS1;HDAC4;MED1;CREB1;PROX1;HDAC1;PRRX1;NCOA2;FIZ1;RBPJ;PPARD
prerank,adrenergic receptor binding (GO:0031690),-0.2826466131308671,-0.8122334702879239,0.7309417040358744,0.971528349853401,1.0,6/16,25.60%,GNAS;ARRDC3;ADRB1;DLG4;AKAP5;C1QBP
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.3141455205435072,-0.8096547593794903,0.6988416988416989,0.968572645968408,1.0,6/12,31.80%,SDHB;ISCA1;ISCU;CIAPIN1;FDX1;AOX1
prerank,insulin-like growth factor I binding (GO:0031994),-0.31090614606665423,-0.80731913259118,0.7300380228136882,0.9650114587962599,1.0,7/13,31.64%,IGF1R;ITGB3;IGFBP4;INSR;ITGB4;IGFBP6;IGFBP3
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.4252040325389777,0.8064259448709764,0.6863905325443787,1.0,1.0,5/10,22.45%,PKIG;PRKAG2;PRKAR2A;PRKAG1;PKIA
prerank,voltage-gated anion channel activity (GO:0008308),0.397641417718438,0.8053703152887096,0.693029490616622,1.0,1.0,1/15,3.03%,VDAC2
prerank,omega peptidase activity (GO:0008242),0.3364927009083311,0.8026046578838568,0.7822085889570553,1.0,1.0,20/89,17.64%,USP27X;USP1;TANK;USP38;DESI2;USP48;USP31;BAP1;UCHL5;USP14;USP24;USP15;VCPIP1;OTUD5;USP50;YOD1;USP21;USP25;USP40;USP7
prerank,exoribonuclease activity (GO:0004532),0.4199782618713589,0.8025212890855755,0.7079889807162535,1.0,1.0,4/12,20.76%,EXOSC8;EXOSC10;CNOT6;CNOT7
prerank,muscle alpha-actinin binding (GO:0051371),0.39852758672363886,0.8001332328340874,0.699614890885751,1.0,1.0,5/15,19.97%,SYNPO2;PDLIM7;PALLD;PDLIM5;PKD2
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.35297758359171255,0.7991846341697056,0.7236693091732729,1.0,1.0,7/35,12.86%,DUS1L;GATC;TRDMT1;FTO;TRMT5;TYW3;NT5C3A
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.4230733992525232,0.7986545434758813,0.6865248226950355,1.0,1.0,1/10,2.56%,CD47
prerank,inward rectifier potassium channel activity (GO:0005242),-0.25253892627101543,-0.7965473760436144,0.7848837209302325,0.9780818898454517,1.0,3/24,5.24%,KCNN2;KCNK6;KCNJ6
prerank,CARD domain binding (GO:0050700),0.40031924703539357,0.796358287846684,0.7065217391304348,1.0,1.0,2/14,10.74%,CARD10;CARD9
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.37938740160392387,0.7941251515205978,0.7058096415327565,1.0,1.0,3/21,8.22%,EZR;AKAP7;PRKACA
prerank,actin monomer binding (GO:0003785),0.3759111765622985,0.793894990671763,0.71760391198044,1.0,1.0,3/22,11.24%,PRKCE;LIMA1;MTSS1
prerank,MAP-kinase scaffold activity (GO:0005078),0.4200254052235269,0.7919761222514098,0.7226074895977809,1.0,1.0,7/11,27.69%,SPAG9;MAP2K1;SH3RF1;IQGAP1;KSR1;AKAP13;MAPK8IP1
prerank,chemorepellent activity (GO:0045499),-0.24407135714048103,-0.7911593166051736,0.8280254777070064,0.979957127545552,1.0,13/25,36.86%,SEMA3D;SEMA3E;SEMA4C;SEMA4G;SEMA3A;SEMA7A;SEMA4D;NRG3;SEMA4F;SEMA6C;SEMA6B;SEMA3B;SEMA3F
prerank,ferrous iron binding (GO:0008198),0.3715063371450851,0.7909916271549062,0.718865598027127,1.0,1.0,3/21,6.55%,HAAO;HEPH;FTO
prerank,thyroid hormone receptor binding (GO:0046966),0.3609289303926965,0.7897257092808405,0.7363013698630136,1.0,1.0,10/28,23.16%,BRD8;MED30;TAF7;MED1;THRAP3;NCOA6;MED13;TAF11;NSD1;NCOA3
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.36372946138841944,0.7892138207400714,0.7236533957845434,1.0,1.0,1/27,1.12%,SLC12A3
prerank,myosin II binding (GO:0045159),0.4165594616005378,0.7847947208086271,0.708507670850767,1.0,1.0,4/10,22.12%,GSN;SHROOM4;TRIOBP;SHROOM1
prerank,mannosyltransferase activity (GO:0000030),0.3694326456606994,0.7804315791122152,0.730816077953715,1.0,1.0,10/21,28.45%,ALG8;TMTC2;POMT1;PIGM;TMTC4;POMT2;PIGV;DPY19L1;TMTC1;TMTC3
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.3906182131864908,0.7794264607244682,0.7225891677675033,1.0,1.0,3/14,13.09%,APAF1;BCL2L13;RACK1
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.34744006019276885,0.7783295662842596,0.7591973244147158,1.0,1.0,7/34,19.51%,RACGAP1;PHLDA3;BTK;ARHGAP9;IQGAP1;KIF16B;MAPKAP1
prerank,semaphorin receptor activity (GO:0017154),-0.3029082178595276,-0.7781728706504115,0.7272727272727273,0.9948706170571122,1.0,2/11,2.38%,NRP2;PLXNA4
prerank,sodium:proton antiporter activity (GO:0015385),0.3947097093446989,0.7777590282662683,0.7162921348314607,1.0,1.0,4/11,19.26%,SLC9A8;SLC9A9;SLC9A7;SLC9A6
prerank,GTPase regulator activity (GO:0030695),0.32342984936895297,0.7762246974697341,0.905,1.0,1.0,42/212,15.61%,ECT2;RACGAP1;GPSM2;ARHGAP15;ARHGAP11A;TBC1D1;RGS12;ARHGAP33;CCDC88A;SEC23B;TBC1D8B;TBC1D22B;RANGAP1;EVI5;ARHGAP35;ARFGAP3;ARFGAP1;RP2;RAP1GAP2;SOS1;ARHGAP19;LARS1;GMIP;PDE6D;IPO7;STARD8;ARHGAP39;ASAP2;ARHGAP30;JUN;PLCB1;RANBP2;ARHGAP9;NRP1;ARHGAP45;ADAP1;ARHGAP26;TBC1D25;ARHGAP31;BCR;IPO5;NPRL3
prerank,RNA polymerase core enzyme binding (GO:0043175),0.3556074608858939,0.7756301771655609,0.755125284738041,1.0,1.0,14/33,23.16%,ZNF326;SPTY2D1;CCAR2;DHX9;RPRD1B;HNRNPU;ELOF1;SCAF8;PCF11;AGO2;RPRD2;AGO1;ELP4;NCOA3
prerank,ATPase activator activity (GO:0001671),-0.25066558872660927,-0.7740186957462918,0.8168316831683168,0.9942527280552953,1.0,6/20,15.44%,DNAJC19;DNAJB6;DNAJA2;ATP1B2;ATP1B1;DNAJC1
prerank,ATPase binding (GO:0051117),0.3224520327571395,0.7738015418940928,0.7979274611398963,1.0,1.0,18/71,20.09%,PEX26;EZR;PPP3CA;CAV1;ANK1;EGFR;RDX;FBL;ZNHIT6;PSEN1;NOP58;TAF9;USP25;DNAJB1;UBXN1;SYVN1;PKD2;SVIP
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.38159374149827957,0.7725377249107314,0.7388963660834454,1.0,1.0,3/14,14.50%,SLC25A12;SLC25A22;SLC25A13
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.38372732397971754,0.7721039394808875,0.7232375979112271,1.0,1.0,4/14,19.00%,AK9;NME4;AK5;CMPK2
prerank,insulin-like growth factor binding (GO:0005520),-0.2835978734172217,-0.7695422889857282,0.7736625514403292,0.9944923131028939,1.0,11/15,42.19%,IGF1R;ITGB3;IGFBP4;INSR;ITGB4;IGFBP6;IGFBP3;IGF2R;LRP2;IGFBP5;IGFALS
prerank,channel activity (GO:0015267),0.33769241964247776,0.7687695831161238,0.7838745800671892,1.0,1.0,1/41,1.86%,AQP1
prerank,metallopeptidase activity (GO:0008237),0.31874566234556795,0.7670293468176103,0.8503538928210314,1.0,1.0,17/113,19.90%,ADAMTS7;KEL;NRDC;MBTPS2;DPEP1;METAP2;PITRM1;MMP19;ADAMTS1;ADAMTSL3;ADAMTS5;PRPF8;ADAM10;ERAP1;RNPEP;MMP12;MME
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.3750198251344078,0.7656572995806673,0.7547892720306514,1.0,1.0,4/16,22.01%,HAAO;PIR;ETHE1;IDO2
prerank,GTPase binding (GO:0051020),0.31832429247817573,0.7653915947554413,0.9128256513026052,1.0,1.0,62/195,24.86%,BIRC5;RCC1;EXOC2;FLNA;ARHGDIB;EXOC4;CAV1;RANGAP1;RIN3;EVI5;CIB1;RAB8A;ERC1;CYRIB;FGD6;LSM2;TNFAIP1;PEX5L;PDE6D;WHAMM;GGA1;BECN1;AMBRA1;FGD3;RANBP2;RNF152;EXOC5;BRK1;CHML;TRIOBP;PAK2;FMNL1;ATP6AP1;EPRS1;NDRG1;GGA2;IQGAP1;LRRK2;GNB2;AP3M1;SGSM3;MAPKAP1;ARHGAP1;OCRL;HPS4;RRAGB;BNIP3;TNPO3;RAB34;EVI5L;FGD4;GNB1;CHM;YBX1;EHD1;CDC42EP4;DAPK3;AKAP13;RNF41;RADIL;SRGAP2;TBC1D20
prerank,G protein-coupled receptor activity (GO:0004930),0.31873645644560383,0.7650181140594856,0.933933933933934,1.0,1.0,22/239,16.26%,ADGRD1;S1PR4;CXCR5;VIPR2;MRGPRE;GPR141;LPAR4;GPR75;P2RY1;CALCRL;GPR63;TAPT1;S1PR2;GPR22;TM2D1;ADGRL3;ADGRV1;F2R;LPAR1;GPR35;LGR4;ELOVL4
prerank,transferrin receptor binding (GO:1990459),0.4003838454036466,0.764381722909655,0.7435158501440923,1.0,1.0,1/10,5.73%,IKBKG
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.39352332855071775,0.7641302665518205,0.7366946778711485,1.0,1.0,2/11,18.18%,SLC25A47;SLC22A4
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.34307700016341264,0.7625876514249426,0.7682789651293588,1.0,1.0,14/33,23.16%,ZNF326;LLPH;CCAR2;DHX9;RPRD1B;HNRNPU;ELOF1;SCAF8;PCF11;AGO2;RPRD2;AGO1;ELP4;NCOA3
prerank,bHLH transcription factor binding (GO:0043425),0.36390122135461545,0.7595663971395586,0.7411616161616161,1.0,1.0,5/19,16.94%,TWIST1;USF1;TCF3;CREBBP;SIRT1
prerank,cholesterol binding (GO:0015485),0.32657972433931426,0.7584109077233928,0.7831325301204819,1.0,1.0,7/47,11.42%,VDAC2;OSBP2;CAV1;OSBPL5;TSPO;OSBPL3;STARD5
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.2762424923473345,-0.7572299648010502,0.759090909090909,1.0,1.0,3/15,11.86%,PIK3R5;PIK3R1;SOCS7
prerank,outward rectifier potassium channel activity (GO:0015271),-0.3142728741975136,-0.7561270979049958,0.7889273356401384,1.0,1.0,3/11,16.59%,KCND2;KCND1;KCND3
prerank,poly-pyrimidine tract binding (GO:0008187),0.35325528734011236,0.7558552069243458,0.7575406032482599,1.0,1.0,4/23,13.49%,HNRNPC;RBMS2;HNRNPU;DAZAP1
prerank,phosphatase activity (GO:0016791),0.32068288052686533,0.7531070581561682,0.835221421215242,1.0,1.0,12/73,17.87%,PLPPR3;ALPL;PTPN22;PPP1CB;ARMT1;EPHX2;PPP1CC;BPNT2;APTX;PLPPR4;DUSP12;PPP1CA
prerank,kinase activity (GO:0016301),0.31361532030554806,0.7504673238611438,0.8766430738119313,1.0,1.0,26/109,21.30%,MASTL;FN3KRP;PANK2;CHKB;TAF1;PRKD3;PKN2;RFK;SEPHS1;NADK2;PAPSS2;DCAKD;DGKD;STK39;CDC7;GSK3B;PDXK;PIK3CA;PGK1;TAOK1;LRRK2;PANK1;NADK;PKMYT1;CHKA;DGKE
prerank,peptidase activator activity (GO:0016504),0.34939485887901073,0.750279242949475,0.7512254901960784,1.0,1.0,10/22,25.74%,TANK;CAV1;PSME1;PCOLCE2;PSME4;PSME2;PSME3;CASP8AP2;NLRC4;VCP
prerank,GTPase activator activity (GO:0005096),0.31061258103239386,0.7478046864418472,0.97,1.0,1.0,56/313,15.61%,ECT2;RACGAP1;ARHGEF5;PSD;ARHGAP15;ARHGAP11A;RCC1;TBC1D1;ARHGAP33;CCDC88A;SEC23B;TIAM1;TBC1D8B;TBC1D22B;ARHGEF18;RASGRP1;RANGAP1;RIN3;EVI5;CCDC88C;DENND4C;EEF1B2;ARHGAP35;ARFGAP3;ARFGAP1;RP2;RAP1GAP2;SOS1;ARHGAP19;LARS1;FGD6;GMIP;STARD8;ARHGAP39;ASAP2;ARHGAP30;JUN;PLCB1;ARHGEF28;FGD3;RANBP2;DENND1B;ARHGAP9;NRP1;DENND1A;ARHGAP45;ADAP1;LAMTOR4;DENND6A;LAMTOR3;ARHGAP26;TBC1D25;ARHGAP31;BCR;EGF;NPRL3
prerank,calcium-dependent phospholipid binding (GO:0005544),-0.19825268932990484,-0.7467998268031619,0.9322033898305084,1.0,1.0,28/49,37.13%,PCLO;ANXA3;SYT1;SYT4;ANXA4;SYT7;SYT9;SYT6;CPNE4;CPNE2;ANXA2;PLA2G4E;ANXA6;ANXA9;DYSF;PLA2G4A;ANXA1;SYT12;SYT11;CPNE9;CPNE5;SYT13;PLA2G4C;ESYT3;SYT5;ESYT1;ANXA5;SYT17
prerank,peptidase inhibitor activity (GO:0030414),0.33552032502540025,0.7436384631499368,0.797979797979798,1.0,1.0,5/33,12.89%,PSMF1;SLPI;PCSK1N;UCHL5;USP14
prerank,nucleotide diphosphatase activity (GO:0004551),0.36941719352986746,0.7426359291196672,0.7745740498034076,1.0,1.0,2/14,8.81%,NUDT13;NUDT4
prerank,histone deacetylase activity (GO:0004407),0.3533620412449005,0.7425004018410303,0.7578419071518193,1.0,1.0,10/19,25.68%,HDAC10;HDAC6;SIRT7;SIRT1;HDAC4;HDAC1;HDAC8;HDAC9;MIER1;HDAC11
prerank,GABA receptor binding (GO:0050811),-0.29533196845278176,-0.7398111542552049,0.8107142857142857,1.0,1.0,5/11,25.15%,ARFGEF2;PLCL2;LHFPL4;AKAP5;SHISA7
prerank,poly(U) RNA binding (GO:0008266),0.3529074109829987,0.7385482457503965,0.7629987908101572,1.0,1.0,3/20,13.49%,HNRNPC;RBMS2;DAZAP1
prerank,potassium ion antiporter activity (GO:0022821),0.36150830411597823,0.7378523208404071,0.7755644090305445,1.0,1.0,6/15,19.26%,SLC9A8;SLC24A4;SLC24A2;SLC9A9;SLC9A7;SLC9A6
prerank,myosin V binding (GO:0031489),-0.2722581459203665,-0.7299816947839349,0.8232558139534883,1.0,1.0,6/15,21.44%,RAB14;RAB6B;RAB11A;RAB3C;RAB3A;RAB3B
prerank,phospholipase C activity (GO:0004629),0.33717045055356837,0.7291626329480655,0.7866666666666666,1.0,1.0,6/25,16.54%,PLCG2;PLCB1;PLCB3;CHRM3;PLCD1;PLCG1
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.2934970694186075,-0.7243783357826481,0.8241042345276873,1.0,1.0,2/10,12.82%,DUSP10;DUSP7
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.2934970694186075,-0.7243783357826481,0.8241042345276873,1.0,1.0,2/10,12.82%,DUSP10;DUSP7
prerank,ion channel activity (GO:0005216),0.3039068558202774,0.7243063331522165,0.8759048603929679,1.0,1.0,4/80,7.84%,CHRNB4;P2RX1;TMC4;TRPM7
prerank,sodium channel activity (GO:0005272),0.3193697121007913,0.72391260276262,0.8302300109529025,1.0,1.0,3/37,7.34%,CACNA1I;HCN3;SHROOM2
prerank,mannose binding (GO:0005537),-0.28586406129100034,-0.7200197270464036,0.8309859154929577,1.0,1.0,4/12,31.73%,CLN5;CLEC4D;LMAN2;CLEC6A
prerank,NAD+ binding (GO:0070403),0.3647126457527065,0.7196575001383008,0.7799174690508941,1.0,1.0,4/12,17.55%,HPGD;UXS1;SIRT1;CRYL1
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.3770896518860736,0.7171457933738841,0.8125,1.0,1.0,4/10,19.40%,CASP2;CFLAR;CASP9;CASP8
prerank,tRNA methyltransferase activity (GO:0008175),0.3491632014709083,0.7158601627642738,0.7846153846153846,1.0,1.0,3/16,11.37%,TRDMT1;TRMT5;TYW3
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.3238040770712484,0.7155358998234155,0.8105625717566016,1.0,1.0,4/32,6.55%,ALKBH4;RIOX1;JMJD4;FTO
prerank,CCR chemokine receptor binding (GO:0048020),-0.209830423394389,-0.7150132238399155,0.9235294117647059,1.0,1.0,10/28,33.52%,NARS1;CCL15;CCL4;CCL3;CCL14;NES;CCL13;CCL2;CCL5;DEFB130A
prerank,nucleoside-diphosphatase activity (GO:0017110),0.36594906734775573,0.714608894050391,0.7848443843031123,1.0,1.0,3/12,17.33%,ENTPD3;ENTPD5;CANT1
prerank,fatty acid synthase activity (GO:0004312),0.3728162036939322,0.7125291213529725,0.7849002849002849,1.0,1.0,3/10,16.26%,CBR4;ELOVL5;ELOVL4
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.26931277224685485,-0.7112311287799753,0.8237547892720306,1.0,1.0,4/13,11.24%,PJA2;PRKAR1A;RYR2;GSK3A
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.37067779066482154,0.7099605750191433,0.810320781032078,1.0,1.0,1/11,9.21%,KCNJ3
prerank,pseudouridine synthase activity (GO:0009982),-0.2595092713838586,-0.7094835839644421,0.8239700374531835,1.0,1.0,2/13,3.30%,PUS10;PUS7
prerank,solute:sodium symporter activity (GO:0015370),-0.20648485610154582,-0.7052902929764664,0.9139072847682119,0.9992631296891747,1.0,27/27,79.39%,SLC5A7;SLC4A8;SLC5A11;SLC5A6;SLC28A2;SLC4A9;SLC13A5;SLC4A10;SLC28A1;SLC4A5;SLC5A1;SLC5A10;SLC20A1;SLC28A3;SLC34A1;SLC17A2;SLC17A1;SLC34A3;SLC5A8;SLC5A9;SLC5A2;SLC17A7;SLC34A2;SLC4A4;SLC4A7;SLC5A3;SLC20A2
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.30072152374820954,0.7043943463436166,0.8735751295336788,1.0,1.0,15/69,23.30%,ESCO2;MOGAT2;KAT6A;KAT2B;NAA16;CERS4;ZDHHC7;CREBBP;CERS6;CERS2;ELP3;ZDHHC6;SOAT1;LPCAT3;ZDHHC21
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.22116159390021348,-0.7031254004212328,0.907103825136612,0.9947226593084156,1.0,1/21,1.61%,FRS2
prerank,glucuronosyltransferase activity (GO:0015020),0.32734472383185154,0.6975996504806422,0.8244746600741656,1.0,1.0,4/19,20.55%,EXT1;CHSY1;B3GAT2;B3GAT1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.2787037411947919,-0.6959334617624722,0.8375796178343949,0.9886991358052452,1.0,4/11,15.42%,PFN1;HSPH1;HSPBP1;SIL1
prerank,adenyl nucleotide binding (GO:0030554),-0.2787037411947919,-0.6959334617624722,0.8375796178343949,0.9886991358052452,1.0,4/11,15.42%,PFN1;HSPH1;HSPBP1;SIL1
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.2931392500125936,0.6958276691195273,0.8789144050104384,1.0,1.0,7/73,15.97%,VIPR2;NPSR1;SORCS2;CALCRL;S1PR2;F2R;LGR4
prerank,cardiolipin binding (GO:1901612),0.36600206127213447,0.694426758906541,0.82,1.0,1.0,2/10,19.90%,NME4;MME
prerank,platelet-derived growth factor binding (GO:0048407),0.3613930773294269,0.6936781310731224,0.8018617021276596,1.0,1.0,2/11,17.16%,COL1A2;COL4A1
prerank,5'-nucleotidase activity (GO:0008253),-0.2573106453457974,-0.6905778482727993,0.8682170542635659,0.987778373228534,1.0,5/13,25.01%,NT5M;NT5DC1;NT5DC3;NT5C;NT5E
prerank,GTPase inhibitor activity (GO:0005095),-0.25906982212437046,-0.6877477450578449,0.8695652173913043,0.9840891451380419,1.0,5/13,17.56%,TNK2;GPS2;RHOH;CDC42SE1;ARL2
prerank,poly(A) binding (GO:0008143),0.32366995800531034,0.6875310798415224,0.8238153098420413,1.0,1.0,5/21,18.41%,EIF4A3;ELAVL4;RBMS2;HNRNPU;PPIE
prerank,cysteine-type endopeptidase activity (GO:0004197),0.2936993747901134,0.6875062054981731,0.9084362139917695,1.0,1.0,23/78,21.33%,ESPL1;USP1;CASP2;USP38;CAPN1;USP48;CTSK;CTSO;USP14;CFLAR;USP24;CASP9;USP15;CAPN10;USP25;USP40;USP7;MALT1;CASP8;USP34;CAPN15;USP47;USP46
prerank,Tat protein binding (GO:0030957),-0.2799964990892694,-0.685622643602566,0.875,0.9795328077052959,1.0,3/10,20.44%,MDFIC;ACTB;TRIM32
prerank,endopeptidase inhibitor activity (GO:0004866),0.29259598735906694,0.6852871380069894,0.9061855670103093,1.0,1.0,10/82,12.89%,UBE2O;PSMF1;LXN;SLPI;UBE2Z;BIRC6;PCSK1N;PTTG1;UCHL5;USP14
prerank,O-methyltransferase activity (GO:0008171),0.35055977256586596,0.6826437456077207,0.8328690807799443,1.0,1.0,2/10,16.08%,CMTR2;LRTOMT
prerank,ligand-gated calcium channel activity (GO:0099604),0.3287773300055376,0.6811255266907501,0.8460575719649562,1.0,1.0,1/19,3.00%,ITPR1
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.3177450210947557,0.6803717887677637,0.8235294117647058,1.0,1.0,4/22,17.61%,HSPG2;CLTC;HSP90B1;LDLRAP1
prerank,neuropeptide receptor activity (GO:0008188),0.3060674176148227,0.6764267683812738,0.8249400479616307,1.0,1.0,2/29,8.66%,NPSR1;SORCS2
prerank,cysteine-type peptidase activity (GO:0008234),0.2886827283005099,0.6757354059014723,0.9030927835051547,1.0,1.0,22/73,21.33%,ESPL1;USP1;CASP2;USP38;USP48;ATG4B;CTSK;CTSO;USP14;USP24;CASP9;USP15;USP50;USP21;USP25;USP40;USP7;MALT1;CASP8;USP34;USP47;USP46
prerank,alpha-actinin binding (GO:0051393),0.3146142117619125,0.6750757337480493,0.8428571428571429,1.0,1.0,7/24,19.97%,SYNPO2;PDLIM7;MAGI1;PALLD;DAG1;PDLIM5;PKD2
prerank,lipoprotein particle receptor binding (GO:0070325),0.30644728057981746,0.6736683012158666,0.8523644752018454,1.0,1.0,5/27,17.61%,HSPG2;CLTC;RELN;HSP90B1;LDLRAP1
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.3426576509137357,0.672760014529719,0.8317880794701987,1.0,1.0,2/14,16.21%,RDH10;RDH5
prerank,phosphoric ester hydrolase activity (GO:0042578),0.28727464972728595,0.6675976220886922,0.9023605150214592,1.0,1.0,16/49,24.31%,PTPN22;PPP1CB;ARMT1;EPHX2;PPP1CC;APEX1;DUSP12;PPP1CA;ENPP6;MPPED2;DUSP16;SACM1L;PGP;SMPD1;PGAM5;SAMHD1
prerank,adenylate cyclase binding (GO:0008179),0.35362027088857073,0.6661844710818055,0.8236953455571228,1.0,1.0,1/10,3.34%,AKAP12
prerank,calcium activated cation channel activity (GO:0005227),0.3203964262287743,0.6631448688934138,0.8520942408376964,1.0,1.0,2/17,4.89%,ANO10;KCNN4
prerank,poly-purine tract binding (GO:0070717),0.30362562832052054,0.6603593536483353,0.8576388888888888,1.0,1.0,7/27,20.20%,EIF4A3;ELAVL4;RBMS2;HNRNPU;DAZAP1;PPIE;PNPT1
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.3297265036962397,0.6598758490831748,0.8510911424903723,1.0,1.0,2/15,10.57%,CCR2;CCR6
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.34225310204714665,0.659530222037498,0.8206896551724138,1.0,1.0,3/10,19.37%,CYBB;CYBA;NCF4
prerank,titin binding (GO:0031432),0.33767346364995854,0.6588728817965929,0.8335588633288228,1.0,1.0,2/13,10.21%,MYBPC1;ACTN2
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.3386904388222738,0.6586522457248289,0.8403247631935047,1.0,1.0,12/12,66.16%,ELOVL4;RHO;OPN1SW;GNAT2;OPN4;OPN5;OPN1MW;OPN1MW3;GPR52;RRH;GPR88;OPN3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.2813951031224121,0.6573497510480112,0.8916046758767269,1.0,1.0,23/54,28.72%,GLS2;HDAC10;HDAC6;SIRT7;NTAQ1;DARS1;ACER3;SIRT1;HDAC4;HDAC1;HDAC8;NAAA;SIRT4;NADSYN1;HDAC9;NIT2;MIER1;HDAC11;HINT1;ASRGL1;NIT1;ASAH1;PIGL
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.33719875342936095,0.6567832015197193,0.8296703296703297,1.0,1.0,5/12,22.19%,TUT1;TENT2;TENT5D;PAPOLA;TENT4A
prerank,G protein-coupled amine receptor activity (GO:0008227),0.3101871070729349,0.6565979346534974,0.8563151796060255,1.0,1.0,2/22,13.28%,HTR2A;CHRM3
prerank,serotonin receptor activity (GO:0099589),0.3101871070729349,0.6565979346534974,0.8563151796060255,1.0,1.0,2/22,13.28%,HTR2A;CHRM3
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.3101871070729349,0.6565979346534974,0.8563151796060255,1.0,1.0,2/22,13.28%,HTR2A;CHRM3
prerank,Hsp90 protein binding (GO:0051879),0.2914112393986243,0.6550705172757214,0.8604118993135011,1.0,1.0,10/33,25.06%,HDAC6;AHR;UNC45A;AHSA1;RPS3;NPAS2;HDAC8;MAPT;TELO2;STIP1
prerank,retinoid binding (GO:0005501),-0.20827379767665313,-0.652504871642089,0.9573170731707317,1.0,1.0,15/22,49.73%,PTGDS;RARA;RBP4;ALDH1A2;CYP26B1;RBP1;ABCA4;CYP26C1;CRABP2;CRABP1;UGT1A7;UGT1A6;UGT1A4;UGT1A8;UGT1A1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.348533961713009,0.6512446583861462,0.8678414096916299,1.0,1.0,1/10,6.22%,DPEP1
prerank,sterol binding (GO:0032934),0.2776716646238975,0.6508246070783756,0.9078389830508474,1.0,1.0,7/56,11.42%,VDAC2;OSBP2;CAV1;OSBPL5;TSPO;OSBPL3;STARD5
prerank,intracellular chloride channel activity (GO:0061778),0.32750046082175943,0.6506574498011324,0.8636942675159236,1.0,1.0,3/16,17.46%,ANO10;ANO3;ANO6
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.32750046082175943,0.6506574498011324,0.8636942675159236,1.0,1.0,3/16,17.46%,ANO10;ANO3;ANO6
prerank,nucleotidase activity (GO:0008252),0.3180743859198314,0.6484498582640854,0.841025641025641,1.0,1.0,3/15,12.86%,NT5C2;BPNT2;NT5C3A
prerank,ribonuclease P RNA binding (GO:0033204),-0.26255795474810295,-0.6483751519878777,0.8970099667774086,0.9997356681440281,1.0,6/10,35.27%,RPP14;RPP21;RPP38;RPP40;POP5;POP7
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.287624643970859,0.6466057425247712,0.8814317673378076,1.0,1.0,10/38,21.01%,SNX3;PHLDA3;DENND1A;RUBCNL;ZFYVE26;ATG2B;KIF16B;NCF4;WDR45B;SNX13
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.3249054985662379,0.6460174076887398,0.8677685950413223,1.0,1.0,4/12,19.26%,SLC9A8;SLC9A9;SLC9A7;SLC9A6
prerank,snoRNA binding (GO:0030515),0.29179947592941136,0.6459875443722799,0.8877551020408163,1.0,1.0,6/30,17.99%,NOP10;NUDT4;UTP6;PRKDC;NOP58;DKC1
prerank,metal ion:proton antiporter activity (GO:0051139),0.3224307698822737,0.6454850375079261,0.8772169167803547,1.0,1.0,4/13,19.26%,SLC9A8;SLC9A9;SLC9A7;SLC9A6
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.2997182824826998,0.6442712134897178,0.8671497584541062,1.0,1.0,4/24,19.75%,SNX3;OSBPL5;RUBCNL;GOLPH3
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.2724338711861745,0.6411984040197549,0.9326424870466321,1.0,1.0,15/72,21.08%,STXBP6;PHLDA3;CGAS;GSN;FLII;ACTN2;PLCB1;KCNJ2;RAB35;PLCD1;LDLRAP1;AMER2;MAPKAP1;MARK1;SVIL
prerank,Notch binding (GO:0005112),-0.20692198180938892,-0.6390303092670755,0.9602272727272727,1.0,1.0,10/22,30.58%,GALNT11;JAG1;SNED1;MEGF10;AAK1;KCTD10;TCIM;JAG2;DLK2;NOTCH4
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.32603934763454384,0.6357283193404101,0.8551532033426184,1.0,1.0,5/12,20.76%,PNLDC1;CNOT1;CNOT6;CNOT8;CNOT7
prerank,protein tyrosine kinase activator activity (GO:0030296),0.30104852024527784,0.6342420944289854,0.8661616161616161,1.0,1.0,4/19,16.34%,ERBB3;EGF;PAK2;CD24
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.2936366833247612,0.6321756064339046,0.8846153846153846,1.0,1.0,8/25,26.52%,ART3;PARP14;SIRT1;SIRT4;PARP11;ZC3HAV1;PARP1;PARP9
prerank,iron ion binding (GO:0005506),0.276990586155252,0.6317586630782283,0.9065217391304348,1.0,1.0,5/48,7.94%,HAAO;RIOX1;HEPH;FTO;PHF2
prerank,wide pore channel activity (GO:0022829),-0.19216030442428558,-0.631192646408497,0.949685534591195,1.0,1.0,11/23,47.24%,GJA1;GJC2;GJB1;GJC1;GJD3;PANX2;PANX1;GJB2;GJD2;PRF1;GJA5
prerank,estrogen receptor binding (GO:0030331),0.2836017805446079,0.6262529716381714,0.9022988505747126,1.0,1.0,11/32,22.94%,LEF1;STRN;LATS1;CNOT1;MED1;DDX54;NCOA6;MMS19;NRIP1;PHB2;NSD1
prerank,anion channel activity (GO:0005253),0.271296449538337,0.6247083998536374,0.9243697478991597,1.0,1.0,7/61,10.79%,VDAC2;GABRA4;LRRC8B;CLIC1;LRRC8C;GABRA5;ANO3
prerank,death receptor activity (GO:0005035),0.3235431855600307,0.6242865511781448,0.8811881188118812,1.0,1.0,2/11,15.83%,FAS;TNFRSF11A
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.30810797268079765,0.6238981107876362,0.8796296296296297,1.0,1.0,4/15,14.94%,KMT2C;KMT2A;RBBP5;KMT2B
prerank,retinoic acid binding (GO:0001972),0.3108123185239415,0.6164046180385705,0.8756756756756757,1.0,1.0,1/12,10.29%,NR2F2
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.31769006148919926,0.6159963930239521,0.8994413407821229,1.0,1.0,4/11,19.40%,CASP2;CFLAR;CASP9;CASP8
prerank,phosphatidylinositol kinase activity (GO:0052742),0.30487980912811274,0.6138428539732459,0.9083769633507853,1.0,1.0,3/15,16.78%,ATM;PI4K2B;PIK3CA
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.29294701963935255,0.6130607166798714,0.8883312421580929,1.0,1.0,7/20,21.29%,AK9;MAGI3;AK3;AK6;CMPK2;AK2;CASK
prerank,gap junction channel activity (GO:0005243),-0.18760252203643757,-0.6078854958245594,0.9520958083832335,1.0,1.0,9/22,43.34%,GJA1;GJC2;GJB1;GJC1;GJD3;PANX2;PANX1;GJB2;GJD2
prerank,calcium ion binding (GO:0005509),0.2504297596815401,0.6078043030325809,0.99,1.0,1.0,53/323,20.94%,EFCAB11;SLC25A12;C2CD5;ITPR1;S100A11;PPP3CA;RCN3;S100A9;SYT8;RASGRP1;S100A8;GSN;CIB1;CDH18;CDH24;SMOC2;CAPN1;CEMIP2;MELK;DNER;MICU3;SYT3;SLIT3;SLIT1;CRACR2A;CANX;BAIAP3;TPM4;MICU1;ADGRL3;SLC25A13;TPT1;ANXA11;ADGRV1;GCA;NDUFAB1;CDH4;ACER3;TRPM4;CANT1;HSP90B1;MCTP1;SNCA;IQGAP1;NRXN1;S100A10;MMP12;PKD2;CDH20;CDH19;CDH7;CCDC47;SYT2
prerank,protein phosphorylated amino acid binding (GO:0045309),0.2663192686633376,0.6025167340796582,0.9269911504424779,1.0,1.0,13/42,22.99%,CRKL;PIN1;GRB2;PLCG2;CRK;IRS1;PTPN5;LDLRAP1;YWHAE;SYK;FGR;PTPN11;NEDD4
prerank,NF-kappaB binding (GO:0051059),0.27813780575620506,0.6024875170588325,0.8739290085679314,1.0,1.0,6/24,18.96%,CDKN2A;FAF1;CDK5RAP3;GSK3B;COMMD6;HDAC1
prerank,phosphate ion binding (GO:0042301),0.31730097059603296,0.6022164065165633,0.9053857350800583,1.0,1.0,2/10,19.48%,PDE2A;PNP
prerank,SH2 domain binding (GO:0042169),0.2696875958892974,0.595709534786446,0.9246813441483198,1.0,1.0,6/31,14.53%,CCDC88A;JAK2;CRK;RACK1;DAG1;IRS1
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.29798448371428377,0.5954483277793475,0.8930041152263375,1.0,1.0,3/13,25.12%,IDI1;SREBF2;MIF
prerank,voltage-gated calcium channel activity (GO:0005245),0.26452411015837346,0.5949981250260221,0.9229910714285714,1.0,1.0,8/37,21.12%,CACNA1I;CACNG5;ITGAV;CACNA1B;CACNG8;PKD2;CACHD1;CACNG4
prerank,histone demethylase activity (GO:0032452),0.277002783796885,0.5949240299419802,0.9242788461538461,1.0,1.0,7/27,20.42%,RIOX1;KDM3B;PHF2;KDM4C;JARID2;KDM2B;KDM2A
prerank,monocarboxylic acid binding (GO:0033293),0.28179191612236476,0.5924764790419121,0.9232704402515723,1.0,1.0,2/18,10.49%,NR2F2;NAPEPLD
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.20993476749944032,-0.592375414988688,0.9711538461538461,1.0,1.0,2/15,11.08%,ALDH7A1;ALDH1A1
prerank,translation initiation factor activity (GO:0003743),0.26060293455805333,0.5883187976839839,0.9440089585666294,1.0,1.0,3/36,5.29%,EIF2S1;EIF2A;EIF3E
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.30803241527685765,0.5828776197588103,0.9124087591240876,1.0,1.0,2/10,16.78%,ATM;PIK3CA
prerank,UDP-glycosyltransferase activity (GO:0008194),0.24996820274839435,0.5805393728631874,0.9525283797729618,1.0,1.0,6/70,9.89%,CSGALNACT2;HAS1;EXT1;GXYLT1;MFNG;B3GNT2
prerank,amyloid-beta binding (GO:0001540),0.24339922142129586,0.5789668789199248,0.9651639344262295,1.0,1.0,13/79,17.61%,IAPP;HSPG2;CD74;VBP1;PFDN5;GRIA3;TM2D1;TLR6;TGFB2;GRIA2;CACNA1B;FCGR2B;LDLRAP1
prerank,adenylyltransferase activity (GO:0070566),-0.18289620784221383,-0.5783519849589528,0.9854368932038835,1.0,1.0,8/21,27.61%,SELENOO;PAPOLG;NMNAT3;FLAD1;NMNAT1;MTPAP;NMNAT2;OASL
prerank,GTPase activity (GO:0003924),0.2355527851715377,0.5749941613334839,0.995,1.0,1.0,35/192,19.06%,RAB33B;GBP4;ATL2;ARHGDIB;RAB1B;RAB22A;RND3;GBP2;GNAI1;RAB8A;MTG2;GNAO1;RIT2;RHOU;GPN2;RAB8B;GFM2;RAB11B;RAB43;RAC2;RAB35;RAB2A;GNG11;EEF2;RAB5A;MMAA;RAC1;SEPTIN9;GSPT1;DRG1;LRRK2;GNB2;RAB6A;NKIRAS1;SAR1B
prerank,enoyl-CoA hydratase activity (GO:0004300),0.29818073987743243,0.5748027742204384,0.9093610698365527,1.0,1.0,3/10,18.76%,AUH;HADHA;HADHB
prerank,lysine N-methyltransferase activity (GO:0016278),-0.1901390961190088,-0.5720654902983389,0.9815668202764977,1.0,1.0,7/20,26.16%,SETD3;SETD4;METTL21A;EEF2KMT;EHMT2;ETFBKMT;ANTKMT
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.24546029273538247,0.5702855452772526,0.9452631578947368,1.0,1.0,11/57,20.68%,NDUFS8;CYBRD1;NDUFB7;COX10;COX4I1;NDUFA1;NDUFA4;NDUFA5;NDUFS1;NDUFS5;UQCRH
prerank,N-acetyltransferase activity (GO:0008080),-0.19053260120164195,-0.5696664589504797,0.9731182795698925,1.0,1.0,9/19,32.93%,SAT1;NAT8L;ESCO1;GNPNAT1;NAA10;NAT2;SAT2;NAA80;EP300
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.264371477960771,0.5687663675735942,0.926487747957993,1.0,1.0,4/26,18.34%,CSGALNACT2;B3GNT2;CHSY1;GBGT1
prerank,receptor tyrosine kinase binding (GO:0030971),0.24341427128507176,0.567701025103485,0.9477533960292581,1.0,1.0,11/56,20.54%,LRP4;PCNA;TRADD;PTPN14;RACK1;IRS1;TP53;ELMO2;MAP3K7;GRB14;FIZ1
prerank,cation channel activity (GO:0005261),0.23850531446208748,0.5665905037193969,0.9806122448979592,1.0,1.0,13/94,17.46%,P2RX1;AQP1;ANO10;TRPM7;KCNA1;MCU;PSEN1;SLC24A4;SLC24A2;HVCN1;UNC80;TRPM4;ANO6
prerank,dynactin binding (GO:0034452),0.2925689809904473,0.5659411567727013,0.9289544235924933,1.0,1.0,4/12,21.27%,PAFAH1B1;BBS4;GSK3B;MAPT
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.23776569140954287,0.5656130861856825,0.9755849440488301,1.0,1.0,19/91,21.27%,STXBP6;SNX3;PHLDA3;CGAS;GSN;FLII;ACTN2;PLCB1;KCNJ2;RAB35;PLCD1;LDLRAP1;AMER2;KIF16B;MAPKAP1;MARK1;WDR45B;SVIL;MAPT
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.2652840776105108,0.5653782434605333,0.9273399014778325,1.0,1.0,2/23,4.84%,SNX3;PHLDA3
prerank,cell adhesion mediator activity (GO:0098631),0.2617250135355214,0.5621186175872012,0.9379562043795621,1.0,1.0,4/24,17.07%,CD47;BSG;PALLD;EMB
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.25932755696676674,0.5584226438528349,0.9522673031026253,1.0,1.0,2/25,4.89%,PHLDA3;PLEKHA2
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.2537316741244444,0.5533026800478534,0.9466824644549763,1.0,1.0,5/24,19.00%,AK9;NME4;AK3;AK5;CMPK2
prerank,mechanosensitive ion channel activity (GO:0008381),0.2846612302866097,0.5501908474604755,0.9394812680115274,1.0,1.0,1/12,5.24%,TMC4
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.2003292459465681,-0.5393463981411796,0.9789029535864979,1.0,1.0,2/13,11.08%,ALDH7A1;ALDH1A1
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.2388792307284931,0.5383919851695832,0.9680170575692963,1.0,1.0,5/46,9.89%,EXT1;PIGA;MGAT2;MFNG;B3GNT2
prerank,voltage-gated chloride channel activity (GO:0005247),-0.2224246640067984,-0.5378423595181501,0.9690402476780186,1.0,1.0,4/10,29.57%,CLCN4;CLCN2;CLCN3;CLCN1
prerank,myosin binding (GO:0017022),0.23066715901591203,0.5378373291164309,0.9703075291622482,1.0,1.0,16/55,22.97%,GSN;RAB8A;MYBPC1;SHROOM4;HAP1;RAB11B;LMTK2;TRIOBP;CALD1;CXCR4;RAB6A;TRAK2;SHROOM1;RAB27B;NCKIPSD;RAB10
prerank,FAD binding (GO:0071949),0.24850258782564383,0.5361040981244081,0.9512195121951219,1.0,1.0,2/24,7.18%,KMO;PRODH
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.2099609528468156,-0.5318644363041604,0.9802371541501976,0.9961655609372244,1.0,7/13,42.47%,PYCARD;BMP6;BMP5;BMP2;BMP4;CDH5;BMP7
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.22187304381093922,0.5291603770032096,0.9867886178861789,1.0,1.0,19/100,21.27%,RACGAP1;SNX3;PHLDA3;OSBPL5;BTK;DENND1B;ARHGAP9;DENND1A;RUBCNL;ZFYVE26;ATG2B;IQGAP1;KIF16B;NCF4;MAPKAP1;GOLPH3;WDR45B;SNX13;MAPT
prerank,BMP receptor binding (GO:0070700),-0.20998760457695195,-0.5259516995348973,0.9710144927536232,0.9916024590992739,1.0,7/12,42.47%,PYCARD;BMP6;BMP5;BMP2;BMP4;CDH5;BMP7
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.2343848360397876,0.5255274533340877,0.9723451327433629,1.0,1.0,7/34,19.07%,NDUFS8;NDUFB7;NDUFA1;NDUFA4;NDUFA5;NDUFS1;NDUFS5
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.2343848360397876,0.5255274533340877,0.9723451327433629,1.0,1.0,7/34,19.07%,NDUFS8;NDUFB7;NDUFA1;NDUFA4;NDUFA5;NDUFS1;NDUFS5
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.23881833843747347,0.5227297533118411,0.9809750297265161,1.0,1.0,3/29,9.07%,HPSE2;GBA2;ENGASE
prerank,voltage-gated cation channel activity (GO:0022843),0.21546287240538475,0.5142600185895378,0.9917948717948718,1.0,1.0,17/97,21.57%,CACNA1I;HCN3;CACNG5;ITGAV;KCNA1;KCNC2;KCNH7;HVCN1;CACNA1B;KCNQ5;CACNG8;PKD2;KCNC1;CACHD1;CACNG4;KCNH8;GRIN2D
prerank,amino acid binding (GO:0016597),0.23219251390193246,0.5131415307331214,0.9710982658959537,1.0,1.0,1/31,2.63%,DDAH2
prerank,N-acyltransferase activity (GO:0016410),0.22639296508721524,0.500105199527026,0.9741282339707537,1.0,1.0,7/32,20.86%,CERS4;SIRT7;CERS6;SIRT1;NAT10;CERS2;NMT2
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.2546099450960796,0.49852973861003425,0.9676511954992968,1.0,1.0,2/12,16.78%,ATM;PIK3CA
prerank,ion gated channel activity (GO:0022839),0.23170396367416685,0.4936567669786701,0.9786729857819905,1.0,1.0,4/24,17.46%,ANO10;ANO3;TRPM4;ANO6
prerank,CXCR chemokine receptor binding (GO:0045236),0.25360954174513484,0.49219344431952905,0.9699453551912568,1.0,1.0,11/11,74.66%,ITCH;CXCL5;PPBP;CXCL13;CXCL2;CXCL1;CXCL9;CXCL10;CXCL12;PF4;YARS1
prerank,kinase inhibitor activity (GO:0019210),0.2221377040603865,0.4888349949422523,0.9773755656108597,1.0,1.0,12/33,28.61%,GMFG;PARVA;HEXIM1;SNCA;CDKN1A;DNAJC3;CDKN1B;NPM1;SH3BP5;SMCR8;MAPK8IP1;GSKIP
prerank,organic cation transmembrane transporter activity (GO:0015101),0.24106754835095578,0.485503585211582,0.9659520807061791,1.0,1.0,3/16,20.66%,SLC44A1;SLC22A4;SLC44A2
prerank,G protein-coupled receptor binding (GO:0001664),0.20028760356204306,0.4846676741365305,0.9949748743718593,1.0,1.0,10/132,13.02%,FLNA;GPRC5B;CCDC88C;GNAI1;INSL3;PICK1;GNAO1;ARRB2;S1PR2;GRK2
prerank,ion channel inhibitor activity (GO:0008200),0.2194161903368937,0.4835125146547826,0.9829931972789115,1.0,1.0,3/35,13.09%,ITPR1;NEDD4L;RACK1
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.18945955058906355,-0.4819795261412594,0.9855595667870036,0.9941301580921758,1.0,4/11,34.23%,SLC2A9;SLC5A11;SLC23A1;SLC23A2
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.23942878003845497,0.4628793968797812,0.9783783783783784,1.0,1.0,1/12,9.89%,B3GNT2
prerank,hexosyltransferase activity (GO:0016758),0.19496907997645635,0.46187541293172996,0.9959349593495935,1.0,1.0,25/101,26.70%,CSGALNACT2;HAS1;EXT1;GBA2;MFNG;B3GNT2;TMTC2;GBE1;POMT1;CHSY1;MTAP;PIGM;B3GLCT;POFUT1;GCNT1;MGAT4C;FUT9;TMTC4;POMT2;B3GALNT1;B4GALT3;PIGV;LFNG;B3GALT1;DPY19L1
prerank,potassium channel activity (GO:0005267),0.19200112388716364,0.4608932512042349,1.0,1.0,1.0,14/89,21.49%,AQP1;HCN3;KCNN4;KCNA1;KCNC2;KCNH7;KCNK12;KCNK2;KCNQ5;PKD2;KCNC1;GRIK5;GRIK3;KCNH8
prerank,potassium channel regulator activity (GO:0015459),0.1946447694420229,0.4538415778376825,0.9936373276776246,1.0,1.0,5/49,17.67%,FLNA;NEDD4L;SUMO1;SGK3;YWHAE
prerank,NAD binding (GO:0051287),0.20538692374535836,0.4463462785602448,0.9905100830367735,1.0,1.0,8/26,26.52%,HPGD;UXS1;SIRT1;CRYL1;ZC3HAV1;ALDH2;QDPR;PARP9
prerank,voltage-gated potassium channel activity (GO:0005249),0.1839896446489369,0.4418235503370848,0.997946611909651,1.0,1.0,13/80,22.19%,HCN3;KCNA1;KCNJ3;KCNC2;KCNH7;KCNJ2;KCNK2;KCNQ5;KCNJ10;PKD2;KCNC1;KCNH8;KCNN3
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.21472750732620782,0.4363850695630358,0.9827586206896551,1.0,1.0,3/14,20.86%,CAPN1;CAPN10;CAPN15
prerank,phosphatidylglycerol binding (GO:1901611),0.21229511488075664,0.4169144221438232,0.9904632152588556,1.0,1.0,2/13,19.90%,NME4;MME
prerank,ribonuclease P activity (GO:0004526),0.21701989883602862,0.4165049962242563,0.9915254237288136,1.0,1.0,3/11,22.78%,PRORP;POP4;RPP30
prerank,ephrin receptor activity (GO:0005003),0.17891195865424708,0.37043323321641736,0.9947575360419397,1.0,1.0,3/17,21.32%,EPHA3;EPHA7;EPHA10
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.17891195865424708,0.37043323321641736,0.9947575360419397,1.0,1.0,3/17,21.32%,EPHA3;EPHA7;EPHA10
prerank,phosphatidic acid binding (GO:0070300),0.17671218207836367,0.36566574758799636,0.9974937343358395,1.0,1.0,8/19,29.80%,PACSIN2;MAPKAP1;MARK1;RAPGEF6;RAPGEF2;OPA1;SMPD3;PITPNM1
prerank,delayed rectifier potassium channel activity (GO:0005251),0.16229060220034988,0.36193380329657887,1.0,1.0,1.0,4/32,19.98%,KCNA1;KCNC2;KCNQ5;KCNC1
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.16192502467642705,0.3256751944758577,1.0,1.0,1.0,3/14,22.78%,PRORP;POP4;RPP30
prerank,P-type ion transporter activity (GO:0015662),0.1658088654468593,0.32525311329077633,1.0,0.99969382899212,1.0,4/12,27.95%,ATP7A;ATP2B4;ATP2A2;ATP6V1E1
